<html class="turbolinks-progress-bar"><head><meta content="width=device-width, initial-scale=1, shrink-to-fit=no" name="viewport"><meta content="text/html; charset=UTF-8" http-equiv="Content-Type"><meta content="fdhmwDBTGwNPe0lKcJVly7AToLfZYvJ-mtjFAPTMZGs" name="google-site-verification"><meta content="296E0FF6379AE64A0D18C39BB40ECD6E" name="msvalidate.01"><meta content="DB00481" name="dc.identifier"><meta content="Raloxifene" name="dc.title"><meta content="Raloxifene is a selective estrogen receptor modulator that is used to prevent and treat osteoporosis and reduce the risk of invasive breast cancer in high-risk postmenopausal women." name="description"><link href="https://go.drugbank.com/drugs/DB00481" rel="canonical"><title>Raloxifene: Uses, Interactions, Mechanism of Action | DrugBank Online</title><link rel="apple-touch-icon" type="image/x-icon" href="/favicons/apple-touch-icon-57x57-precomposed.png" sizes="57x57"><link rel="apple-touch-icon" type="image/x-icon" href="/favicons/apple-touch-icon-60x60-precomposed.png" sizes="60x60"><link rel="apple-touch-icon" type="image/x-icon" href="/favicons/apple-touch-icon-72x72-precomposed.png" sizes="72x72"><link rel="apple-touch-icon" type="image/x-icon" href="/favicons/apple-touch-icon-76x76-precomposed.png" sizes="76x76"><link rel="apple-touch-icon" type="image/x-icon" href="/favicons/apple-touch-icon-114x114-precomposed.png" sizes="114x114"><link rel="apple-touch-icon" type="image/x-icon" href="/favicons/apple-touch-icon-120x120-precomposed.png" sizes="120x120"><link rel="apple-touch-icon" type="image/x-icon" href="/favicons/apple-touch-icon-144x144-precomposed.png" sizes="144x144"><link rel="apple-touch-icon" type="image/x-icon" href="/favicons/apple-touch-icon-152x152-precomposed.png" sizes="152x152"><link rel="apple-touch-icon" type="image/x-icon" href="/favicons/apple-touch-icon-180x180-precomposed.png" sizes="180x180"><link rel="apple-touch-icon" type="image/x-icon" href="/favicons/apple-touch-icon-precomposed.png" sizes="57x57"><link rel="apple-touch-icon" type="image/x-icon" href="/favicons/apple-touch-icon.png" sizes="57x57"><link rel="icon" type="image/png" href="/favicons/favicon-96x96.png" sizes="96x96"><link rel="icon" type="image/png" href="/favicons/favicon-32x32.png" sizes="32x32"><link rel="icon" type="image/png" href="/favicons/favicon-16x16.png" sizes="16x16"><link rel="icon" type="image/png" href="/favicons/favicon.png" sizes="16x16"><link rel="shortcut icon" type="image/x-icon" href="/favicons/favicon.ico"><meta content="#da532c" name="msapplication-TileColor"><meta content="/favicons/mstile-144x144.png" name="msapplication-TileImage"><meta content="#ffffff" name="theme-color"><meta content="DrugBank" name="application-name"><link as="font" crossorigin="" href="/assets/GemeliWeb-Regular-9ccb07b090f3aef673e3b29ba66e2e685ccf3d438e550624d9739f1bd5164cb2.woff2" rel="preload" type="font/woff2"><link as="font" crossorigin="" href="/assets/GemeliWeb-Bold-f344ff98a063f8cb6ac490b132bda4035ecc8984358dfa8d9bd8621fa38744e2.woff2" rel="preload" type="font/woff2"><link as="font" crossorigin="" href="/assets/GemeliWeb-Light-8227f53ee1957ae57cc0c81d1cfecb59238e3fd9d32b1e792432e1f8c81784a1.woff2" rel="preload" type="font/woff2"><link as="style" data-turbolinks-track="true" href="/assets/public_preload-7bb75340a5ff537e87bf7e9a8383724bc35f25c2f2b5d8e411fdd2a4a657bac3.css" media="all" onload="this.onload=null;this.rel='stylesheet'" rel="stylesheet"><noscript><link href="/assets/public_preload-7bb75340a5ff537e87bf7e9a8383724bc35f25c2f2b5d8e411fdd2a4a657bac3.css" media="all" rel="stylesheet" /></noscript><link rel="stylesheet" media="all" href="/assets/public-7ce82bb78ae55836a7f2a53437b0f77072d3139afdc068f210e726c7d69ac96a.css" data-turbolinks-track="true"><script type="text/javascript" async="" src="https://www.googleadservices.com/pagead/conversion_async.js"></script><script type="text/javascript" async="" src="https://snap.licdn.com/li.lms-analytics/insight.min.js"></script><script async="" src="https://f.clarity.ms/s/0.6.32/clarity.js"></script><script src="https://js.hsadspixel.net/fb.js" type="text/javascript" id="hs-ads-pixel-2224137" data-ads-portal-id="2224137" data-ads-env="prod" data-loader="hs-scriptloader" data-hsjs-portal="2224137" data-hsjs-env="prod" data-hsjs-hublet="na1"></script><script src="https://js.hs-analytics.net/analytics/1646930700000/2224137.js" type="text/javascript" id="hs-analytics"></script><script src="https://js.hs-banner.com/2224137.js" type="text/javascript" id="cookieBanner-2224137" data-cookieconsent="ignore" data-hs-ignore="true" data-loader="hs-scriptloader" data-hsjs-portal="2224137" data-hsjs-env="prod" data-hsjs-hublet="na1"></script><script async="" src="//www.google-analytics.com/analytics.js"></script><script async="" src="https://www.clarity.ms/tag/5600r08mxy"></script><script src="/assets/public-de346f4079123b7b086ddbb3dacbeacd104b373dfb9a9b48e26fc885e64a13ac.js" media="all" data-turbolinks-track="true" defer="defer"></script><script>(function(c,l,a,r,i,t,y){
    c[a]=c[a]||function(){(c[a].q=c[a].q||[]).push(arguments)};
    t=l.createElement(r);t.async=1;t.src="https://www.clarity.ms/tag/"+i;
    y=l.getElementsByTagName(r)[0];y.parentNode.insertBefore(t,y);
})(window, document, "clarity", "script", "5600r08mxy");</script><meta name="csrf-param" content="authenticity_token">
<meta name="csrf-token" content="DuMpYOSCX1GMlusOedsowXWRS00SLsWW8wN6VY_EPnYVFbDXKcVMowdYyjkZ1bofY13XcCqSMHOMhDf7KBriJA"><style>html.turbolinks-progress-bar::before {
  content: '';
  position: fixed;
  top: 0;
  left: 0;
  z-index: 2000;
  background-color: #0076ff;
  height: 3px;
  opacity: 0.99;
  width: 0%;
  transition: width 300ms ease-out, opacity 150ms ease-in;
  transform: translate3d(0,0,0);
}</style><script async="" src="https://www.googletagmanager.com/gtag/js?id=AW-704543816"></script><script src="https://googleads.g.doubleclick.net/pagead/viewthroughconversion/704543816/?random=1646930961780&amp;cv=9&amp;fst=1646930961780&amp;num=1&amp;bg=ffffff&amp;guid=ON&amp;resp=GooglemKTybQhCsO&amp;u_h=864&amp;u_w=1536&amp;u_ah=816&amp;u_aw=1536&amp;u_cd=24&amp;u_his=32&amp;u_tz=0&amp;u_java=false&amp;u_nplug=5&amp;u_nmime=2&amp;gtm=2oa370&amp;sendb=1&amp;ig=1&amp;data=event%3Dgtag.config&amp;frm=0&amp;url=https%3A%2F%2Fgo.drugbank.com%2Fdrugs%2FDB00481&amp;tiba=Raloxifene%3A%20Uses%2C%20Interactions%2C%20Mechanism%20of%20Action%20%7C%20DrugBank%20Online&amp;hn=www.googleadservices.com&amp;async=1&amp;rfmt=3&amp;fmt=4"></script></head><body class="drugs-c show-a has-banner"><header><nav class="navbar fixed-top navbar-expand-custom navbar-light" id="main-nav" style="background-color: #ff00b8;"><a class="navbar-brand" href="/"><img style="width: 178px; height: 20px;" src="/assets/logo-white-dd185d748ee0164b8ee8f88df29235cd8cfc7936a3c974589262c667e9294219.svg"><div class="online">Online</div></a><button aria-controls="navbar" aria-expanded="false" aria-label="Toggle navigation" class="navbar-toggler navbar-toggler-right" data-target="#navbar" data-toggle="collapse" type="button"><span class="navbar-toggler-icon"></span></button><div class="collapse navbar-collapse" id="navbar"><ul class="navbar-nav ml-auto"><li class="nav-item dropdown"><a class="nav-link dropdown-toggle" data-toggle="dropdown" href="#">Browse</a><div class="dropdown-menu"><a class="dropdown-item" href="/drugs"><div class="icon-circle drugbank-icon icon-drugs"><svg class="icon" role="img" title="drugs">
<use xlink:href="/assets/icons-539be351b538129271b9ee92cb0ebbd16efad4fccf6e2fe95aa6234f1e7417fa.svg#drugs"></use>
</svg>
</div> Drugs</a><a class="dropdown-item" href="/drugs/starred"><div class="icon-circle drugbank-icon icon-star-fill"><svg class="icon" role="img" title="star-fill">
<use xlink:href="/assets/icons-539be351b538129271b9ee92cb0ebbd16efad4fccf6e2fe95aa6234f1e7417fa.svg#star-fill"></use>
</svg>
</div> Starred Drugs</a><a class="dropdown-item" href="/categories"><div class="icon-circle drugbank-icon icon-categories"><svg class="icon" role="img" title="categories">
<use xlink:href="/assets/icons-539be351b538129271b9ee92cb0ebbd16efad4fccf6e2fe95aa6234f1e7417fa.svg#categories"></use>
</svg>
</div> Categories</a><a class="dropdown-item" href="/pathways"><div class="icon-circle drugbank-icon icon-pathways"><svg class="icon" role="img" title="pathways">
<use xlink:href="/assets/icons-539be351b538129271b9ee92cb0ebbd16efad4fccf6e2fe95aa6234f1e7417fa.svg#pathways"></use>
</svg>
</div> Pathways</a><a class="dropdown-item" href="/reactions"><div class="icon-circle drugbank-icon icon-reactions"><svg class="icon" role="img" title="reactions">
<use xlink:href="/assets/icons-539be351b538129271b9ee92cb0ebbd16efad4fccf6e2fe95aa6234f1e7417fa.svg#reactions"></use>
</svg>
</div> Drug Reactions</a><a class="dropdown-item" href="/classyfication"><div class="icon-circle drugbank-icon icon-classifications"><svg class="icon" role="img" title="classifications">
<use xlink:href="/assets/icons-539be351b538129271b9ee92cb0ebbd16efad4fccf6e2fe95aa6234f1e7417fa.svg#classifications"></use>
</svg>
</div> Drug Classification</a><a class="dropdown-item" href="/targets"><div class="icon-circle drugbank-icon icon-targets"><svg class="icon" role="img" title="targets">
<use xlink:href="/assets/icons-539be351b538129271b9ee92cb0ebbd16efad4fccf6e2fe95aa6234f1e7417fa.svg#targets"></use>
</svg>
</div> Drug Targets</a><div class="dropdown-divider"></div><a class="dropdown-item" href="/pharmaco/genomics"><div class="icon-circle drugbank-icon icon-geno-browse"><svg class="icon" role="img" title="geno-browse">
<use xlink:href="/assets/icons-539be351b538129271b9ee92cb0ebbd16efad4fccf6e2fe95aa6234f1e7417fa.svg#geno-browse"></use>
</svg>
</div> Pharmaco-genomics</a><a class="dropdown-item" href="/pharmaco/metabolomics"><div class="icon-circle drugbank-icon icon-chemquery"><svg class="icon" role="img" title="chemquery">
<use xlink:href="/assets/icons-539be351b538129271b9ee92cb0ebbd16efad4fccf6e2fe95aa6234f1e7417fa.svg#chemquery"></use>
</svg>
</div> Pharmaco-metabolomics</a><a class="dropdown-item" href="/pharmaco/transcriptomics"><div class="icon-circle drugbank-icon icon-interax"><svg class="icon" role="img" title="interax">
<use xlink:href="/assets/icons-539be351b538129271b9ee92cb0ebbd16efad4fccf6e2fe95aa6234f1e7417fa.svg#interax"></use>
</svg>
</div> Pharmaco-transcriptomics</a><a class="dropdown-item" href="/pharmaco/proteomics"><div class="icon-circle drugbank-icon icon-interax"><svg class="icon" role="img" title="interax">
<use xlink:href="/assets/icons-539be351b538129271b9ee92cb0ebbd16efad4fccf6e2fe95aa6234f1e7417fa.svg#interax"></use>
</svg>
</div> Pharmaco-proteomics</a></div></li><li class="nav-item dropdown"><a class="nav-link dropdown-toggle" data-toggle="dropdown" href="#">COVID-19</a><div class="dropdown-menu"><a class="dropdown-item" href="/covid-19"><div class="icon-circle drugbank-icon icon-covid-overview"><svg class="icon" role="img" title="covid-overview">
<use xlink:href="/assets/icons-539be351b538129271b9ee92cb0ebbd16efad4fccf6e2fe95aa6234f1e7417fa.svg#covid-overview"></use>
</svg>
</div> Overview</a><a class="dropdown-item" href="/covid-19-vaccination"><div class="icon-circle drugbank-icon icon-covid-vaccination"><svg class="icon" role="img" title="covid-vaccination">
<use xlink:href="/assets/icons-539be351b538129271b9ee92cb0ebbd16efad4fccf6e2fe95aa6234f1e7417fa.svg#covid-vaccination"></use>
</svg>
</div> Vaccine Side Effects</a></div></li><li class="nav-item dropdown"><a class="nav-link dropdown-toggle" data-toggle="dropdown" href="#">Search</a><div class="dropdown-menu"><a data-no-turbolink="true" class="dropdown-item" href="/structures/search/small_molecule_drugs/structure"><div class="icon-circle drugbank-icon icon-chemquery"><svg class="icon" role="img" title="chemquery">
<use xlink:href="/assets/icons-539be351b538129271b9ee92cb0ebbd16efad4fccf6e2fe95aa6234f1e7417fa.svg#chemquery"></use>
</svg>
</div> Chemical Structure</a><a data-no-turbolink="true" class="dropdown-item" href="/structures/search/small_molecule_drugs/mass"><div class="icon-circle drugbank-icon icon-molecular-weight"><svg class="icon" role="img" title="molecular-weight">
<use xlink:href="/assets/icons-539be351b538129271b9ee92cb0ebbd16efad4fccf6e2fe95aa6234f1e7417fa.svg#molecular-weight"></use>
</svg>
</div> Molecular Weight</a><a class="dropdown-item" href="/drug-interaction-checker"><div class="icon-circle drugbank-icon icon-interax"><svg class="icon" role="img" title="interax">
<use xlink:href="/assets/icons-539be351b538129271b9ee92cb0ebbd16efad4fccf6e2fe95aa6234f1e7417fa.svg#interax"></use>
</svg>
</div> Drug &amp; Food Interactions</a><a class="dropdown-item" data-no-turbolink="true" href="/structures/search/bonds/sequence"><div class="icon-circle drugbank-icon icon-sequence"><svg class="icon" role="img" title="sequence">
<use xlink:href="/assets/icons-539be351b538129271b9ee92cb0ebbd16efad4fccf6e2fe95aa6234f1e7417fa.svg#sequence"></use>
</svg>
</div> Target Sequences</a><a class="dropdown-item" data-no-turbolink="true" href="/pharmaco/search"><div class="icon-circle drugbank-icon icon-pathways"><svg class="icon" role="img" title="pathways">
<use xlink:href="/assets/icons-539be351b538129271b9ee92cb0ebbd16efad4fccf6e2fe95aa6234f1e7417fa.svg#pathways"></use>
</svg>
</div> Pharmaco-omics</a><a class="dropdown-item" href="/unearth/advanced/drugs"><div class="icon-circle drugbank-icon icon-advanced"><svg class="icon" role="img" title="advanced">
<use xlink:href="/assets/icons-539be351b538129271b9ee92cb0ebbd16efad4fccf6e2fe95aa6234f1e7417fa.svg#advanced"></use>
</svg>
</div> Advanced Search</a><div class="dropdown-divider"></div><a class="dropdown-item" href="/spectra/ms/search"><div class="icon-circle drugbank-icon icon-ms"><svg class="icon" role="img" title="ms">
<use xlink:href="/assets/icons-539be351b538129271b9ee92cb0ebbd16efad4fccf6e2fe95aa6234f1e7417fa.svg#ms"></use>
</svg>
</div> MS Search</a><a class="dropdown-item" href="/spectra/ms_ms/search"><div class="icon-circle drugbank-icon icon-msms"><svg class="icon" role="img" title="msms">
<use xlink:href="/assets/icons-539be351b538129271b9ee92cb0ebbd16efad4fccf6e2fe95aa6234f1e7417fa.svg#msms"></use>
</svg>
</div> MS/MS Search</a><a class="dropdown-item" href="/spectra/c_ms/search"><div class="icon-circle drugbank-icon icon-gcms"><svg class="icon" role="img" title="gcms">
<use xlink:href="/assets/icons-539be351b538129271b9ee92cb0ebbd16efad4fccf6e2fe95aa6234f1e7417fa.svg#gcms"></use>
</svg>
</div> GC/MS Search</a><a class="dropdown-item" href="/spectra/nmr_one_d/search"><div class="icon-circle drugbank-icon icon-nmr-1d"><svg class="icon" role="img" title="nmr-1d">
<use xlink:href="/assets/icons-539be351b538129271b9ee92cb0ebbd16efad4fccf6e2fe95aa6234f1e7417fa.svg#nmr-1d"></use>
</svg>
</div> 1D NMR Search</a><a class="dropdown-item" href="/spectra/nmr_two_d/search"><div class="icon-circle drugbank-icon icon-nmr-2d"><svg class="icon" role="img" title="nmr-2d">
<use xlink:href="/assets/icons-539be351b538129271b9ee92cb0ebbd16efad4fccf6e2fe95aa6234f1e7417fa.svg#nmr-2d"></use>
</svg>
</div> 2D NMR Search</a></div></li><li class="nav-item"><a class="nav-link" href="/drug-interaction-checker">Interaction Checker</a></li><li class="nav-item"><a class="nav-link" href="/releases/latest">Downloads</a></li><li class="nav-item dropdown" role="presentation"><a class="nav-link dropdown-toggle" data-toggle="dropdown" href="#">Solutions</a><div class="dropdown-menu"><div class="link-header dropdown-item">Products</div><div class="link-header dropdown-item blue-header">Commercial Research</div><a class="dropdown-item dropdown-item-last" target="_blank" href="https://www.drugbank.com/datasets"><div class="icon-pink product-icon drugbank-icon icon-scientific"><svg class="icon" role="img" title="scientific"> <use xlink:href="/assets/plus/icons-70333afa0729472c7516e40340ba51254bb889e8a9a12dcd9b4434a43b7ee583.svg#scientific"> </use></svg></div> Drug Datasets</a><div class="link-header dropdown-item blue-header">Academic Research</div><a class="dropdown-item dropdown-item-last" target="_blank" href="https://www.drugbank.com/academic_research"><div class="icon-pink product-icon drugbank-icon icon-academic"><svg class="icon" role="img" title="academic"> <use xlink:href="/assets/plus/icons-70333afa0729472c7516e40340ba51254bb889e8a9a12dcd9b4434a43b7ee583.svg#academic"> </use></svg></div> Drug Datasets</a><div class="dropdown-divider"></div><a class="dropdown-item dropdown-item-extra-padding" target="_blank" href="https://www.drugbank.com/clinical"><div class="icon-pink product-icon drugbank-icon icon-clinical"><svg class="icon" role="img" title="clinical"> <use xlink:href="/assets/plus/icons-70333afa0729472c7516e40340ba51254bb889e8a9a12dcd9b4434a43b7ee583.svg#clinical"> </use></svg></div> Clinical API</a><div class="link-header dropdown-item">Use Cases</div><a class="dropdown-item" target="_blank" href="https://www.drugbank.com/use_cases/ml-drug-discovery-repurposing">Drug Discovery &amp; Repurposing</a><a class="dropdown-item" target="_blank" href="https://www.drugbank.com/use_cases/in-silico-testing"><i>In Silico </i>Testing</a><a class="dropdown-item" target="_blank" href="https://www.drugbank.com/use_cases/precision_medicine">Precision Medicine</a><a class="dropdown-item" target="_blank" href="https://www.drugbank.com/use_cases/telehealth">Telehealth</a><a class="dropdown-item dropdown-item-last" target="_blank" href="https://www.drugbank.com/use_cases/electronic_medical_records">Electronic Medical Records</a><div class="link-header dropdown-item">Resources</div><a class="dropdown-item" target="_blank" href="https://www.drugbank.com/downloads">White Papers</a></div></li><li class="nav-item dropdown"><a class="nav-link dropdown-toggle" data-toggle="dropdown" href="#">About</a><div class="dropdown-menu right-menu"><div class="col-menu"><div class="menu-col"><div class="link-header dropdown-item"><a target="_blank" href="https://dev.drugbank.com/guides/index"><div class=" drugbank-icon icon-help_center"><svg class="icon" role="img" title="help_center"> <use xlink:href="/assets/plus/icons-70333afa0729472c7516e40340ba51254bb889e8a9a12dcd9b4434a43b7ee583.svg#help_center"> </use></svg></div> Help Center</a></div><a class="dropdown-item" target="_blank" href="https://dev.drugbank.com/guides/drugbank/citing"><div class="icon-circle drugbank-icon icon-citing"><svg class="icon" role="img" title="citing">
<use xlink:href="/assets/icons-539be351b538129271b9ee92cb0ebbd16efad4fccf6e2fe95aa6234f1e7417fa.svg#citing"></use>
</svg>
</div> Citing DrugBank</a><a class="dropdown-item" target="_blank" href="https://dev.drugbank.com/guides/faqs"><div class="icon-circle drugbank-icon icon-faq"><svg class="icon" role="img" title="faq">
<use xlink:href="/assets/icons-539be351b538129271b9ee92cb0ebbd16efad4fccf6e2fe95aa6234f1e7417fa.svg#faq"></use>
</svg>
</div> DrugBank Online FAQs</a><a class="dropdown-item" target="_blank" href="https://dev.drugbank.com/guides/drugbank/searching"><div class="icon-circle drugbank-icon icon-search"><svg class="icon" role="img" title="search">
<use xlink:href="/assets/icons-539be351b538129271b9ee92cb0ebbd16efad4fccf6e2fe95aa6234f1e7417fa.svg#search"></use>
</svg>
</div> Searching DrugBank</a><a class="dropdown-item" target="_blank" href="https://dev.drugbank.com/guides/drugbank/other_databases"><div class="icon-circle drugbank-icon icon-database"><svg class="icon" role="img" title="database">
<use xlink:href="/assets/icons-539be351b538129271b9ee92cb0ebbd16efad4fccf6e2fe95aa6234f1e7417fa.svg#database"></use>
</svg>
</div> Other Databases</a><a class="dropdown-item" target="_blank" href="https://dev.drugbank.com/guides/fields/drugs"><div class="icon-circle drugbank-icon icon-data-sources"><svg class="icon" role="img" title="data-sources">
<use xlink:href="/assets/icons-539be351b538129271b9ee92cb0ebbd16efad4fccf6e2fe95aa6234f1e7417fa.svg#data-sources"></use>
</svg>
</div> Data Sources</a></div><div class="menu-col"><div class="link-header dropdown-item"><div class=" drugbank-icon icon-quick_link"><svg class="icon" role="img" title="quick_link"> <use xlink:href="/assets/plus/icons-70333afa0729472c7516e40340ba51254bb889e8a9a12dcd9b4434a43b7ee583.svg#quick_link"> </use></svg></div> About</div><a class="dropdown-item" href="/about"><div class="icon-circle drugbank-icon icon-drugbank"><svg class="icon" role="img" title="drugbank">
<use xlink:href="/assets/icons-539be351b538129271b9ee92cb0ebbd16efad4fccf6e2fe95aa6234f1e7417fa.svg#drugbank"></use>
</svg>
</div> About DrugBank Online</a><a class="dropdown-item" target="_blank" href="https://dev.drugbank.com/publications"><div class="icon-circle drugbank-icon icon-search"><svg class="icon" role="img" title="search">
<use xlink:href="/assets/icons-539be351b538129271b9ee92cb0ebbd16efad4fccf6e2fe95aa6234f1e7417fa.svg#search"></use>
</svg>
</div> DrugBank in Research</a><a class="dropdown-item" href="/stats"><div class="icon-circle drugbank-icon icon-statistics"><svg class="icon" role="img" title="statistics">
<use xlink:href="/assets/icons-539be351b538129271b9ee92cb0ebbd16efad4fccf6e2fe95aa6234f1e7417fa.svg#statistics"></use>
</svg>
</div> Statistics</a><a class="dropdown-item" target="_blank" rel="noopener" href="https://blog.drugbank.com/"><div class="icon-circle drugbank-icon icon-news"><svg class="icon" role="img" title="news">
<use xlink:href="/assets/icons-539be351b538129271b9ee92cb0ebbd16efad4fccf6e2fe95aa6234f1e7417fa.svg#news"></use>
</svg>
</div> Blog</a><a target="_blank" rel="noopener" class="dropdown-item" href="http://www.wishartlab.com"><div class="icon-circle drugbank-icon icon-wishart"><svg class="icon" role="img" title="wishart">
<use xlink:href="/assets/icons-539be351b538129271b9ee92cb0ebbd16efad4fccf6e2fe95aa6234f1e7417fa.svg#wishart"></use>
</svg>
</div> Wishart Research Group</a><a class="dropdown-item" href="/contact"><div class="small-icon icon-circle drugbank-icon icon-paper-plane"><svg class="icon" role="img" title="paper-plane">
<use xlink:href="/assets/icons-539be351b538129271b9ee92cb0ebbd16efad4fccf6e2fe95aa6234f1e7417fa.svg#paper-plane"></use>
</svg>
</div> Contact Us</a></div></div></div></li></ul></div></nav><nav class="navbar fixed-top navbar-expand search-bar justify-content-center justify-content-sm-end d-flex"><div class="form-container"><form class="form-inline" action="/unearth/q" accept-charset="UTF-8" method="get"><div class="search-group d-none d-sm-block" style="margin-right: 0.5rem;"><select name="searcher" id="searcher" class="form-control input-md"><option value="drugs">Drugs</option>
<option value="bio_entities">Targets</option>
<option value="pathways">Pathways</option>
<option value="indications">Indications</option></select> <div class="drugbank-icon icon-arrow-down"><svg class="icon" role="img" title="arrow-down">
<use xlink:href="/assets/icons-539be351b538129271b9ee92cb0ebbd16efad4fccf6e2fe95aa6234f1e7417fa.svg#arrow-down"></use>
</svg>
</div> </div><div class="search-group"><input type="text" name="query" id="query" class="search-query"> <div class="drugbank-icon icon-search"><svg class="icon" role="img" title="search">
<use xlink:href="/assets/icons-539be351b538129271b9ee92cb0ebbd16efad4fccf6e2fe95aa6234f1e7417fa.svg#search"></use>
</svg>
</div> </div></form></div><div class="mini-banner banner-holder"><a target="_blank" href="https://www.drugbank.com/academic_research"><div class="banner-text"><span class="mr-3">Are you in academia? Check out our <b>free datasets</b> for students, professors, &amp; university labs!</span><span class="banner-link"><span>Learn more</span><div class="icon-circle drugbank-icon icon-arrow-right"><svg class="icon" role="img" title="arrow-right">
<use xlink:href="/assets/icons-539be351b538129271b9ee92cb0ebbd16efad4fccf6e2fe95aa6234f1e7417fa.svg#arrow-right"></use>
</svg>
</div></span></div></a><div class="close-banner"><div class="drugbank-icon icon-cross"><svg class="icon" role="img" title="cross">
<use xlink:href="/assets/icons-539be351b538129271b9ee92cb0ebbd16efad4fccf6e2fe95aa6234f1e7417fa.svg#cross"></use>
</svg>
</div></div></div></nav></header><main role="main"><div class="content-container"><div class="drug-content"><div class="sidebar"><a href="#" id="nav-button"><span>NAV<div class=" toggler"><svg class="hamburger" role="img" title="hamburger" viewBox="0 0 30 20" width="30" height="20"> <use xlink:href="/assets/plus/Mobile_Hamburger-f38f662ee947784bf77c5d4fd6d664e5d38434e2dfa967616cd85abaec045cbc.svg#hamburger"> </use></svg></div></span></a><div class="sidebar-content" style="max-height: 596px;"><div class="sidebar-search"><input type="text" name="sidebar_query" id="sidebar_query" class="search-query"> <div class="drugbank-icon icon-search"><svg class="icon" role="img" title="search">
<use xlink:href="/assets/icons-539be351b538129271b9ee92cb0ebbd16efad4fccf6e2fe95aa6234f1e7417fa.svg#search"></use>
</svg>
</div> </div><div class="accordion" id="drug-sidebar"><div class="card"><a class="sidebar-header sidebar-link" id="identification-sidebar-header" href="#identification-header" data-toggle="collapse" data-target="#identification-list">Identification</a><div class="sidebar-list collapse" data-parent="#drug-sidebar" id="identification-list"><a class="sidebar-link" href="#summary">Summary</a><a class="sidebar-link" href="#brand-names">Brand Names</a><a class="sidebar-link" href="#name">Name</a><a class="sidebar-link" href="#accession-number">Accession Number</a><a class="sidebar-link" href="#background">Background</a><a class="sidebar-link" href="#type">Type</a><a class="sidebar-link" href="#groups">Groups</a><a class="sidebar-link" href="#structure">Structure</a><a class="sidebar-link" href="#weight">Weight</a><a class="sidebar-link" href="#chemical-formula">Chemical Formula</a><a class="sidebar-link" href="#synonyms">Synonyms</a><a class="sidebar-link" href="#external-ids">External IDs</a></div></div><div class="card"><a class="sidebar-header sidebar-link" id="pharmacology-sidebar-header" href="#pharmacology-header" data-toggle="collapse" data-target="#pharmacology-list">Pharmacology</a><div class="sidebar-list collapse" data-parent="#drug-sidebar" id="pharmacology-list"><a class="sidebar-link" href="#indication">Indication</a><a class="sidebar-link" href="#associated-conditions">Associated Conditions</a><a class="sidebar-link" href="#contraindications-blackbox-warnings">Contraindications &amp; Blackbox Warnings</a><a class="sidebar-link" href="#pharmacodynamics">Pharmacodynamics</a><a class="sidebar-link" href="#mechanism-of-action">Mechanism of action</a><a class="sidebar-link" href="#absorption">Absorption</a><a class="sidebar-link" href="#volume-of-distribution">Volume of distribution</a><a class="sidebar-link" href="#protein-binding">Protein binding</a><a class="sidebar-link" href="#metabolism">Metabolism</a><a class="sidebar-link" href="#route-of-elimination">Route of elimination</a><a class="sidebar-link" href="#half-life">Half-life</a><a class="sidebar-link" href="#clearance">Clearance</a><a class="sidebar-link" href="#adverse-effects">Adverse Effects</a><a class="sidebar-link" href="#toxicity">Toxicity</a><a class="sidebar-link" href="#pathways">Pathways</a><a class="sidebar-link" href="#pharmacogenomic-effects-adrs">Pharmacogenomic Effects/ADRs</a></div></div><div class="card"><a class="sidebar-header sidebar-link" id="interactions-sidebar-header" href="#interactions-header" data-toggle="collapse" data-target="#interactions-list">Interactions</a><div class="sidebar-list collapse" data-parent="#drug-sidebar" id="interactions-list"><a class="sidebar-link" href="#drug-interactions">Drug Interactions</a><a class="sidebar-link" href="#food-interactions">Food Interactions</a></div></div><div class="card"><a class="sidebar-header sidebar-link" id="products-sidebar-header" href="#products-header" data-toggle="collapse" data-target="#products-list">Products</a><div class="sidebar-list collapse" data-parent="#drug-sidebar" id="products-list"><a class="sidebar-link" href="#product-ingredients">Product Ingredients</a><a class="sidebar-link" href="#product-images">Product Images</a><a class="sidebar-link" href="#international-other-brands">International/Other Brands</a><a class="sidebar-link" href="#brand-name-prescription-products">Brand Name Prescription Products</a><a class="sidebar-link" href="#generic-prescription-products">Generic Prescription Products</a><a class="sidebar-link" href="#unapproved-other-products">Unapproved/Other Products</a></div></div><div class="card"><a class="sidebar-header sidebar-link" id="categories-sidebar-header" href="#categories-header" data-toggle="collapse" data-target="#categories-list">Categories</a><div class="sidebar-list collapse" data-parent="#drug-sidebar" id="categories-list"><a class="sidebar-link" href="#atc-codes">ATC Codes</a><a class="sidebar-link" href="#drug-categories">Drug Categories</a><a class="sidebar-link" href="#chemical-taxonomy">Chemical Taxonomy</a><a class="sidebar-link" href="#affected-organisms">Affected organisms</a></div></div><div class="card"><a class="sidebar-header sidebar-link" id="chemical-identifiers-sidebar-header" href="#chemical-identifiers-header" data-toggle="collapse" data-target="#chemical-identifiers-list">Chemical Identifiers</a><div class="sidebar-list collapse" data-parent="#drug-sidebar" id="chemical-identifiers-list"><a class="sidebar-link" href="#unii">UNII</a><a class="sidebar-link" href="#cas-number">CAS number</a><a class="sidebar-link" href="#inchi-key">InChI Key</a><a class="sidebar-link" href="#inchi">InChI</a><a class="sidebar-link" href="#iupac-name">IUPAC Name</a><a class="sidebar-link" href="#smiles">SMILES</a></div></div><div class="card"><a class="sidebar-header sidebar-link" id="references-sidebar-header" href="#references-header" data-toggle="collapse" data-target="#references-list">References</a><div class="sidebar-list collapse" data-parent="#drug-sidebar" id="references-list"><a class="sidebar-link" href="#synthesis-reference">Synthesis Reference</a><a class="sidebar-link" href="#general-references">General References</a><a class="sidebar-link" href="#external-links">External Links</a><a class="sidebar-link" href="#pdb-entries">PDB Entries</a><a class="sidebar-link" href="#fda-label">FDA label</a><a class="sidebar-link" href="#msds">MSDS</a></div></div><div class="card"><a class="sidebar-header sidebar-link" id="clinical-trials-sidebar-header" href="#clinical-trials-header" data-toggle="collapse" data-target="#clinical-trials-list">Clinical Trials</a></div><div class="card"><a class="sidebar-header sidebar-link" id="pharmacoeconomics-sidebar-header" href="#pharmacoeconomics-header" data-toggle="collapse" data-target="#pharmacoeconomics-list">Pharmacoeconomics</a><div class="sidebar-list collapse" data-parent="#drug-sidebar" id="pharmacoeconomics-list"><a class="sidebar-link" href="#manufacturers">Manufacturers</a><a class="sidebar-link" href="#packagers">Packagers</a><a class="sidebar-link" href="#dosage-forms">Dosage Forms</a><a class="sidebar-link" href="#prices">Prices</a><a class="sidebar-link" href="#patents">Patents</a></div></div><div class="card"><a class="sidebar-header sidebar-link" id="properties-sidebar-header" href="#properties-header" data-toggle="collapse" data-target="#properties-list">Properties</a><div class="sidebar-list collapse" data-parent="#drug-sidebar" id="properties-list"><a class="sidebar-link" href="#state">State</a><a class="sidebar-link" href="#experimental-properties">Experimental Properties</a><a class="sidebar-link" href="#predicted-properties">Predicted Properties</a><a class="sidebar-link" href="#predicted-admet-features">Predicted ADMET Features</a></div></div><div class="card"><a class="sidebar-header sidebar-link" id="spectra-sidebar-header" href="#spectra-header" data-toggle="collapse" data-target="#spectra-list">Spectra</a><div class="sidebar-list collapse" data-parent="#drug-sidebar" id="spectra-list"><a class="sidebar-link" href="#mass-spec">Mass Spec</a><a class="sidebar-link" href="#spectra">Spectra</a></div></div><div class="card"><a class="sidebar-header sidebar-link" id="targets-sidebar-header" href="#targets">Targets (4)</a></div><div class="card"><a class="sidebar-header sidebar-link" id="enzymes-sidebar-header" href="#enzymes">Enzymes (8)</a></div><div class="card"><a class="sidebar-header sidebar-link" id="carriers-sidebar-header" href="#carriers">Carriers (2)</a></div><div class="card"><a class="sidebar-header sidebar-link" id="transporters-sidebar-header" href="#transporters">Transporters (7)</a></div></div></div></div><div class="drug-card"><div class="content-header d-sm-flex align-items-center"><h1 class="align-self-center mr-4">Raloxifene</h1><div class="page-actions ml-auto justify-content-sm-end mt-2 mt-sm-0"><div class="record-user-actions d-flex"><div class="record-watch-controls" id="record-watch-controls"><div aria-label="Watch an entry" class="btn-group ml-auto" role="group"><div class="btn-group" role="group"><button aria-expanded="false" aria-haspopup="true" class="btn btn-pink-filled dropdown-toggle" data-toggle="dropdown" type="button"><div class="drugbank-icon icon-eye"><svg class="icon" role="img" title="eye">
<use xlink:href="/assets/icons-539be351b538129271b9ee92cb0ebbd16efad4fccf6e2fe95aa6234f1e7417fa.svg#eye"></use>
</svg>
</div><strong class="pl-1">Watch</strong></button><div class="dropdown-menu"><a class="dropdown-item" href="/public_users/sign_in?record_watch_accession=DB00481"><div class="button-label" data-placement="left" data-toggle="watch-tooltip" title="You must be signed in to watch an entry">All Activity</div><small class="text-muted">Notified of all changes on this drug.</small></a><a class="dropdown-item" data-toggle="watch-tooltip" href="/public_users/sign_in?record_watch_accession=DB00481" title="You must be signed in to watch an entry"><div class="button-label">Major changes</div><small class="text-muted">Notified of marketing changes.</small></a></div></div><a aria-label="0 readers watchred this entry" class="btn btn-pink" href="#"><strong class="px-2">0</strong></a></div></div><div class="record-star-controls ml-2" id="record-star-controls"><div aria-label="Star an entry" class="btn-group ml-auto" role="group"><a class="btn btn-pink-filled d-flex justify-content-center d-md-table mx-auto" data-placement="left" data-toggle="star-tooltip" href="/public_users/sign_in?record_star_accession=DB00481" title="You must be signed in to star an entry"><div class="drugbank-icon icon-star"><svg class="icon" role="img" title="star">
<use xlink:href="/assets/icons-539be351b538129271b9ee92cb0ebbd16efad4fccf6e2fe95aa6234f1e7417fa.svg#star"></use>
</svg>
</div><strong class="pl-1">Star</strong></a><a aria-label="0 readers starred this entry" class="btn btn-pink" href="#"><strong class="px-2">0</strong></a></div></div></div></div></div><div class="card-content px-md-4 px-sm-2 pb-md-4 pb-sm-2"><h2 id="identification-header" class="section-header hidden-header">Identification</h2><dl><dt class="col-xl-2 col-md-3 col-sm-4" id="summary">Summary</dt><dd class="col-xl-10 col-md-9 col-sm-8"><p><strong>Raloxifene</strong> is a selective estrogen receptor modulator that is used to prevent and treat osteoporosis and reduce the risk of invasive breast cancer in high-risk postmenopausal women.</p></dd><dt class="col-xl-2 col-md-3 col-sm-4" id="brand-names">Brand Names</dt><dd class="col-xl-10 col-md-9 col-sm-8"><div class="truncate-overflow show-less"><em class="brand-list">Evista, Optruma</em><span class="truncate-btn" style="display: none;"></span></div></dd><dt class="col-xl-2 col-md-3 col-sm-4" id="generic-name">Generic Name</dt><dd class="col-xl-4 col-md-9 col-sm-8 pr-xl-2">Raloxifene</dd><dt class="col-xl-2 col-md-3 col-sm-4 pl-xl-2" id="drugbank-accession-number">DrugBank Accession Number</dt><dd class="col-xl-4 col-md-9 col-sm-8">DB00481</dd><dt class="col-xl-2 col-md-3 col-sm-4" id="background">Background</dt><dd class="col-xl-10 col-md-9 col-sm-8"><p>Raloxifene is a second generation selective estrogen receptor modulator (SERM) that mediates anti-estrogenic effects on breast and uterine tissues, and estrogenic effects on bone, lipid metabolism, and blood coagulation.<sup class="text-reference-group"><a class="reference-popover-link" data-content="Moen MD, Keating GM: Raloxifene: a review of its use in the prevention of invasive breast cancer. Drugs. 2008;68(14):2059-83. (PubMed ID 18778124)" href="#reference-A4979" data-original-title="" title="">6</a>,<a class="reference-popover-link" data-content="Rang, H. P. and Dale, M. M. (2012). Rang and Dale's Pharmacology  (7th ed.). Edinburgh: Elsevier/Churchill Livingstone. (ISBN 978-0-7020-3471-8)" href="#reference-T28" data-original-title="" title="">12</a></sup> Exhibiting tissue-specific effects distinct from <a href="https://go.drugbank.com/drugs/DB00783">estradiol</a>, raloxifene is the first of the benzothiophene group of antiestrogens to be labelled a SERM.<sup class="text-reference-group"><a class="reference-popover-link" data-content="Scott JA, Da Camara CC, Early JE: Raloxifene: a selective estrogen receptor modulator. Am Fam Physician. 1999 Sep 15;60(4):1131-9. (PubMed ID 10507743)" href="#reference-A4977" data-original-title="" title="">7</a></sup> Available in many countries worldwide, raloxifene was initially approved by the FDA in December, 1997 under the market name Evista® for the management and prevention of osteoporosis in postmenopausal women and reduction in risk for invasive breast cancer in postmenopausal women with osteoporosis or those who are at high risk for invasive breast cancer. However, it has a negligible effect on altering the development and progression of breast cancer itself.<sup class="text-reference-group"><a class="reference-popover-link" data-content="Official drug label" href="#label-reference" data-original-title="" title="">Label</a></sup> The most common causes of osteoporosis include postmenopausal deficiency of estrogen and age-related deterioration in bone homeostasis. Due to the risk of bone fractures that may lead to morbidities and reduced quality of life, the management of osteoporosis in postmenopausal women with the use of therapeutic agents in addition to concurrent therapies is critical. Due to the decline in estrogen levels in postmenopausal osteoporosis, hormone replacement therapy (HRT), such as estradiol, has been used to ameliorate the condition. However, due to the off-target actions by HRT, newer non-hormonal agents such as raloxifene and <a href="https://go.drugbank.com/drugs/DB00675">tamoxifen</a> have been developed to reduce adverse events through selective pharmacological actions on tissue-specific therapeutic targets.<sup class="text-reference-group"><a class="reference-popover-link" data-content="Rang, H. P. and Dale, M. M. (2012). Rang and Dale's Pharmacology  (7th ed.). Edinburgh: Elsevier/Churchill Livingstone. (ISBN 978-0-7020-3471-8)" href="#reference-T28" data-original-title="" title="">12</a></sup></p>
<p>The main effects of raloxifene are to preserve the bone mineral density and decrease the risk of breast cancer in postmenopausal women. Compared to estrogen and tamoxifen, raloxifene was not associated with an increased risk of uterine cancer and it does not cause endometrial proliferation.<sup class="text-reference-group"><a class="reference-popover-link" data-content="Heringa M: Review on raloxifene: profile of a selective estrogen receptor modulator. Int J Clin Pharmacol Ther. 2003 Aug;41(8):331-45. (PubMed ID 12940590)" href="#reference-A716" data-original-title="" title="">1</a></sup> Although rare, there was an increased risk of venous thromboembolism during clinical trials of postmenopausal women receiving raloxifene. In addition, a clinical study consisting of postmenopausal women with documented coronary heart disease or at increased risk for coronary events showed an increased risk for fatal stroke with raloxifene therapy compared to placebo.<sup class="text-reference-group"><a class="reference-popover-link" data-content="Official drug label" href="#label-reference" data-original-title="" title="">Label</a></sup> It is strongly advised that the risk-benefit ratio is considered before starting raloxifene therapy in women at risk of thromboembolic disease or strokes, such as the prior history of stroke, transient ischemic attack, atrial fibrillation, hypertension, or cigarette smoking.<sup class="text-reference-group"><a class="reference-popover-link" data-content="Official drug label" href="#label-reference" data-original-title="" title="">Label</a></sup></p>
</dd><dt class="col-xl-2 col-md-3 col-sm-4" id="type">Type</dt><dd class="col-xl-4 col-md-9 col-sm-8 pr-xl-2">Small Molecule</dd><dt class="col-xl-2 col-md-3 col-sm-4 pl-xl-2" id="groups">Groups</dt><dd class="col-xl-4 col-md-9 col-sm-8">Approved, Investigational</dd><dt class="col-xl-2 col-md-3 col-sm-4" id="structure">Structure</dt><dd class="col-xl-4 col-md-9 col-sm-8 pr-xl-2"><div class="structure"><a class="moldbi-vector-thumbnail" href="/structures/DB00481/image.svg"><img src="/structures/DB00481/thumb.svg"></a></div><div class="structure-links"><div class="btn-group btn-group-sm" data-no-turbolink=""><a data-toggle="modal" class="btn btn-outline-secondary" rel="nofollow" href="#structure-zoom"><div class="drugbank-icon icon-zoom-in"><svg class="icon" role="img" title="zoom-in">
<use xlink:href="/assets/icons-539be351b538129271b9ee92cb0ebbd16efad4fccf6e2fe95aa6234f1e7417fa.svg#zoom-in"></use>
</svg>
</div></a><a class="btn btn-outline-secondary" rel="nofollow" href="/structures/small_molecule_drugs/DB00481">3D</a><div class="btn-group btn-group-sm" id="structure-download"><button aria-expanded="false" aria-haspopup="true" class="btn btn-outline-secondary dropdown-toggle" data-toggle="dropdown" id="structure-download" type="button">Download </button><div aria-labelledby="structure-download" class="dropdown-menu"><a class="dropdown-item" rel="nofollow" href="/structures/small_molecule_drugs/DB00481.mol">MOL</a><a class="dropdown-item" rel="nofollow" href="/structures/small_molecule_drugs/DB00481.sdf">SDF</a><a class="dropdown-item" rel="nofollow" href="/structures/small_molecule_drugs/DB00481.sdf?type=3d">3D-SDF</a><a class="dropdown-item" rel="nofollow" href="/structures/small_molecule_drugs/DB00481.pdb">PDB</a><a class="dropdown-item" rel="nofollow" href="/structures/small_molecule_drugs/DB00481.smiles">SMILES</a><a class="dropdown-item" rel="nofollow" href="/structures/small_molecule_drugs/DB00481.inchi">InChI</a></div></div><a class="btn btn-outline-secondary" rel="nofollow" href="/structures/search/small_molecule_drugs/structure?database_id=DB00481&amp;search_type=similarity#results"><div class="drugbank-icon icon-chemquery"><svg class="icon" role="img" title="chemquery">
<use xlink:href="/assets/icons-539be351b538129271b9ee92cb0ebbd16efad4fccf6e2fe95aa6234f1e7417fa.svg#chemquery"></use>
</svg>
</div> Similar Structures</a></div><div class="modal fade" id="structure-zoom"><div class="modal-dialog modal-lg" role="document"><div class="modal-content"><div class="modal-header"><h4 class="modal-title">Structure for Raloxifene (DB00481)</h4><button aria-hidden="true" class="close" data-dismiss="modal" type="button"><span aria-hidden="true">×</span></button></div><div class="modal-body"><div class="d-flex justify-content-center"><img src="/structures/DB00481/image.svg"></div></div><div class="modal-footer"><button class="btn btn-default" data-dismiss="modal" type="button"> Close</button></div></div></div></div></div></dd><dl class="right-dl col-xl-6 col-lg-12"><dt class="col-xl-4 col-md-3 col-sm-4 pl-xl-2" id="weight">Weight</dt><dd class="col-xl-8 col-md-9 col-sm-8">Average: 473.583 <br>Monoisotopic: 473.166079047 </dd><dt class="col-xl-4 col-md-3 col-sm-4 pl-xl-2" id="chemical-formula">Chemical Formula</dt><dd class="col-xl-8 col-md-9 col-sm-8">C<sub>28</sub>H<sub>27</sub>NO<sub>4</sub>S</dd></dl><dt class="col-xl-2 col-md-3 col-sm-4" id="synonyms">Synonyms<a class="note table-toggle synonyms-toggle" href=""></a></dt><dd class="col-xl-10 col-md-9 col-sm-8 allow-overflow"><ul class="list-unstyled inline-list-break common-synonym-list"><li>(2-(4-Hydroxyphenyl)-6-hydroxybenzo(b)thien-3-yl)(4-(2-(1-piperidinyl)ethoxy)phenyl)methanone</li><li class="common">Raloxifène<div class="language-flag french" title="" data-original-title="French"></div></li><li class="common">Raloxifene</li><li class="common">Raloxifeno<div class="language-flag spanish" title="" data-original-title="Spanish"></div></li><li class="common">Raloxifenum<div class="language-flag latin" title="" data-original-title="Latin"></div></li></ul></dd><dt class="col-xl-2 col-md-3 col-sm-4" id="external-ids">External IDs <a tabindex="0" role="button" data-toggle="popover" data-content="Codes and identifiers used by other resources and companies, often used before choosing a marketing name." title="" id="external-identifiers-info" class="drug-info-popup" href="javascript:void(0);" data-original-title="About External Identifiers"><div class="drugbank-icon icon-information"><svg class="icon" role="img" title="information">
<use xlink:href="/assets/icons-539be351b538129271b9ee92cb0ebbd16efad4fccf6e2fe95aa6234f1e7417fa.svg#information"></use>
</svg>
</div></a><a class="note table-toggle" href=""><div class="icon-blue drugbank-icon icon-table"><svg class="icon" role="img" title="table">
<use xlink:href="/assets/icons-539be351b538129271b9ee92cb0ebbd16efad4fccf6e2fe95aa6234f1e7417fa.svg#table"></use>
</svg>
</div><div class="icon-blue drugbank-icon icon-list"><svg class="icon" role="img" title="list">
<use xlink:href="/assets/icons-539be351b538129271b9ee92cb0ebbd16efad4fccf6e2fe95aa6234f1e7417fa.svg#list"></use>
</svg>
</div></a></dt><dd class="col-xl-10 col-md-9 col-sm-8"><ul class="list-unstyled inline-list"><li>J22.982B</li>
<li>LY 139481</li>
<li>LY-139481</li></ul></dd></dl><h2 id="pharmacology-header" class="section-header">Pharmacology</h2><dl><dt class="col-xl-2 col-md-3 col-sm-4" id="indication">Indication</dt><dd class="col-xl-10 col-md-9 col-sm-8"><p>Indicated for the prevention and treatment of osteoporosis in postmenopausal women, as well as prevention and treatment of corticosteroid-induced bone loss.<sup class="text-reference-group"><a class="reference-popover-link" data-content="Official drug label" href="#label-reference" data-original-title="" title="">Label</a></sup></p>
<p>Indicated for the reduction in the risk of invasive breast cancer in postmenopausal women with osteoporosis or postmenopausal women with a high risk for invasive breast cancer.<sup class="text-reference-group"><a class="reference-popover-link" data-content="Official drug label" href="#label-reference" data-original-title="" title="">Label</a></sup></p>
<a class="locked-incopy track-link" target="_blank" data-link-id="locked/pharmacology-desktop-2" href="https://bit.ly/3l5TIQu?li=locked/pharmacology-desktop-2"><div class="incopy-left incopy-pharmacology"><img class="locked-pharmacology-img" src="/assets/locked/Pharmacology-fb0b317cceb9ebe868032aa87f450091c78706fb3ea0aad5bc263dda3db7a021.png"><div class="incopy-text pharmacology-text"><div class="title"><strong>Reduce drug development failure rates</strong></div><div class="subtitle"><strong>Build, train, &amp; validate machine-learning models</strong><br>with evidence-based and structured datasets.</div></div></div><div class="incopy-button btn btn-pink-filled">See how<div class=" drugbank-icon icon-see_more"><svg class="icon" role="img" title="see_more"> <use xlink:href="/assets/plus/icons-70333afa0729472c7516e40340ba51254bb889e8a9a12dcd9b4434a43b7ee583.svg#see_more"> </use></svg></div></div></a><a class="locked-incopy locked-incopy-mobile track-link" target="_blank" data-link-id="locked/pharmacology-mobile-2" href="https://bit.ly/3yeDgkJ?li=locked/pharmacology-mobile-2" style=""><div class="title">Build, train, &amp; validate predictive machine-learning models with structured datasets.</div><div class="button-container"><div class="incopy-button btn btn-pink-filled">See how</div></div></a></dd><dt class="col-xl-2 col-md-3 col-sm-4" id="associated-conditions">Associated Conditions<a class="note table-toggle" href=""><div class="icon-blue drugbank-icon icon-table"><svg class="icon" role="img" title="table">
<use xlink:href="/assets/icons-539be351b538129271b9ee92cb0ebbd16efad4fccf6e2fe95aa6234f1e7417fa.svg#table"></use>
</svg>
</div><div class="icon-blue drugbank-icon icon-list"><svg class="icon" role="img" title="list">
<use xlink:href="/assets/icons-539be351b538129271b9ee92cb0ebbd16efad4fccf6e2fe95aa6234f1e7417fa.svg#list"></use>
</svg>
</div></a></dt><dd class="col-xl-10 col-md-9 col-sm-8"><ul class="list-unstyled inline-list"><li><a href="/indications/DBCOND0037365">Invasive Breast Cancer</a></li>
<li><a href="/indications/DBCOND0015928">Osteoporosis</a></li>
<li><a href="/indications/DBCOND0022002">Osteoporosis caused by glucocorticoid</a></li></ul></dd><dt class="col-xl-2 col-md-3 col-sm-4" id="contraindications-blackbox-warnings">Contraindications &amp; Blackbox Warnings</dt><dd class="col-xl-10 col-md-9 col-sm-8"><a class="locked-incopy track-link" target="_blank" data-link-id="locked/contraindications-4" href="https://bit.ly/3l7in7x?li=locked/contraindications-4"><div class="incopy-left incopy-contraindications"><img class="locked-contraindications-img" src="/assets/locked/Contraindications-703de7931a118c8a7155ed9794980af9aab5ab60b4091bbf501e7524634ca922.png"><div class="incopy-text contraindications-text"><div class="title"><strong>Avoid life-threatening adverse drug events</strong></div><div class="subtitle">Improve clinical decision support with information on <strong>contraindications &amp; blackbox warnings, population restrictions, harmful risks, &amp; more.</strong></div></div></div><div class="incopy-button btn btn-pink-filled">Learn more<div class=" drugbank-icon icon-see_more"><svg class="icon" role="img" title="see_more"> <use xlink:href="/assets/plus/icons-70333afa0729472c7516e40340ba51254bb889e8a9a12dcd9b4434a43b7ee583.svg#see_more"> </use></svg></div></div></a><a class="locked-incopy locked-incopy-mobile track-link" target="_blank" data-link-id="locked/contraindications-4" href="https://bit.ly/2US5HGY?li=locked/contraindications-4" style=""><div class="title">Avoid life-threatening adverse drug events &amp; improve clinical decision support.</div><div class="button-container"><div class="incopy-button btn btn-pink-filled">Learn more</div></div></a></dd><dt class="col-xl-2 col-md-3 col-sm-4" id="pharmacodynamics">Pharmacodynamics</dt><dd class="col-xl-10 col-md-9 col-sm-8"><p>Raloxifene belongs to the selective estrogen receptor modulator (SERM) drug class that exhibits estrogenic effects on bone and lipid metabolism while mediating anti-estrogenic effects on uterine endometrium and breast tissues.<sup class="text-reference-group"><a class="reference-popover-link" data-content="Scott JA, Da Camara CC, Early JE: Raloxifene: a selective estrogen receptor modulator. Am Fam Physician. 1999 Sep 15;60(4):1131-9. (PubMed ID 10507743)" href="#reference-A4977" data-original-title="" title="">7</a></sup> On skeletal tissues, raloxifene stimulates bone-depositing osteoblasts and inhibits bone-resorbing osteoclasts<sup class="text-reference-group"><a class="reference-popover-link" data-content="Rang, H. P. and Dale, M. M. (2012). Rang and Dale's Pharmacology  (7th ed.). Edinburgh: Elsevier/Churchill Livingstone. (ISBN 978-0-7020-3471-8)" href="#reference-T28" data-original-title="" title="">12</a></sup> to augument bone mineral density.<sup class="text-reference-group"><a class="reference-popover-link" data-content="Scott JA, Da Camara CC, Early JE: Raloxifene: a selective estrogen receptor modulator. Am Fam Physician. 1999 Sep 15;60(4):1131-9. (PubMed ID 10507743)" href="#reference-A4977" data-original-title="" title="">7</a></sup> Raloxifene produces estrogen-like effects on bone, reducing the resorption of bone and increasing bone mineral density in postmenopausal women, thus slowing the rate of bone loss.<sup class="text-reference-group"><a class="reference-popover-link" data-content="Official drug label" href="#label-reference" data-original-title="" title="">Label</a></sup> In three randomized, placebo-controlled trials in Europe, postmenopausal women receiving raloxifene at variable doses of 30 to 150 mg daily demonstrated significant increases in bone mineral density in the lumbar spine, total hip, femoral neck and total body compared to placebo.<sup class="text-reference-group"><a class="reference-popover-link" data-content="Scott JA, Da Camara CC, Early JE: Raloxifene: a selective estrogen receptor modulator. Am Fam Physician. 1999 Sep 15;60(4):1131-9. (PubMed ID 10507743)" href="#reference-A4977" data-original-title="" title="">7</a></sup> In the MORE and RUTH trials, there were fewer incidences of vertebral fractures in postmeopausal women receiving raloxifene compared to placebo.<sup class="text-reference-group"><a class="reference-popover-link" data-content="Moen MD, Keating GM: Raloxifene: a review of its use in the prevention of invasive breast cancer. Drugs. 2008;68(14):2059-83. (PubMed ID 18778124)" href="#reference-A4979" data-original-title="" title="">6</a></sup> In a eight-week study evaluating short-term effects of raloxifene in healthy postmenopausal women, there was a decrease in the bone turnover markers, such as serum alkaline phosphatase level, serum osteocalcin level and urinary calcium excretion.<sup class="text-reference-group"><a class="reference-popover-link" data-content="Scott JA, Da Camara CC, Early JE: Raloxifene: a selective estrogen receptor modulator. Am Fam Physician. 1999 Sep 15;60(4):1131-9. (PubMed ID 10507743)" href="#reference-A4977" data-original-title="" title="">7</a></sup> </p>
<p>Raloxifene was shown to inhibit estrogen-dependent proliferation of human breast cancer cells <em>in vitro</em> and development of induced mammary tumors in rats <em>in vivo</em>.<sup class="text-reference-group"><a class="reference-popover-link" data-content="Balfour JA, Goa KL: Raloxifene. Drugs Aging. 1998 Apr;12(4):335-41; discussion 342. (PubMed ID 9571395)" href="#reference-A721" data-original-title="" title="">4</a></sup> In adult female rats, raloxifene produced a greater regression of the mammary gland than <a href="https://go.drugbank.com/drugs/DB00675">tamoxifen</a>.<sup class="text-reference-group"><a class="reference-popover-link" data-content="Balfour JA, Goa KL: Raloxifene. Drugs Aging. 1998 Apr;12(4):335-41; discussion 342. (PubMed ID 9571395)" href="#reference-A721" data-original-title="" title="">4</a></sup> The MORE trial was a multicenter, randomized, double-blind clinical trial that investigated the long-term effects of the drug therapy in European and American postmenopausal women receiving raloxifene for 40 months.<sup class="text-reference-group"><a class="reference-popover-link" data-content="Cummings SR, Eckert S, Krueger KA, Grady D, Powles TJ, Cauley JA, Norton L, Nickelsen T, Bjarnason NH, Morrow M, Lippman ME, Black D, Glusman JE, Costa A, Jordan VC: The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple Outcomes of Raloxifene Evaluation. JAMA. 1999 Jun 16;281(23):2189-97. (PubMed ID 10376571)" href="#reference-A719" data-original-title="" title="">2</a></sup> Additionally, a reduction in the incidence of invasive breast cancer was also demonstrates in the CORE and RUTH trials.<sup class="text-reference-group"><a class="reference-popover-link" data-content="Moen MD, Keating GM: Raloxifene: a review of its use in the prevention of invasive breast cancer. Drugs. 2008;68(14):2059-83. (PubMed ID 18778124)" href="#reference-A4979" data-original-title="" title="">6</a></sup> Study findings demonstrated that compared to placebo, the risk of invasive breast cancer was decreased by 76% among postmenopausal women with osteoporosis. There was a decrease in the risk of estrogen receptor-positive breast cancer by 90% but there was no increase in the risk of endometrial cancer. Unlike hormone replacement therapy, raloxifene does not mediate proliferative or stimulatory effects on endometrial tissue. Findings from both animal and human studies demonstrated no significant changes in the histologic appearance of the endometrium.<sup class="text-reference-group"><a class="reference-popover-link" data-content="Scott JA, Da Camara CC, Early JE: Raloxifene: a selective estrogen receptor modulator. Am Fam Physician. 1999 Sep 15;60(4):1131-9. (PubMed ID 10507743)" href="#reference-A4977" data-original-title="" title="">7</a></sup></p>
<p>Raloxifene promotes estrogen-like effects on lipid metabolism. In a European trial that evaluated lipid profiles following raloxifene therapy over the 24-month period, there were significant decreases in the serum concentrations of total and low-density lipoprotein (LDL) cholesterol over a 24-month period of raloxifene therapy.<sup class="text-reference-group"><a class="reference-popover-link" data-content="Scott JA, Da Camara CC, Early JE: Raloxifene: a selective estrogen receptor modulator. Am Fam Physician. 1999 Sep 15;60(4):1131-9. (PubMed ID 10507743)" href="#reference-A4977" data-original-title="" title="">7</a></sup> Raloxifene is not associated with causing alterations in the serum levels of HDL cholesterol or triglycerides.<sup class="text-reference-group"><a class="reference-popover-link" data-content="Scott JA, Da Camara CC, Early JE: Raloxifene: a selective estrogen receptor modulator. Am Fam Physician. 1999 Sep 15;60(4):1131-9. (PubMed ID 10507743)" href="#reference-A4977" data-original-title="" title="">7</a></sup> As the HDL choesterol level is considered a strong inverse predictor of cardiovascular disease in women, the cardioprotective effects of raloxifene were questioned. Due to limited data on the long-term trials, it is not possible to determine whether the small lipid effects produced by raloxifene correlate with a smaller degree of cardioprotective activity compared with hormone replacement therapy.<sup class="text-reference-group"><a class="reference-popover-link" data-content="Scott JA, Da Camara CC, Early JE: Raloxifene: a selective estrogen receptor modulator. Am Fam Physician. 1999 Sep 15;60(4):1131-9. (PubMed ID 10507743)" href="#reference-A4977" data-original-title="" title="">7</a></sup> </p>
</dd><dt class="col-xl-2 col-md-3 col-sm-4" id="mechanism-of-action">Mechanism of action</dt><dd class="col-xl-10 col-md-9 col-sm-8"><p>Raloxifene is a selective estrogen receptor modulator that acts as both an estrogen agonist and antagonist via differential effects on the tissue-specific estrogen receptors. Based on the findings of competitive binding assays, raloxifene displays binding affinity that is similar to that of <a href="https://go.drugbank.com/drugs/DB00783">estradiol</a><sup class="text-reference-group"><a class="reference-popover-link" data-content="Balfour JA, Goa KL: Raloxifene. Drugs Aging. 1998 Apr;12(4):335-41; discussion 342. (PubMed ID 9571395)" href="#reference-A721" data-original-title="" title="">4</a></sup>, the predominant circulating estrogen.<sup class="text-reference-group"><a class="reference-popover-link" data-content="Palmisano BT, Zhu L, Stafford JM: Role of Estrogens in the Regulation of Liver Lipid Metabolism. Adv Exp Med Biol. 2017;1043:227-256. doi: 10.1007/978-3-319-70178-3_12. (PubMed ID 29224098)" href="#reference-A178861" data-original-title="" title="">9</a></sup> Estrogens play variable roles at different tissues in females, including the bone, breasts, uterus and liver, by binding to the steroid nuclear hormone receptors, Estrogen Receptor alpha (ERα) or Estrogen Receptor beta (ERβ).<sup class="text-reference-group"><a class="reference-popover-link" data-content="Palmisano BT, Zhu L, Stafford JM: Role of Estrogens in the Regulation of Liver Lipid Metabolism. Adv Exp Med Biol. 2017;1043:227-256. doi: 10.1007/978-3-319-70178-3_12. (PubMed ID 29224098)" href="#reference-A178861" data-original-title="" title="">9</a></sup> These receptors are normally bound to the Heat Shock Protein 90 (Hsp90) when unbound to the ligand. Ligand binding induces a conformational change in the receptor that promotes dissociation of the receptor from Hsp90, dimerization and translocation into the nucleus. This movement into the nucleus allows the receptor to bind to genomic locations based on sequence recognition of the DNA binding domain, also known as the Estrogen Response Elements (EREs).<sup class="text-reference-group"><a class="reference-popover-link" data-content="Palmisano BT, Zhu L, Stafford JM: Role of Estrogens in the Regulation of Liver Lipid Metabolism. Adv Exp Med Biol. 2017;1043:227-256. doi: 10.1007/978-3-319-70178-3_12. (PubMed ID 29224098)" href="#reference-A178861" data-original-title="" title="">9</a></sup> </p>
<p>In bones, endogenous estrogens normally modulate multiple DNA response elements, including the gene-encoding transforming growth factor-β3 (TGF-β3), which is a cytokine embedded in the bone matrix.<sup class="text-reference-group"><a class="reference-popover-link" data-content="Rang, H. P. and Dale, M. M. (2012). Rang and Dale's Pharmacology  (7th ed.). Edinburgh: Elsevier/Churchill Livingstone. (ISBN 978-0-7020-3471-8)" href="#reference-T28" data-original-title="" title="">12</a></sup> TGF-β3 plays an important role in bone remodelling<sup class="text-reference-group"><a class="reference-popover-link" data-content="Yang NN, Venugopalan M, Hardikar S, Glasebrook A: Identification of an estrogen response element activated by metabolites of 17beta-estradiol and raloxifene. Science. 1996 Aug 30;273(5279):1222-5. (PubMed ID 8703055)" href="#reference-A178756" data-original-title="" title="">8</a></sup> by working with other cytokines to induce production of osteoblasts, such as IL-6<sup class="text-reference-group"><a class="reference-popover-link" data-content="Bryant HU, Glasebrook AL, Yang NN, Sato M: An estrogen receptor basis for raloxifene action in bone. J Steroid Biochem Mol Biol. 1999 Apr-Jun;69(1-6):37-44. (PubMed ID 10418979)" href="#reference-A720" data-original-title="" title="">3</a></sup>, and attenuate the activity of osetoclasts. Estrogens typically maintain the bone integrity by inhibiting the cytokines that recruit osteoclasts and oppose the bone-resorbing, Ca2+-mobilizing action of parathyroid hormone. In contrast, estrogens promote osteoblast proliferation, augment the production of TGF-β3 and bone morphogenic proteins, and inhibit apoptosis.<sup class="text-reference-group"><a class="reference-popover-link" data-content="Rang, H. P. and Dale, M. M. (2012). Rang and Dale's Pharmacology  (7th ed.). Edinburgh: Elsevier/Churchill Livingstone. (ISBN 978-0-7020-3471-8)" href="#reference-T28" data-original-title="" title="">12</a></sup> Mimicking the action of endogenous estrogen in bone tissues, raloxifene binds to the estrogen receptor to influence gene transcription through interactions with the estrogen response element (ERE) and a distinct DNA target, the raloxifene response element (RRE).<sup class="text-reference-group"><a class="reference-popover-link" data-content="Clemett D, Spencer CM: Raloxifene: a review of its use in postmenopausal osteoporosis. Drugs. 2000 Aug;60(2):379-411. (PubMed ID 10983739)" href="#reference-A722" data-original-title="" title="">5</a></sup> It occupies the same ER ligand binding site as estrogen.<sup class="text-reference-group"><a class="reference-popover-link" data-content="Diez-Perez A: Selective estrogen receptor modulators (SERMS). Arq Bras Endocrinol Metabol. 2006 Aug;50(4):720-34. (PubMed ID 17117297)" href="#reference-A724" data-original-title="" title="">11</a></sup> Upon binding, raloxifene induces a conformational change of the receptor, allowing mediation of direct binding to transcriptional elements by accessory proteins. Increased expression of bone matrix proteins, such as alkaline phosphatase, osteonectin, osteocalcin and collagen may be seen.<sup class="text-reference-group"><a class="reference-popover-link" data-content="Clemett D, Spencer CM: Raloxifene: a review of its use in postmenopausal osteoporosis. Drugs. 2000 Aug;60(2):379-411. (PubMed ID 10983739)" href="#reference-A722" data-original-title="" title="">5</a></sup> The agonistic or antagonistic action of raloxifene depends on the extent of recruitment of coactivators and corepressors to estrogen receptor (ER) target gene promotors.<sup class="text-reference-group"><a class="reference-popover-link" data-content="Official drug label" href="#label-reference" data-original-title="" title="">Label</a></sup> In breast tissues, raloxifene acts as an estrogen receptor antagonist to attenuate the estrogen-dependent proliferative effects of epithelial cell expansion. In addition to the antiproliferative effects, raloxifene prevents the production of cytokines and recruitment of macrophages and lymphocytes into tumor mass.<sup class="text-reference-group"><a class="reference-popover-link" data-content="Yaghjyan L, Colditz GA: Estrogens in the breast tissue: a systematic review. Cancer Causes Control. 2011 Apr;22(4):529-40. doi: 10.1007/s10552-011-9729-4. Epub 2011 Feb 1. (PubMed ID 21286801)" href="#reference-A178921" data-original-title="" title="">10</a></sup></p>
<table class="table table-sm responsive-table" id="drug-moa-target-table"><thead><tr><th>Target</th><th>Actions</th><th>Organism</th></tr></thead><tbody><tr><td><span class="badge badge-pill badge-yes mr-2 tips" title="" data-original-title="Pharmacologically Active">A</span><a href="#BE0000123">Estrogen receptor alpha</a></td><td><div class="badge badge-default">agonist</div></td><td>Humans</td></tr><tr><td><span class="badge badge-pill badge-yes mr-2 tips" title="" data-original-title="Pharmacologically Active">A</span><a href="#BE0000792">Estrogen receptor beta</a></td><td><div class="badge badge-default">agonist</div></td><td>Humans</td></tr><tr><td><span class="badge badge-pill badge-unknown mr-2 tips" title="" data-original-title="Pharmacological Action Unknown">U</span><a href="#BE0008982">Serpin B9</a></td><td><span class="not-available">Not Available</span></td><td>Humans</td></tr><tr><td><span class="badge badge-pill badge-unknown mr-2 tips" title="" data-original-title="Pharmacological Action Unknown">U</span><a href="#BE0008981">Trefoil factor 1</a></td><td><span class="not-available">Not Available</span></td><td>Humans</td></tr></tbody></table></dd><dt class="col-xl-2 col-md-3 col-sm-4" id="absorption">Absorption</dt><dd class="col-xl-10 col-md-9 col-sm-8"><p>Raloxifene is well absorbed from the gastrointestinal tract, with approximately 60% fo the drug being absorbed following oral administration.<sup class="text-reference-group"><a class="reference-popover-link" data-content="Rang, H. P. and Dale, M. M. (2012). Rang and Dale's Pharmacology  (7th ed.). Edinburgh: Elsevier/Churchill Livingstone. (ISBN 978-0-7020-3471-8)" href="#reference-T28" data-original-title="" title="">12</a></sup> Due to the extensive first-pass hepatic metabolism that involves glucuronide conjugation, the absolute oral bioavailability of raloxifene is about 2%.<sup class="text-reference-group"><a class="reference-popover-link" data-content="Rang, H. P. and Dale, M. M. (2012). Rang and Dale's Pharmacology  (7th ed.). Edinburgh: Elsevier/Churchill Livingstone. (ISBN 978-0-7020-3471-8)" href="#reference-T28" data-original-title="" title="">12</a></sup> Following oral ingestion of a single dose or multiple dose of raloxifen in healthy postmenopausal women, the mean peak plasma concentrations (Cmax) were 0.50 and 1.36 ng/mL, respectively, and the AUC values were 27.2 and 24.2 ngxhr/mL, respectively. The time to reach Cmax following a single or multiple oral doses were 27.7 and 32.5 hours, respectively.<sup class="text-reference-group"><a class="reference-popover-link" data-content="Official drug label" href="#label-reference" data-original-title="" title="">Label</a></sup> Although not clinically significant, oral ingestion of raloxifene with high-fat meals is thought to increase the systemic bioavailability of the drug<sup class="text-reference-group"><a class="reference-popover-link" data-content="Scott JA, Da Camara CC, Early JE: Raloxifene: a selective estrogen receptor modulator. Am Fam Physician. 1999 Sep 15;60(4):1131-9. (PubMed ID 10507743)" href="#reference-A4977" data-original-title="" title="">7</a></sup> by increasnig the peak plasma concentrations (Cmax) and AUC by 28% and 16%, respectively.<sup class="text-reference-group"><a class="reference-popover-link" data-content="Official drug label" href="#label-reference" data-original-title="" title="">Label</a></sup></p>
</dd><dt class="col-xl-2 col-md-3 col-sm-4" id="volume-of-distribution">Volume of distribution</dt><dd class="col-xl-10 col-md-9 col-sm-8"><p>Following oral administration of single doses randing from 30 to 150 mg in postmenopausal women, the volume of distribution was about 2348 L/kg. Following oral administration of multiple doses, the value increased to 2853 L/kg. Raloxifene is widely distributed in the tissues. It is not known whether raloxifene is excreted in human milk.<sup class="text-reference-group"><a class="reference-popover-link" data-content="Official drug label" href="#label-reference" data-original-title="" title="">Label</a></sup> </p>
</dd><dt class="col-xl-2 col-md-3 col-sm-4" id="protein-binding">Protein binding</dt><dd class="col-xl-10 col-md-9 col-sm-8"><p>About 95% of raloxifene and its glucuronide metabolites are bound to plasma proteins.<sup class="text-reference-group"><a class="reference-popover-link" data-content="Official drug label" href="#label-reference" data-original-title="" title="">Label</a></sup> Although this is a relatively high protein binding profile, <em>in vitro</em> studies suggest that raloxifene and its metabolites do not significantly interact with binding of highly protein-bound drugs.<sup class="text-reference-group"><a class="reference-popover-link" data-content="Scott JA, Da Camara CC, Early JE: Raloxifene: a selective estrogen receptor modulator. Am Fam Physician. 1999 Sep 15;60(4):1131-9. (PubMed ID 10507743)" href="#reference-A4977" data-original-title="" title="">7</a></sup> FDA Label still advises patients to use raloxifene with caution co-administering with other highly protein-bound drugs.<sup class="text-reference-group"><a class="reference-popover-link" data-content="Official drug label" href="#label-reference" data-original-title="" title="">Label</a></sup></p>
</dd><dt class="col-xl-2 col-md-3 col-sm-4" id="metabolism">Metabolism</dt><dd class="col-xl-10 col-md-9 col-sm-8"><p>Raloxifene is reported to undergo metabolism in the intestines and liver devoid of cytochrome P450 pathway.<sup class="text-reference-group"><a class="reference-popover-link" data-content="Scott JA, Da Camara CC, Early JE: Raloxifene: a selective estrogen receptor modulator. Am Fam Physician. 1999 Sep 15;60(4):1131-9. (PubMed ID 10507743)" href="#reference-A4977" data-original-title="" title="">7</a></sup> It is extensively metabolized, where less than 1% of the total dose exists as unchanged compound.<sup class="text-reference-group"><a class="reference-popover-link" data-content="Official drug label" href="#label-reference" data-original-title="" title="">Label</a></sup> It mainly undergoes first-pass metabolism to form glucuronide conjugates, raloxifene-4'-glucuronide (raloxifene-4'-β-glucuronide), raloxifene-6-glucuronide (raloxifene-6-β-glucuronide), and raloxifene-6,4'-diglucuronide. No other metabolites have been detected in human plasma. The terminal log-linear portions of the plasma concentration curves for raloxifene and the glucuronides are generally parallel. This is consistent with interconversion of raloxifene and the glucuronide metabolites.<sup class="text-reference-group"><a class="reference-popover-link" data-content="Official drug label" href="#label-reference" data-original-title="" title="">Label</a></sup></p>
<p class="d-none d-sm-block"><strong>Hover over products below to view reaction partners</strong></p><ul class="list-unstyled metabolite-pathway"><li><span class="metabolite" data-metabolite-id="481">Raloxifene</span><ul class="list-unstyled"><li data-parent-id="481"><div class="drugbank-icon icon-list-arrow"><svg class="icon" role="img" title="list-arrow">
<use xlink:href="/assets/icons-539be351b538129271b9ee92cb0ebbd16efad4fccf6e2fe95aa6234f1e7417fa.svg#list-arrow"></use>
</svg>
</div><a class="metabolite" data-metabolite-id="3355" href="/reactions/3586">Raloxifene-4′-glucuronide</a> + <a class="metabolite" data-metabolite-id="3364" href="/reactions/3586">Raloxifene-6, 4′-diglucuronide</a> + <a class="metabolite" data-metabolite-id="3349" href="/reactions/3586">Raloxifene-6-glucuronide</a></li></ul></li></ul></dd><dt class="col-xl-2 col-md-3 col-sm-4" id="route-of-elimination">Route of elimination</dt><dd class="col-xl-10 col-md-9 col-sm-8"><p>Raloxifene predominantly undergoes fecal excretion, with less than 0.2% of the dose being excreted in the urine as unchanged form of the compound and less than 6% of the dose being excreted as glucuronide conjugates. Co-administration with <a href="https://go.drugbank.com/drugs/DB01432">cholestyramine</a>, a bile acid sequestrant, was shown to reduce the enterohepatic recycling of raloxifene by 60%.<sup class="text-reference-group"><a class="reference-popover-link" data-content="Rang, H. P. and Dale, M. M. (2012). Rang and Dale's Pharmacology  (7th ed.). Edinburgh: Elsevier/Churchill Livingstone. (ISBN 978-0-7020-3471-8)" href="#reference-T28" data-original-title="" title="">12</a></sup></p>
</dd><dt class="col-xl-2 col-md-3 col-sm-4" id="half-life">Half-life</dt><dd class="col-xl-10 col-md-9 col-sm-8"><p>The average plasma elimination half-life of raloxifene ranges from 27 to 32 hours.<sup class="text-reference-group"><a class="reference-popover-link" data-content="Scott JA, Da Camara CC, Early JE: Raloxifene: a selective estrogen receptor modulator. Am Fam Physician. 1999 Sep 15;60(4):1131-9. (PubMed ID 10507743)" href="#reference-A4977" data-original-title="" title="">7</a>,<a class="reference-popover-link" data-content="Rang, H. P. and Dale, M. M. (2012). Rang and Dale's Pharmacology  (7th ed.). Edinburgh: Elsevier/Churchill Livingstone. (ISBN 978-0-7020-3471-8)" href="#reference-T28" data-original-title="" title="">12</a></sup> The prolonged half-life has been attributed to the drug's reversible systemic metabolism and significant enterohepatic cycling.<sup class="text-reference-group"><a class="reference-popover-link" data-content="Scott JA, Da Camara CC, Early JE: Raloxifene: a selective estrogen receptor modulator. Am Fam Physician. 1999 Sep 15;60(4):1131-9. (PubMed ID 10507743)" href="#reference-A4977" data-original-title="" title="">7</a></sup></p>
</dd><dt class="col-xl-2 col-md-3 col-sm-4" id="clearance">Clearance</dt><dd class="col-xl-10 col-md-9 col-sm-8"><p>Following intravenous administration, raloxifene was shown to be cleared at a rate approximating hepatic blood flow. The apparent oral clearance is reported to be 44.1 L/kgxhr. The clearance can range from 40 to 60L/kgxhr following chronic dosing. In healthy postmenopausal women receiving multiple oral dose, the mean clearance was 47.4 L/kgxhr. Apparent clearance can be reduced by 56% in patients with hepatic impairment.<sup class="text-reference-group"><a class="reference-popover-link" data-content="Official drug label" href="#label-reference" data-original-title="" title="">Label</a></sup></p>
</dd><dt class="col-xl-2 col-md-3 col-sm-4" id="adverse-effects">Adverse Effects</dt><dd class="col-xl-10 col-md-9 col-sm-8"><a class="locked-incopy track-link" target="_blank" data-link-id="locked/adverse-effects-4" href="https://bit.ly/3rGqlWb?li=locked/adverse-effects-4"><div class="incopy-left incopy-adverseeffects"><img class="locked-adverseeffects-img" src="/assets/locked/AdverseEffects-37e38307d7a0e56f1351d8c6540669aa1ac302bb3a4d74e7b5b6ef7c4a95f515.png"><div class="incopy-text adverseeffects-text"><div class="title"><strong>Improve decision support &amp; research outcomes</strong></div><div class="subtitle">With structured adverse effects data, including: <strong>blackbox warnings, adverse reactions, warning &amp; precautions, &amp; incidence rates.</strong></div></div></div><div class="incopy-button btn btn-pink-filled">Learn more<div class=" drugbank-icon icon-see_more"><svg class="icon" role="img" title="see_more"> <use xlink:href="/assets/plus/icons-70333afa0729472c7516e40340ba51254bb889e8a9a12dcd9b4434a43b7ee583.svg#see_more"> </use></svg></div></div></a><a class="locked-incopy locked-incopy-mobile track-link" target="_blank" data-link-id="locked/adverse-effects-4" href="https://bit.ly/2VkZH9d?li=locked/adverse-effects-4" style=""><div class="title">Improve decision support &amp; research outcomes with our structured adverse effects data.</div><div class="button-container"><div class="incopy-button btn btn-pink-filled">Learn more</div></div></a></dd><dt class="col-xl-2 col-md-3 col-sm-4" id="toxicity">Toxicity</dt><dd class="col-xl-10 col-md-9 col-sm-8"><p><strong>LD<sub>50</sub> and Overdose</strong></p>
<p>The oral LD<sub>50</sub> value in rats is &gt; 5000 mg/kg, which is about 810 times the human dose.<sup class="text-reference-group"><a class="reference-popover-link" data-content="Material Safety Data Sheet" href="#msds-reference" data-original-title="" title="">MSDS</a></sup> In monkeys, no mortality was seen after a single oral dose of 1000 mg/kg.<sup class="text-reference-group"><a class="reference-popover-link" data-content="Official drug label" href="#label-reference" data-original-title="" title="">Label</a></sup> No cases of raloxifene overdose have been reported during clinical trials. A rare postmarketing report of a non-fatal overdose after oral ingestion of 1.5 g has been reported. Common adverse events of leg cramps, hot flushes, and dizziness have been reported with the use of raloxifene at doses of greater than 180 mg. More serious adverse event of venous thromboembolic events were observed with raloxifene.<sup class="text-reference-group"><a class="reference-popover-link" data-content="Balfour JA, Goa KL: Raloxifene. Drugs Aging. 1998 Apr;12(4):335-41; discussion 342. (PubMed ID 9571395)" href="#reference-A721" data-original-title="" title="">4</a></sup> Two 18-month-old children accidentally ingested 180 mg of raloxifene and symptoms of ataxia, dizziness, vomiting, rash, diarrhea, tremor, flushing, and elevated alkaline phosphatase levels were reported. There is no known antidote for raloxifene. <sup class="text-reference-group"><a class="reference-popover-link" data-content="Official drug label" href="#label-reference" data-original-title="" title="">Label</a></sup> </p>
<p><strong>Nonclinical Toxicology</strong></p>
<p>In a two-year mouse carcinogenicity study at raloxifene doses that are higher than the human therapeutic doses, there was an increased incidence of benign and malignant ovarian tumors of granulosa or theca cell origin. Another study showed an increased incidence of testicular interstitial cell tumors, prostatic adenomas, adenocarcinomas, and prostatic leiomyoblastoma in male mice receiving doses higher than human therapeutic doses. There was no evidence of the genotoxic potential of raloxifene in bacterial mutagenicity assays, <em>in vitro</em> rat DNA assays, or other <em>in vitro</em> rodent cell line assays. When assessing effects on the reproductive system of male and female rats, raloxifene caused lack of pregnancy and disruptions in estrous cycles and inhibited ovulation at dose of 0.1 to 10 mg/kg/day. Administration of raloxifene during the preimplantation period at doses greater than 0.1 mg/kg resulted in delayed and disrupted embryo implantation, further leading to prolonged gestation and reduced litter size. There were no effects on sperm production or quality or reproductive performance in male rats. The effects on the fertility by raloxifene were reversible.<sup class="text-reference-group"><a class="reference-popover-link" data-content="Official drug label" href="#label-reference" data-original-title="" title="">Label</a></sup> </p>
<p><strong>Use in special populations</strong></p>
<p>The use of raloxifene in pregnant or nursing women is not advised. Although there are no specific dosing adjustment guidelines, caution should be undertaken when administering raloxifene in geriatric patients or patients with renal or hepatic impairment.<sup class="text-reference-group"><a class="reference-popover-link" data-content="Official drug label" href="#label-reference" data-original-title="" title="">Label</a></sup></p>
</dd><dt class="col-xl-2 col-md-3 col-sm-4" id="pathways">Pathways</dt><dd class="col-xl-10 col-md-9 col-sm-8"><span class="not-available">Not Available</span></dd><dt class="col-xl-2 col-md-3 col-sm-4" id="pharmacogenomic-effects-adrs">Pharmacogenomic Effects/ADRs <a tabindex="0" role="button" data-toggle="popover" data-content="SNP Mediated Pharmacological Effects and Adverse Drug Reactions (ADRs) is a compilation of drug-specific pharmacogenomic information from various sources and primary literature. — <a target=&quot;_blank&quot; href=&quot;/snp_actions&quot;>Browse all</a>" title="" id="snp-actions-info" class="drug-info-popup" href="javascript:void(0);" data-original-title="About SNP Mediated Effects/ADRs"><div class="drugbank-icon icon-information"><svg class="icon" role="img" title="information">
<use xlink:href="/assets/icons-539be351b538129271b9ee92cb0ebbd16efad4fccf6e2fe95aa6234f1e7417fa.svg#information"></use>
</svg>
</div></a></dt><dd class="col-xl-10 col-md-9 col-sm-8"><span class="not-available">Not Available</span></dd></dl><h2 id="interactions-header" class="section-header">Interactions</h2><dl><dt class="col-xl-2 col-md-3 col-sm-4" id="drug-interactions">Drug Interactions <a tabindex="0" role="button" data-toggle="popover" data-content="Drug-drug interactions extracted from drug labels and scientific publications. The commercial version includes severity and basis for interaction. — <a target=&quot;_blank&quot; href=&quot;https://www.drugbank.com/scientific&quot;>Learn More</a>" title="" id="structured-interactions-info" class="drug-info-popup" href="javascript:void(0);" data-original-title="About Drug Interactions"><div class="drugbank-icon icon-information"><svg class="icon" role="img" title="information">
<use xlink:href="/assets/icons-539be351b538129271b9ee92cb0ebbd16efad4fccf6e2fe95aa6234f1e7417fa.svg#information"></use>
</svg>
</div></a></dt><dd class="col-xl-10 col-md-9 col-sm-8"><div class="alert alert-danger">This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist. </div><ul class="nav nav-tabs drug-interaction-tabs"><li class="interactions approved nav-item"><a class="toggle-row-display nav-link active" data-source="/drugs/DB00481/drug_interactions.json?group=approved" href="#show-approved">Approved</a></li><li class="interactions approved nav-item"><a class="toggle-row-display nav-link " data-source="/drugs/DB00481/drug_interactions.json?group=vet_approved" href="#show-vet_approved">Vet approved</a></li><li class="interactions approved nav-item"><a class="toggle-row-display nav-link " data-source="/drugs/DB00481/drug_interactions.json?group=nutraceutical" href="#show-nutraceutical">Nutraceutical</a></li><li class="interactions approved nav-item"><a class="toggle-row-display nav-link " data-source="/drugs/DB00481/drug_interactions.json?group=illicit" href="#show-illicit">Illicit</a></li><li class="interactions approved nav-item"><a class="toggle-row-display nav-link " data-source="/drugs/DB00481/drug_interactions.json?group=withdrawn" href="#show-withdrawn">Withdrawn</a></li><li class="interactions approved nav-item"><a class="toggle-row-display nav-link " data-source="/drugs/DB00481/drug_interactions.json?group=investigational" href="#show-investigational">Investigational</a></li><li class="interactions approved nav-item"><a class="toggle-row-display nav-link " data-source="/drugs/DB00481/drug_interactions.json?group=experimental" href="#show-experimental">Experimental</a></li><li class="interactions index nav-item"><a class="toggle-row-display nav-link" data-source="/drugs/DB00481/drug_interactions.json" href="#show-all">All Drugs</a></li></ul><div class="drug-interaction-table has-locked-panel"><table class="table table-sm dt-responsive datatable-remote" data-source="/drugs/DB00481/drug_interactions.json?group=approved" data-total="417" id="drug-interactions-table" style="width: 100%"><thead><tr><th class="head-sm">Drug</th><th>Interaction</th></tr><tr class="unlock-interactions-row"><th class="no-sort" colspan="2"><div class="locked-link" data-target="#locked-interactions-modal" data-toggle="modal">Integrate drug-drug <br>interactions in your software<div class="drugbank-icon icon-plus"><svg class="icon" role="img" title="plus">
<use xlink:href="/assets/icons-539be351b538129271b9ee92cb0ebbd16efad4fccf6e2fe95aa6234f1e7417fa.svg#plus"></use>
</svg>
</div></div></th></tr></thead><tbody><tr><td><a href="/drugs/DB12001">Abemaciclib</a></td><td>The metabolism of Abemaciclib can be decreased when combined with Raloxifene.</td></tr><tr><td><a href="/drugs/DB11703">Acalabrutinib</a></td><td>The metabolism of Acalabrutinib can be decreased when combined with Raloxifene.</td></tr><tr><td><a href="/drugs/DB01418">Acenocoumarol</a></td><td>The serum concentration of Acenocoumarol can be increased when it is combined with Raloxifene.</td></tr><tr><td><a href="/drugs/DB06151">Acetylcysteine</a></td><td>The excretion of Raloxifene can be decreased when combined with Acetylcysteine.</td></tr><tr><td><a href="/drugs/DB00173">Adenine</a></td><td>The metabolism of Raloxifene can be decreased when combined with Adenine.</td></tr><tr><td><a href="/drugs/DB08916">Afatinib</a></td><td>Afatinib may decrease the excretion rate of Raloxifene which could result in a higher serum level.</td></tr><tr><td><a href="/drugs/DB00518">Albendazole</a></td><td>The metabolism of Albendazole can be decreased when combined with Raloxifene.</td></tr><tr><td><a href="/drugs/DB11363">Alectinib</a></td><td>The metabolism of Alectinib can be decreased when combined with Raloxifene.</td></tr><tr><td><a href="/drugs/DB00346">Alfuzosin</a></td><td>The metabolism of Alfuzosin can be decreased when combined with Raloxifene.</td></tr><tr><td><a href="/drugs/DB00918">Almotriptan</a></td><td>The metabolism of Almotriptan can be decreased when combined with Raloxifene.</td></tr></tbody></table><div class="locked-panel-holder" data-for="#drug-interactions-table"><div class="locked-interactions-content"><img class="locked-interactions-img" src="/assets/locked/Interactions-a0b9baf74954e8e26155347c9fde26bca0898cecdb887b212605f778364855c2.png"><div class="locked-panel-header">Identify potential medication risks</div><div class="locked-panel-subheader">Easily compare up to 40 drugs with our drug interaction checker.</div><div class="locked-panel-subheader"><strong>Get severity rating, description, and management advice. </strong></div><a class="btn btn-pink-filled track-link" target="_blank" data-link-id="locked/drug-interactions-desktop-2" href="https://bit.ly/3iW94Vb?li=locked/drug-interactions-desktop-2">Learn more <div class=" drugbank-icon icon-see_more"><svg class="icon" role="img" title="see_more"> <use xlink:href="/assets/plus/icons-70333afa0729472c7516e40340ba51254bb889e8a9a12dcd9b4434a43b7ee583.svg#see_more"> </use></svg></div></a></div></div></div></dd><dt class="col-xl-2 col-md-3 col-sm-4" id="food-interactions">Food Interactions</dt><dd class="col-xl-10 col-md-9 col-sm-8"><ul class="list-unstyled table-list"><li>Avoid excessive or chronic alcohol consumption. Excessive and chronic alcohol consumption may be associated with vitamin D deficiency.</li>
<li>Take with or without food. The absorption is unaffected by food.</li></ul></dd></dl><h2 id="products-header" class="section-header">Products</h2><dl><dt class="col-xl-2 col-md-3 col-sm-4"></dt><dd class="col-xl-10 col-md-9 col-sm-8"><a class="locked-incopy track-link" target="_blank" data-link-id="locked/products-desktop-2" href="https://bit.ly/3jfwN2X?li=locked/products-desktop-2"><div class="incopy-left incopy-products2"><img class="locked-products2-img" src="/assets/locked/Products2-edc20e8268d35c9156660b16a7756bc2ba8eede8248449398cdfd75016ea3ade.png"><div class="incopy-text products2-text"><div class="title"><strong>Drug product information from 10+ global regions</strong></div><div class="subtitle">Our datasets provide approved product information including:<br><strong>dosage, form, labeller, route of administration, and marketing period.</strong></div></div></div><div class="incopy-button btn btn-pink-filled">Access now<div class=" drugbank-icon icon-see_more"><svg class="icon" role="img" title="see_more"> <use xlink:href="/assets/plus/icons-70333afa0729472c7516e40340ba51254bb889e8a9a12dcd9b4434a43b7ee583.svg#see_more"> </use></svg></div></div></a><a class="locked-incopy locked-incopy-mobile track-link" target="_blank" data-link-id="locked/products-mobile-2" href="https://bit.ly/3rDRysG?li=locked/products-mobile-2" style=""><div class="title">Access drug product information from over 10 global regions.</div><div class="button-container"><div class="incopy-button btn btn-pink-filled">Access now</div></div></a></dd><dt class="col-xl-2 col-md-3 col-sm-4" id="product-ingredients">Product Ingredients <a tabindex="0" role="button" data-toggle="popover" data-content="Active ingredients including salts and other forms of exact ingredients used in drug products." title="" id="product-ingredients-info" class="drug-info-popup" href="javascript:void(0);" data-original-title="About Product Ingredients"><div class="drugbank-icon icon-information"><svg class="icon" role="img" title="information">
<use xlink:href="/assets/icons-539be351b538129271b9ee92cb0ebbd16efad4fccf6e2fe95aa6234f1e7417fa.svg#information"></use>
</svg>
</div></a></dt><dd class="col-xl-10 col-md-9 col-sm-8"><table class="table table-sm responsive-table" id="drug-salts-table"><thead><tr><th>Ingredient</th><th>UNII</th><th>CAS</th><th>InChI Key</th></tr></thead><tbody><tr><td><strong><a href="/salts/DBSALT000272">Raloxifene Hydrochloride</a></strong></td><td><a target="_blank" rel="noopener" href="https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=4F86W47BR6">4F86W47BR6</a></td><td>82640-04-8</td><td class="break-cell">BKXVVCILCIUCLG-UHFFFAOYSA-N</td></tr></tbody></table></dd><dt class="col-xl-2 col-md-3 col-sm-4" id="product-images">Product Images</dt><dd class="col-xl-10 col-md-9 col-sm-8"><div id="product-carousel-row" style="max-width: 592px"><div class="carousel slide" data-active="true" id="product-carousel"><ol class="carousel-indicators"><li class="active" data-slide-to="0" data-target="#product-carousel"></li><li data-slide-to="1" data-target="#product-carousel"></li><li data-slide-to="2" data-target="#product-carousel"></li></ol><div class="carousel-inner"><div class="carousel-item w-100 active"><a class="package-picture" data-toggle="modal" data-url="//s3-us-west-2.amazonaws.com/drugbank/product_images/images/medium/00002-4165-02_NLMIMAGE10_EF3AF7C7.jpg?1498436025" data-fullurl="//s3-us-west-2.amazonaws.com/drugbank/product_images/images/original/00002-4165-02_NLMIMAGE10_EF3AF7C7.jpg?1498436025" data-description="Raloxifene Hydrochloride 60 MG Oral Tablet [Evista]" href="#modal-package"><img class="img-fluid" height="111px" loading="lazy" src="//s3-us-west-2.amazonaws.com/drugbank/product_images/images/thumb/00002-4165-02_NLMIMAGE10_EF3AF7C7.jpg?1498436025"></a><a class="package-picture" data-toggle="modal" data-url="//s3-us-west-2.amazonaws.com/drugbank/product_images/images/medium/55289-026620210219-17607-1xplcsl.jpg?1613720984" data-fullurl="//s3-us-west-2.amazonaws.com/drugbank/product_images/images/original/55289-026620210219-17607-1xplcsl.jpg?1613720984" data-description="Raloxifene Hydrochloride 60 MG Oral Tablet [Evista]" href="#modal-package"><img class="img-fluid" height="111px" loading="lazy" src="//s3-us-west-2.amazonaws.com/drugbank/product_images/images/thumb/55289-026620210219-17607-1xplcsl.jpg?1613720984"></a><a class="package-picture" data-toggle="modal" data-url="//s3-us-west-2.amazonaws.com/drugbank/product_images/images/medium/0002-416520180810-16125-1ebbynl.jpg?1533914835" data-fullurl="//s3-us-west-2.amazonaws.com/drugbank/product_images/images/original/0002-416520180810-16125-1ebbynl.jpg?1533914835" data-description="Raloxifene Hydrochloride 60 MG Oral Tablet [Evista]" href="#modal-package"><img class="img-fluid" height="111px" loading="lazy" src="//s3-us-west-2.amazonaws.com/drugbank/product_images/images/thumb/0002-416520180810-16125-1ebbynl.jpg?1533914835"></a><a class="package-picture" data-toggle="modal" data-url="//s3-us-west-2.amazonaws.com/drugbank/product_images/images/medium/0591-236720180907-15195-xsrogv.jpg?1536302279" data-fullurl="//s3-us-west-2.amazonaws.com/drugbank/product_images/images/original/0591-236720180907-15195-xsrogv.jpg?1536302279" data-description="Raloxifene Hydrochloride 60 MG Oral Tablet" href="#modal-package"><img class="img-fluid" height="111px" loading="lazy" src="//s3-us-west-2.amazonaws.com/drugbank/product_images/images/thumb/0591-236720180907-15195-xsrogv.jpg?1536302279"></a></div><div class="carousel-item w-100"><a class="package-picture" data-toggle="modal" data-url="//s3-us-west-2.amazonaws.com/drugbank/product_images/images/medium/31722-0256-30_NLMIMAGE10_1B478DDC.jpg?1498438214" data-fullurl="//s3-us-west-2.amazonaws.com/drugbank/product_images/images/original/31722-0256-30_NLMIMAGE10_1B478DDC.jpg?1498438214" data-description="Not available" href="#modal-package"><img class="img-fluid" data-source="//s3-us-west-2.amazonaws.com/drugbank/product_images/images/thumb/31722-0256-30_NLMIMAGE10_1B478DDC.jpg?1498438214" height="111px" loading="lazy" src=""></a><a class="package-picture" data-toggle="modal" data-url="//s3-us-west-2.amazonaws.com/drugbank/product_images/images/medium/42291-072620210404-13371-hzxh4a.jpg?1617558621" data-fullurl="//s3-us-west-2.amazonaws.com/drugbank/product_images/images/original/42291-072620210404-13371-hzxh4a.jpg?1617558621" data-description="Raloxifene Hydrochloride 60 MG Oral Tablet" href="#modal-package"><img class="img-fluid" data-source="//s3-us-west-2.amazonaws.com/drugbank/product_images/images/thumb/42291-072620210404-13371-hzxh4a.jpg?1617558621" height="111px" loading="lazy" src=""></a><a class="package-picture" data-toggle="modal" data-url="//s3-us-west-2.amazonaws.com/drugbank/product_images/images/medium/65162-05720180913-8702-15s3jib.jpg?1536868400" data-fullurl="//s3-us-west-2.amazonaws.com/drugbank/product_images/images/original/65162-05720180913-8702-15s3jib.jpg?1536868400" data-description="Bethanechol Chloride 25 MG Oral Tablet" href="#modal-package"><img class="img-fluid" data-source="//s3-us-west-2.amazonaws.com/drugbank/product_images/images/thumb/65162-05720180913-8702-15s3jib.jpg?1536868400" height="111px" loading="lazy" src=""></a><a class="package-picture" data-toggle="modal" data-url="//s3-us-west-2.amazonaws.com/drugbank/product_images/images/medium/00093-7290-56_NLMIMAGE10_A73953CA.jpg?1498436028" data-fullurl="//s3-us-west-2.amazonaws.com/drugbank/product_images/images/original/00093-7290-56_NLMIMAGE10_A73953CA.jpg?1498436028" data-description="Raloxifene Hydrochloride 60 MG Oral Tablet" href="#modal-package"><img class="img-fluid" data-source="//s3-us-west-2.amazonaws.com/drugbank/product_images/images/thumb/00093-7290-56_NLMIMAGE10_A73953CA.jpg?1498436028" height="111px" loading="lazy" src=""></a></div><div class="carousel-item w-100"><a class="package-picture" data-toggle="modal" data-url="//s3-us-west-2.amazonaws.com/drugbank/product_images/images/medium/69189-041820180907-15195-1d4k2lc.jpg?1536298728" data-fullurl="//s3-us-west-2.amazonaws.com/drugbank/product_images/images/original/69189-041820180907-15195-1d4k2lc.jpg?1536298728" data-description="Raloxifene Hydrochloride 60 MG Oral Tablet" href="#modal-package"><img class="img-fluid" data-source="//s3-us-west-2.amazonaws.com/drugbank/product_images/images/thumb/69189-041820180907-15195-1d4k2lc.jpg?1536298728" height="111px" loading="lazy" src=""></a></div></div><a class="carousel-control-prev" data-slide="prev" href="#product-carousel" role="button"><span aria-hidden="true" class="carousel-control-prev-icon"></span><span class="sr-only">Previous</span></a><a class="carousel-control-next" data-slide="next" href="#product-carousel" role="button"><span aria-hidden="true" class="carousel-control-next-icon"></span><span class="sr-only">Next</span></a></div></div></dd><dt class="col-xl-2 col-md-3 col-sm-4" id="international-other-brands">International/Other Brands</dt><dd class="col-xl-10 col-md-9 col-sm-8"><span class="separated-list-container"><span class="separated-list col-lg-12 col-xl-6"><span class="separated-list-item">Keoxifene</span></span></span></dd><dt class="col-xl-2 col-md-3 col-sm-4" id="brand-name-prescription-products">Brand Name Prescription Products</dt><dd class="col-xl-10 col-md-9 col-sm-8"><table class="products table table-sm dt-responsive datatable-remote" data-source="/drugs/DB00481/products.json?group=approved" data-total="19" id="approved-products" style="width: 100%"><thead><tr><th class="all">Name</th><th>Dosage</th><th>Strength</th><th class="all">Route</th><th>Labeller</th><th>Marketing Start</th><th>Marketing End</th><th><span class="hidden-title">Region</span></th><th class="drug-image"><span class="hidden-title">Image</span></th></tr></thead><tbody><tr><td>Act Raloxifene</td><td>Tablet</td><td>60 mg</td><td>Oral</td><td>TEVA Canada Limited</td><td>2012-06-19</td><td><span class="not-available">Not applicable</span></td><td><span class="country"><span hidden="hidden">Canada</span><img loading="lazy" title="Canada" alt="Canada flag" src="/assets/countries/ca-64ffe8c476c257597eca3ded684da90a2b1a500bd6389ebd2ca5e213b1cc7574.svg"></span></td><td></td></tr><tr><td>Evista</td><td>Tablet, film coated</td><td>60 mg</td><td>Oral</td><td>Substipharm</td><td>2020-12-17</td><td><span class="not-available">Not applicable</span></td><td><span class="country"><span hidden="hidden">EU</span><img loading="lazy" title="EU" alt="EU flag" src="/assets/countries/eu-dda0a77d72bbe9085912a87221977afb68d43d8dbf280688345b7a73f2498514.svg"></span></td><td></td></tr><tr><td>Evista</td><td>Tablet</td><td>60 mg/1</td><td>Oral</td><td>Eli Lilly and Company</td><td>1998-01-06</td><td><span class="not-available">Not applicable</span></td><td><span class="country"><span hidden="hidden">US</span><img loading="lazy" title="US" alt="US flag" src="/assets/countries/us-827348b033d3b349931e036455f341029a75d10b2533057ebfbfdb0ca0e45c47.svg"></span></td><td></td></tr><tr><td>Evista</td><td>Tablet, film coated</td><td>60 mg</td><td>Oral</td><td>Substipharm</td><td>2020-12-17</td><td><span class="not-available">Not applicable</span></td><td><span class="country"><span hidden="hidden">EU</span><img loading="lazy" title="EU" alt="EU flag" src="/assets/countries/eu-dda0a77d72bbe9085912a87221977afb68d43d8dbf280688345b7a73f2498514.svg"></span></td><td></td></tr><tr><td>Evista</td><td>Tablet</td><td>60 mg/1</td><td>Oral</td><td>Lake Erie Medical &amp;Surgical Supply Dba Quality Care Products Llc</td><td>2012-03-07</td><td>2014-12-31</td><td><span class="country"><span hidden="hidden">US</span><img loading="lazy" title="US" alt="US flag" src="/assets/countries/us-827348b033d3b349931e036455f341029a75d10b2533057ebfbfdb0ca0e45c47.svg"></span></td><td></td></tr><tr><td>Evista</td><td>Tablet</td><td>60 mg/1</td><td>Oral</td><td>Eli Lilly and Company</td><td>2006-04-17</td><td>2006-04-17</td><td><span class="country"><span hidden="hidden">US</span><img loading="lazy" title="US" alt="US flag" src="/assets/countries/us-827348b033d3b349931e036455f341029a75d10b2533057ebfbfdb0ca0e45c47.svg"></span></td><td><a class="package-picture" data-toggle="modal" data-url="//s3-us-west-2.amazonaws.com/drugbank/product_images/images/medium/0002-416520180810-16125-1ebbynl.jpg?1533914835" data-fullurl="//s3-us-west-2.amazonaws.com/drugbank/product_images/images/original/0002-416520180810-16125-1ebbynl.jpg?1533914835" data-description="Raloxifene Hydrochloride 60 MG Oral Tablet [Evista]" href="#modal-package"><img class="package-thumb" src="//s3-us-west-2.amazonaws.com/drugbank/product_images/images/tiny/0002-416520180810-16125-1ebbynl.jpg?1533914835"></a></td></tr><tr><td>Evista</td><td>Tablet, film coated</td><td>60 mg</td><td>Oral</td><td>Substipharm</td><td>2020-12-17</td><td><span class="not-available">Not applicable</span></td><td><span class="country"><span hidden="hidden">EU</span><img loading="lazy" title="EU" alt="EU flag" src="/assets/countries/eu-dda0a77d72bbe9085912a87221977afb68d43d8dbf280688345b7a73f2498514.svg"></span></td><td></td></tr><tr><td>Evista</td><td>Tablet</td><td>60 mg/1</td><td>Oral</td><td>Physicians Total Care, Inc.</td><td>2000-05-11</td><td><span class="not-available">Not applicable</span></td><td><span class="country"><span hidden="hidden">US</span><img loading="lazy" title="US" alt="US flag" src="/assets/countries/us-827348b033d3b349931e036455f341029a75d10b2533057ebfbfdb0ca0e45c47.svg"></span></td><td><a class="package-picture" data-toggle="modal" data-url="//s3-us-west-2.amazonaws.com/drugbank/product_images/images/medium/00002-4165-02_NLMIMAGE10_EF3AF7C7.jpg?1498436025" data-fullurl="//s3-us-west-2.amazonaws.com/drugbank/product_images/images/original/00002-4165-02_NLMIMAGE10_EF3AF7C7.jpg?1498436025" data-description="Raloxifene Hydrochloride 60 MG Oral Tablet [Evista]" href="#modal-package"><img class="package-thumb" src="//s3-us-west-2.amazonaws.com/drugbank/product_images/images/tiny/00002-4165-02_NLMIMAGE10_EF3AF7C7.jpg?1498436025"></a></td></tr><tr><td>Evista</td><td>Tablet</td><td>60 mg/1</td><td>Oral</td><td>Pd Rx Pharmaceuticals, Inc.</td><td>1998-01-06</td><td>2018-07-17</td><td><span class="country"><span hidden="hidden">US</span><img loading="lazy" title="US" alt="US flag" src="/assets/countries/us-827348b033d3b349931e036455f341029a75d10b2533057ebfbfdb0ca0e45c47.svg"></span></td><td><a class="package-picture" data-toggle="modal" data-url="//s3-us-west-2.amazonaws.com/drugbank/product_images/images/medium/55289-026620210219-17607-1xplcsl.jpg?1613720984" data-fullurl="//s3-us-west-2.amazonaws.com/drugbank/product_images/images/original/55289-026620210219-17607-1xplcsl.jpg?1613720984" data-description="Raloxifene Hydrochloride 60 MG Oral Tablet [Evista]" href="#modal-package"><img class="package-thumb" src="//s3-us-west-2.amazonaws.com/drugbank/product_images/images/tiny/55289-026620210219-17607-1xplcsl.jpg?1613720984"></a></td></tr><tr><td>Evista</td><td>Tablet, film coated</td><td>60 mg</td><td>Oral</td><td>Substipharm</td><td>2020-12-17</td><td><span class="not-available">Not applicable</span></td><td><span class="country"><span hidden="hidden">EU</span><img loading="lazy" title="EU" alt="EU flag" src="/assets/countries/eu-dda0a77d72bbe9085912a87221977afb68d43d8dbf280688345b7a73f2498514.svg"></span></td><td></td></tr></tbody></table></dd><dt class="col-xl-2 col-md-3 col-sm-4" id="generic-prescription-products">Generic Prescription Products</dt><dd class="col-xl-10 col-md-9 col-sm-8"><table class="products table table-sm dt-responsive datatable-remote" data-source="/drugs/DB00481/products.json?group=generic" data-total="46" id="generic-products" style="width: 100%"><thead><tr><th class="all">Name</th><th>Dosage</th><th>Strength</th><th class="all">Route</th><th>Labeller</th><th>Marketing Start</th><th>Marketing End</th><th><span class="hidden-title">Region</span></th><th class="drug-image"><span class="hidden-title">Image</span></th></tr></thead><tbody><tr><td>Apo-raloxifene</td><td>Tablet</td><td>60 mg</td><td>Oral</td><td>Apotex Corporation</td><td>2009-03-31</td><td><span class="not-available">Not applicable</span></td><td><span class="country"><span hidden="hidden">Canada</span><img loading="lazy" title="Canada" alt="Canada flag" src="/assets/countries/ca-64ffe8c476c257597eca3ded684da90a2b1a500bd6389ebd2ca5e213b1cc7574.svg"></span></td><td></td></tr><tr><td>PMS-raloxifene</td><td>Tablet</td><td>60 mg</td><td>Oral</td><td>Pharmascience Inc</td><td>2011-09-19</td><td>2020-04-22</td><td><span class="country"><span hidden="hidden">Canada</span><img loading="lazy" title="Canada" alt="Canada flag" src="/assets/countries/ca-64ffe8c476c257597eca3ded684da90a2b1a500bd6389ebd2ca5e213b1cc7574.svg"></span></td><td></td></tr><tr><td>Raloxifene</td><td>Tablet, film coated</td><td>60 mg/1</td><td>Oral</td><td>Avera McKennan Hospital</td><td>2016-05-09</td><td>2017-05-24</td><td><span class="country"><span hidden="hidden">US</span><img loading="lazy" title="US" alt="US flag" src="/assets/countries/us-827348b033d3b349931e036455f341029a75d10b2533057ebfbfdb0ca0e45c47.svg"></span></td><td></td></tr><tr><td>Raloxifene</td><td>Tablet, film coated</td><td>60 mg/1</td><td>Oral</td><td>Actavis Pharma Company</td><td>2015-06-18</td><td><span class="not-available">Not applicable</span></td><td><span class="country"><span hidden="hidden">US</span><img loading="lazy" title="US" alt="US flag" src="/assets/countries/us-827348b033d3b349931e036455f341029a75d10b2533057ebfbfdb0ca0e45c47.svg"></span></td><td><a class="package-picture" data-toggle="modal" data-url="//s3-us-west-2.amazonaws.com/drugbank/product_images/images/medium/0591-236720180907-15195-xsrogv.jpg?1536302279" data-fullurl="//s3-us-west-2.amazonaws.com/drugbank/product_images/images/original/0591-236720180907-15195-xsrogv.jpg?1536302279" data-description="Raloxifene Hydrochloride 60 MG Oral Tablet" href="#modal-package"><img class="package-thumb" src="//s3-us-west-2.amazonaws.com/drugbank/product_images/images/tiny/0591-236720180907-15195-xsrogv.jpg?1536302279"></a></td></tr><tr><td>Raloxifene Hydrochloride</td><td>Tablet, film coated</td><td>60 mg/1</td><td>Oral</td><td>bryant ranch prepack</td><td>2014-03-28</td><td><span class="not-available">Not applicable</span></td><td><span class="country"><span hidden="hidden">US</span><img loading="lazy" title="US" alt="US flag" src="/assets/countries/us-827348b033d3b349931e036455f341029a75d10b2533057ebfbfdb0ca0e45c47.svg"></span></td><td></td></tr><tr><td>Raloxifene Hydrochloride</td><td>Tablet</td><td>60 mg/1</td><td>Oral</td><td>Cipla USA Inc.</td><td>2016-06-29</td><td><span class="not-available">Not applicable</span></td><td><span class="country"><span hidden="hidden">US</span><img loading="lazy" title="US" alt="US flag" src="/assets/countries/us-827348b033d3b349931e036455f341029a75d10b2533057ebfbfdb0ca0e45c47.svg"></span></td><td></td></tr><tr><td>Raloxifene Hydrochloride</td><td>Tablet, film coated</td><td>60 mg/1</td><td>Oral</td><td>KAISER FOUNDATION HOSPITALS</td><td>2016-10-12</td><td>2018-03-31</td><td><span class="country"><span hidden="hidden">US</span><img loading="lazy" title="US" alt="US flag" src="/assets/countries/us-827348b033d3b349931e036455f341029a75d10b2533057ebfbfdb0ca0e45c47.svg"></span></td><td></td></tr><tr><td>Raloxifene hydrochloride</td><td>Tablet, coated</td><td>60 mg/1</td><td>Oral</td><td>Modavar Pharmaceuticals LLC</td><td>2017-12-30</td><td><span class="not-available">Not applicable</span></td><td><span class="country"><span hidden="hidden">US</span><img loading="lazy" title="US" alt="US flag" src="/assets/countries/us-827348b033d3b349931e036455f341029a75d10b2533057ebfbfdb0ca0e45c47.svg"></span></td><td></td></tr><tr><td>Raloxifene hydrochloride</td><td>Tablet, film coated</td><td>60 mg/1</td><td>Oral</td><td>ScieGen Pharmaceuticals Inc</td><td>2016-10-12</td><td><span class="not-available">Not applicable</span></td><td><span class="country"><span hidden="hidden">US</span><img loading="lazy" title="US" alt="US flag" src="/assets/countries/us-827348b033d3b349931e036455f341029a75d10b2533057ebfbfdb0ca0e45c47.svg"></span></td><td></td></tr><tr><td>Raloxifene Hydrochloride</td><td>Tablet, film coated</td><td>60 mg/1</td><td>Oral</td><td>Aurobindo Pharma Limited</td><td>2015-08-28</td><td><span class="not-available">Not applicable</span></td><td><span class="country"><span hidden="hidden">US</span><img loading="lazy" title="US" alt="US flag" src="/assets/countries/us-827348b033d3b349931e036455f341029a75d10b2533057ebfbfdb0ca0e45c47.svg"></span></td><td></td></tr></tbody></table></dd><dt class="col-xl-2 col-md-3 col-sm-4" id="unapproved-other-products">Unapproved/Other Products <a tabindex="0" role="button" data-toggle="popover" data-content="Products that have not been approved by a regulatory body (such as the FDA), but are still available on the market due to historical reasons." title="" id="unapproved-products-info" class="drug-info-popup" href="javascript:void(0);" data-original-title="About Unapproved/Other Products"><div class="drugbank-icon icon-information"><svg class="icon" role="img" title="information">
<use xlink:href="/assets/icons-539be351b538129271b9ee92cb0ebbd16efad4fccf6e2fe95aa6234f1e7417fa.svg#information"></use>
</svg>
</div></a></dt><dd class="col-xl-10 col-md-9 col-sm-8"><table class="products table table-sm dt-responsive datatable-remote" data-source="/drugs/DB00481/products.json?group=unapproved" data-total="1" style="width: 100%"><thead><tr><th class="all">Name</th><th class="no-sort">Ingredients</th><th>Dosage</th><th class="all">Route</th><th>Labeller</th><th>Marketing Start</th><th>Marketing End</th><th><span class="hidden-title">Region</span></th><th class="drug-image"><span class="hidden-title">Image</span></th></tr></thead><tbody><tr><td>EVISTA 60 MG TABLET, 28 ADET</td><td class="ingredients">Raloxifene <span class="text-muted">(60 mg)</span></td><td>Tablet</td><td>Oral</td><td>DAİİCHİ SANKYO İLAÇ TİC. LTD. ŞTİ.</td><td>2020-08-14</td><td>2020-12-29</td><td><span class="country"><span hidden="hidden">Turkey</span><img loading="lazy" title="Turkey" alt="Turkey flag" src="/assets/countries/tr-bd8ba126596f483a0430c66b811a50bf7c03ad9b8522f6b0324af3df997e5847.svg"></span></td><td></td></tr></tbody></table></dd></dl><h2 id="categories-header" class="section-header">Categories</h2><dl><dt class="col-xl-2 col-md-3 col-sm-4" id="atc-codes">ATC Codes</dt><dd class="col-xl-10 col-md-9 col-sm-8"><a data-no-turbolink="true" href="/atc/G03XC01">G03XC01 — Raloxifene</a><ul class="atc-drug-tree"><li><a data-no-turbolink="true" href="/atc/G03XC">G03XC — Selective estrogen receptor modulators</a></li><li><a data-no-turbolink="true" href="/atc/G03X">G03X — OTHER SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM</a></li><li><a data-no-turbolink="true" href="/atc/G03">G03 — SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM</a></li><li><a data-no-turbolink="true" href="/atc/G">G — GENITO URINARY SYSTEM AND SEX HORMONES</a></li></ul></dd><dt class="col-xl-2 col-md-3 col-sm-4" id="drug-categories">Drug Categories</dt><dd class="col-xl-10 col-md-9 col-sm-8"><div class="category-columns"><ul class="list-unstyled table-list"><li><a href="/categories/DBCAT002663">BCRP/ABCG2 Substrates</a></li>
<li><a href="/categories/DBCAT000418">Benzene Derivatives</a></li>
<li><a href="/categories/DBCAT000619">Benzylidene Compounds</a></li>
<li><a href="/categories/DBCAT000089">Bone Density Conservation Agents</a></li>
<li><a href="/categories/DBCAT001285">Cytochrome P-450 CYP2B6 Inhibitors</a></li>
<li><a href="/categories/DBCAT002620">Cytochrome P-450 CYP2B6 Inhibitors (strong)</a></li>
<li><a href="/categories/DBCAT000868">Cytochrome P-450 CYP2C8 Inhibitors</a></li>
<li><a href="/categories/DBCAT004479">Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)</a></li>
<li><a href="/categories/DBCAT000934">Cytochrome P-450 CYP3A Inhibitors</a></li>
<li><a href="/categories/DBCAT003232">Cytochrome P-450 CYP3A4 Inhibitors</a></li>
<li><a href="/categories/DBCAT004049">Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)</a></li>
<li><a href="/categories/DBCAT000394">Cytochrome P-450 Enzyme Inhibitors</a></li>
<li><a href="/categories/DBCAT003693">Estrogen Agonist-antagonists</a></li>
<li><a href="/categories/DBCAT003358">Estrogen Agonist/Antagonist</a></li>
<li><a href="/categories/DBCAT000786">Estrogen Antagonists</a></li>
<li><a href="/categories/DBCAT000917">Estrogen Receptor Modulators</a></li>
<li><a href="/categories/DBCAT002114">Genito Urinary System and Sex Hormones</a></li>
<li><a href="/categories/DBCAT000144">Hormone Antagonists</a></li>
<li><a href="/categories/DBCAT000057">Hormones, Hormone Substitutes, and Hormone Antagonists</a></li>
<li><a href="/categories/DBCAT002658">OATP1B1/SLCO1B1 Substrates</a></li>
<li><a href="/categories/DBCAT004563">OATP1B3 substrates</a></li>
<li><a href="/categories/DBCAT002668">P-glycoprotein substrates</a></li>
<li><a href="/categories/DBCAT000918">Selective Estrogen Receptor Modulators</a></li>
<li><a href="/categories/DBCAT002113">Sex Hormones and Modulators of the Genital System</a></li>
<li><a href="/categories/DBCAT000618">Stilbenes</a></li>
<li><a href="/categories/DBCAT003871">UGT1A1 Substrates</a></li></ul></div></dd><dt class="col-xl-2 col-md-3 col-sm-4" id="chemical-taxonomy">Chemical Taxonomy<span class="note">Provided by <a target="_blank" href="http://classyfire.wishartlab.com">Classyfire</a></span></dt><dd class="col-xl-10 col-md-9 col-sm-8"><dl class="inner-dl"><dt class="col-md-4 col-sm-5" id="description">Description</dt><dd class="col-md-8 col-sm-7">This compound belongs to the class of organic compounds known as aryl-phenylketones. These are aromatic compounds containing a ketone substituted by one aryl group, and a phenyl group.</dd><dt class="col-md-4 col-sm-5" id="kingdom">Kingdom</dt><dd class="col-md-8 col-sm-7"><a class="classyfire-taxnode" data-content="Compounds that contain at least one carbon atom, excluding isocyanide/cyanide and their non-hydrocarbyl derivatives, thiophosgene, carbon diselenide, carbon monosulfide, carbon disulfide, carbon subsulfide, carbon monoxide, carbon dioxide, Carbon suboxide, and dicarbon monoxide." target="_blank" rel="noopener" href="http://classyfire.wishartlab.com/tax_nodes/C0000000" data-original-title="" title="">Organic compounds</a></dd><dt class="col-md-4 col-sm-5" id="super-class">Super Class</dt><dd class="col-md-8 col-sm-7"><a class="classyfire-taxnode" data-content="Organic compounds that contain one or more oxygen atoms." target="_blank" rel="noopener" href="http://classyfire.wishartlab.com/tax_nodes/C0004603" data-original-title="" title="">Organic oxygen compounds</a></dd><dt class="col-md-4 col-sm-5" id="class">Class</dt><dd class="col-md-8 col-sm-7"><a class="classyfire-taxnode" data-content="Organic compounds containing a bond between a carbon atom and an oxygen atom." target="_blank" rel="noopener" href="http://classyfire.wishartlab.com/tax_nodes/C0000323" data-original-title="" title="">Organooxygen compounds</a></dd><dt class="col-md-4 col-sm-5" id="sub-class">Sub Class</dt><dd class="col-md-8 col-sm-7"><a class="classyfire-taxnode" data-content="Organic compounds containing a carbonyl group, with the general structure RC(=O)R', where R=organyl, R'=H, N, O, organyl group or halide group." target="_blank" rel="noopener" href="http://classyfire.wishartlab.com/tax_nodes/C0001831" data-original-title="" title="">Carbonyl compounds</a></dd><dt class="col-md-4 col-sm-5" id="direct-parent">Direct Parent</dt><dd class="col-md-8 col-sm-7"><a class="classyfire-taxnode" data-content="Aromatic compounds containing a ketone substituted by one aryl group, and a phenyl group." target="_blank" rel="noopener" href="http://classyfire.wishartlab.com/tax_nodes/C0004297" data-original-title="" title="">Aryl-phenylketones</a></dd><dt class="col-md-4 col-sm-5" id="alternative-parents">Alternative Parents</dt><dd class="col-md-8 col-sm-7"><span class="separated-list-container"><span class="separated-list col-lg-12 col-xl-6"><span class="separated-list-item"><a class="classyfire-taxnode" data-content="Thiophenes which are substituted by an aroyl group at the 3-position." target="_blank" rel="noopener" href="http://classyfire.wishartlab.com/tax_nodes/C0003216" data-original-title="" title="">3-aroylthiophenes</a></span><span class="list-separator"> / </span><span class="separated-list-item"><a class="classyfire-taxnode" data-content="Aromatic heterocyclic compound containing the Benzo[b]thiophene ring system." target="_blank" rel="noopener" href="http://classyfire.wishartlab.com/tax_nodes/C0004293" data-original-title="" title="">1-benzothiophenes</a></span><span class="list-separator"> / </span><span class="separated-list-item"><a class="classyfire-taxnode" data-content="Compounds containing a thiophene ring which bears a carboxylic acid group (or a salt/ester thereof)." target="_blank" rel="noopener" href="http://classyfire.wishartlab.com/tax_nodes/C0002017" data-original-title="" title="">Thiophene carboxylic acids and derivatives</a></span><span class="list-separator"> / </span><span class="separated-list-item"><a class="classyfire-taxnode" data-content="Aromatic compounds contaning a phenoxy group." target="_blank" rel="noopener" href="http://classyfire.wishartlab.com/tax_nodes/C0004742" data-original-title="" title="">Phenoxy compounds</a></span><span class="list-separator"> / </span><span class="separated-list-item"><a class="classyfire-taxnode" data-content="Aromatic compounds containing an ether group substituted with a benzene ring." target="_blank" rel="noopener" href="http://classyfire.wishartlab.com/tax_nodes/C0002341" data-original-title="" title="">Phenol ethers</a></span><span class="list-separator"> / </span><span class="separated-list-item"><a class="classyfire-taxnode" data-content="Organic compounds containing an acyl moiety of benzoic acid with the formula (C6H5CO-)." target="_blank" rel="noopener" href="http://classyfire.wishartlab.com/tax_nodes/C0000321" data-original-title="" title="">Benzoyl derivatives</a></span><span class="list-separator"> / </span><span class="separated-list-item"><a class="classyfire-taxnode" data-content="Organic compounds containing the alkyl aryl ether functional group with the generic formula R-O-R' , where R is an alkyl group and R' is an aryl group." target="_blank" rel="noopener" href="http://classyfire.wishartlab.com/tax_nodes/C0000128" data-original-title="" title="">Alkyl aryl ethers</a></span><span class="list-separator"> / </span><span class="separated-list-item"><a class="classyfire-taxnode" data-content="Phenols that a unsubstituted at the 2-position." target="_blank" rel="noopener" href="http://classyfire.wishartlab.com/tax_nodes/C0004646" data-original-title="" title="">1-hydroxy-2-unsubstituted benzenoids</a></span><span class="list-separator"> / </span><span class="separated-list-item"><a class="classyfire-taxnode" data-content="Compounds containing a piperidine ring, which is a saturated aliphatic six-member ring with one nitrogen atom and five carbon atoms." target="_blank" rel="noopener" href="http://classyfire.wishartlab.com/tax_nodes/C0000195" data-original-title="" title="">Piperidines</a></span><span class="list-separator"> / </span><span class="separated-list-item"><a class="classyfire-taxnode" data-content="Compounds containing an aromatic ring where a carbon atom is linked to an hetero atom." target="_blank" rel="noopener" href="http://classyfire.wishartlab.com/tax_nodes/C0004144" data-original-title="" title="">Heteroaromatic compounds</a></span></span></span><span class="hidden-taxonomy" style="display: none"><span class="list-separator"> / </span><span class="separated-list-container"><span class="separated-list col-lg-12 col-xl-6"><span class="separated-list-item"><a class="classyfire-taxnode" data-content="Organic compounds containing a trialkylamine group, characterized by exactly three alkyl groups bonded to the amino nitrogen." target="_blank" rel="noopener" href="http://classyfire.wishartlab.com/tax_nodes/C0002239" data-original-title="" title="">Trialkylamines</a></span><span class="list-separator"> / </span><span class="separated-list-item"><a class="classyfire-taxnode" data-content="Organic compounds containing an heterocycle with at least one nitrogen atom and one carbon atom linked to each other." target="_blank" rel="noopener" href="http://classyfire.wishartlab.com/tax_nodes/C0004139" data-original-title="" title="">Azacyclic compounds</a></span><span class="list-separator"> / </span><span class="separated-list-item"><a class="classyfire-taxnode" data-content="Compounds containing a bond between carbon a pnictogen atom. Pnictogens are p-block element atoms that are in the group 15 of the periodic table." target="_blank" rel="noopener" href="http://classyfire.wishartlab.com/tax_nodes/C0004557" data-original-title="" title="">Organopnictogen compounds</a></span><span class="list-separator"> / </span><span class="separated-list-item"><a class="classyfire-taxnode" data-content="Organic compounds containing an oxide group." target="_blank" rel="noopener" href="http://classyfire.wishartlab.com/tax_nodes/C0003940" data-original-title="" title="">Organic oxides</a></span><span class="list-separator"> / </span><span class="separated-list-item"><a class="classyfire-taxnode" data-content="Derivatives of hydrocarbons obtained by substituting one or more carbon atoms by an heteroatom. They contain at least one carbon atom and heteroatom." target="_blank" rel="noopener" href="http://classyfire.wishartlab.com/tax_nodes/C0004150" data-original-title="" title="">Hydrocarbon derivatives</a></span></span></span></span><a class="taxonomy-toggler" href="javascript:void();"><div class="drugbank-icon icon-expand"><svg class="icon" role="img" title="expand">
<use xlink:href="/assets/icons-539be351b538129271b9ee92cb0ebbd16efad4fccf6e2fe95aa6234f1e7417fa.svg#expand"></use>
</svg>
</div> show 5 more</a></dd><dt class="col-md-4 col-sm-5" id="substituents">Substituents</dt><dd class="col-md-8 col-sm-7"><span class="separated-list-container"><span class="separated-list col-lg-12 col-xl-6"><span class="separated-list-item">1-benzothiophene</span><span class="list-separator"> / </span><span class="separated-list-item">1-hydroxy-2-unsubstituted benzenoid</span><span class="list-separator"> / </span><span class="separated-list-item">3-aroylthiophene</span><span class="list-separator"> / </span><span class="separated-list-item">Alkyl aryl ether</span><span class="list-separator"> / </span><span class="separated-list-item">Amine</span><span class="list-separator"> / </span><span class="separated-list-item">Aromatic heteropolycyclic compound</span><span class="list-separator"> / </span><span class="separated-list-item">Aryl-phenylketone</span><span class="list-separator"> / </span><span class="separated-list-item">Azacycle</span><span class="list-separator"> / </span><span class="separated-list-item">Benzenoid</span><span class="list-separator"> / </span><span class="separated-list-item">Benzothiophene</span></span></span><span class="hidden-taxonomy" style="display: none"><span class="list-separator"> / </span><span class="separated-list-container"><span class="separated-list col-lg-12 col-xl-6"><span class="separated-list-item">Benzoyl</span><span class="list-separator"> / </span><span class="separated-list-item">Ether</span><span class="list-separator"> / </span><span class="separated-list-item">Heteroaromatic compound</span><span class="list-separator"> / </span><span class="separated-list-item">Hydrocarbon derivative</span><span class="list-separator"> / </span><span class="separated-list-item">Monocyclic benzene moiety</span><span class="list-separator"> / </span><span class="separated-list-item">Organic nitrogen compound</span><span class="list-separator"> / </span><span class="separated-list-item">Organic oxide</span><span class="list-separator"> / </span><span class="separated-list-item">Organoheterocyclic compound</span><span class="list-separator"> / </span><span class="separated-list-item">Organonitrogen compound</span><span class="list-separator"> / </span><span class="separated-list-item">Organopnictogen compound</span><span class="list-separator"> / </span><span class="separated-list-item">Phenol</span><span class="list-separator"> / </span><span class="separated-list-item">Phenol ether</span><span class="list-separator"> / </span><span class="separated-list-item">Phenoxy compound</span><span class="list-separator"> / </span><span class="separated-list-item">Piperidine</span><span class="list-separator"> / </span><span class="separated-list-item">Tertiary aliphatic amine</span><span class="list-separator"> / </span><span class="separated-list-item">Tertiary amine</span><span class="list-separator"> / </span><span class="separated-list-item">Thiophene</span><span class="list-separator"> / </span><span class="separated-list-item">Thiophene carboxylic acid or derivatives</span></span></span></span><a class="taxonomy-toggler" href="javascript:void();"><div class="drugbank-icon icon-expand"><svg class="icon" role="img" title="expand">
<use xlink:href="/assets/icons-539be351b538129271b9ee92cb0ebbd16efad4fccf6e2fe95aa6234f1e7417fa.svg#expand"></use>
</svg>
</div> show 18 more</a></dd><dt class="col-md-4 col-sm-5" id="molecular-framework">Molecular Framework</dt><dd class="col-md-8 col-sm-7">Aromatic heteropolycyclic compounds</dd><dt class="col-md-4 col-sm-5" id="external-descriptors">External Descriptors</dt><dd class="col-md-8 col-sm-7"><span class="inline-separated-list-container"><span class="simple-separated-list-item">1-benzothiophenes, N-oxyethylpiperidine (<a target="_blank" rel="noopener" href="https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:45355">CHEBI:45355</a>) </span></span></dd></dl></dd><dt class="col-xl-2 col-md-3 col-sm-4" id="affected-organisms">Affected organisms</dt><dd class="col-xl-10 col-md-9 col-sm-8"><ul class="list-unstyled table-list"><li>Humans and other mammals</li></ul></dd></dl><h2 id="chemical-identifiers-header" class="section-header">Chemical Identifiers</h2><dl><dt class="col-xl-2 col-md-3 col-sm-4" id="unii">UNII</dt><dd class="col-xl-10 col-md-9 col-sm-8"><a target="_blank" rel="noopener" href="https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=YX9162EO3I">YX9162EO3I</a></dd><dt class="col-xl-2 col-md-3 col-sm-4" id="cas-number">CAS number</dt><dd class="col-xl-10 col-md-9 col-sm-8">84449-90-1</dd><dt class="col-xl-2 col-md-3 col-sm-4" id="inchi-key">InChI Key</dt><dd class="col-xl-10 col-md-9 col-sm-8">GZUITABIAKMVPG-UHFFFAOYSA-N</dd><dt class="col-xl-2 col-md-3 col-sm-4" id="inchi">InChI</dt><dd class="col-xl-10 col-md-9 col-sm-8"><div class="wrap">InChI=1S/C28H27NO4S/c30-21-8-4-20(5-9-21)28-26(24-13-10-22(31)18-25(24)34-28)27(32)19-6-11-23(12-7-19)33-17-16-29-14-2-1-3-15-29/h4-13,18,30-31H,1-3,14-17H2</div></dd><dt class="col-xl-2 col-md-3 col-sm-4" id="iupac-name">IUPAC Name</dt><dd class="col-xl-10 col-md-9 col-sm-8"><div class="wrap">2-(4-hydroxyphenyl)-3-{4-[2-(piperidin-1-yl)ethoxy]benzoyl}-1-benzothiophen-6-ol</div></dd><dt class="col-xl-2 col-md-3 col-sm-4" id="smiles">SMILES</dt><dd class="col-xl-10 col-md-9 col-sm-8"><div class="wrap">OC1=CC=C(C=C1)C1=C(C(=O)C2=CC=C(OCCN3CCCCC3)C=C2)C2=C(S1)C=C(O)C=C2</div></dd></dl><h2 id="references-header" class="section-header">References</h2><dl><dt class="col-xl-2 col-md-3 col-sm-4" id="synthesis-reference">Synthesis Reference</dt><dd class="col-xl-10 col-md-9 col-sm-8"><span class="citations"><p>Massimo Ferrari, Fabrizio Zinetti, Paolo Belotti, "Process for preparing raloxifene hydrochloride." U.S. Patent US20070100147, issued May 03, 2007.</p>
</span><a target="_blank" rel="noopener" href="https://www.google.com/?tbm=pts#q=20070100147&amp;tbm=pts">US20070100147</a></dd><dt class="col-xl-2 col-md-3 col-sm-4" id="general-references">General References</dt><dd class="col-xl-10 col-md-9 col-sm-8"><ol class="cite-this-references"><li id="reference-A716">Heringa M: Review on raloxifene: profile of a selective estrogen receptor modulator. Int J Clin Pharmacol Ther. 2003 Aug;41(8):331-45. [<a target="_blank" href="/articles/A716">Article</a>] </li><li id="reference-A719">Cummings SR, Eckert S, Krueger KA, Grady D, Powles TJ, Cauley JA, Norton L, Nickelsen T, Bjarnason NH, Morrow M, Lippman ME, Black D, Glusman JE, Costa A, Jordan VC: The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple Outcomes of Raloxifene Evaluation. JAMA. 1999 Jun 16;281(23):2189-97. [<a target="_blank" href="/articles/A719">Article</a>] </li><li id="reference-A720">Bryant HU, Glasebrook AL, Yang NN, Sato M: An estrogen receptor basis for raloxifene action in bone. J Steroid Biochem Mol Biol. 1999 Apr-Jun;69(1-6):37-44. [<a target="_blank" href="/articles/A720">Article</a>] </li><li id="reference-A721">Balfour JA, Goa KL: Raloxifene. Drugs Aging. 1998 Apr;12(4):335-41; discussion 342. [<a target="_blank" href="/articles/A721">Article</a>] </li><li id="reference-A722">Clemett D, Spencer CM: Raloxifene: a review of its use in postmenopausal osteoporosis. Drugs. 2000 Aug;60(2):379-411. [<a target="_blank" href="/articles/A722">Article</a>] </li><li id="reference-A4979">Moen MD, Keating GM: Raloxifene: a review of its use in the prevention of invasive breast cancer. Drugs. 2008;68(14):2059-83. [<a target="_blank" href="/articles/A4979">Article</a>] </li><li id="reference-A4977">Scott JA, Da Camara CC, Early JE: Raloxifene: a selective estrogen receptor modulator. Am Fam Physician. 1999 Sep 15;60(4):1131-9. [<a target="_blank" href="/articles/A4977">Article</a>] </li><li id="reference-A178756">Yang NN, Venugopalan M, Hardikar S, Glasebrook A: Identification of an estrogen response element activated by metabolites of 17beta-estradiol and raloxifene. Science. 1996 Aug 30;273(5279):1222-5. [<a target="_blank" href="/articles/A178756">Article</a>] </li><li id="reference-A178861">Palmisano BT, Zhu L, Stafford JM: Role of Estrogens in the Regulation of Liver Lipid Metabolism. Adv Exp Med Biol. 2017;1043:227-256. doi: 10.1007/978-3-319-70178-3_12. [<a target="_blank" href="/articles/A178861">Article</a>] </li><li id="reference-A178921">Yaghjyan L, Colditz GA: Estrogens in the breast tissue: a systematic review. Cancer Causes Control. 2011 Apr;22(4):529-40. doi: 10.1007/s10552-011-9729-4. Epub 2011 Feb 1. [<a target="_blank" href="/articles/A178921">Article</a>] </li><li id="reference-A724">Diez-Perez A: Selective estrogen receptor modulators (SERMS). Arq Bras Endocrinol Metabol. 2006 Aug;50(4):720-34. [<a target="_blank" href="/articles/A724">Article</a>] </li><li id="reference-T28">35. (2012). In Rang and Dale's Pharmacology (7th ed., pp. 438-439). Edinburgh: Elsevier/Churchill Livingstone. [<a target="_blank" rel="noopener" href="https://www.google.com/search?tbo=p&amp;tbm=bks&amp;q=978-0-7020-3471-8">ISBN:978-0-7020-3471-8</a>] </li><li id="reference-L10662">EVISTA (raloxifene hydrochloride) Tablet for Oral Use - FDA Label [<a target="_blank" href="https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/022042lbl.pdf">Link</a>] </li></ol></dd><dt class="col-xl-2 col-md-3 col-sm-4" id="external-links">External Links</dt><dd class="col-xl-10 col-md-9 col-sm-8"><dl class="inner-dl"><dt class="col-md-4 col-sm-5" id="human-metabolome-database">Human Metabolome Database</dt><dd class="col-md-8 col-sm-7"><a target="_blank" rel="noopener" href="http://www.hmdb.ca/metabolites/HMDB0014624">HMDB0014624</a></dd><dt class="col-md-4 col-sm-5" id="kegg-compound">KEGG Compound</dt><dd class="col-md-8 col-sm-7"><a target="_blank" rel="noopener" href="http://www.genome.jp/dbget-bin/www_bget?cpd:C07228">C07228</a></dd><dt class="col-md-4 col-sm-5" id="pubchem-compound">PubChem Compound</dt><dd class="col-md-8 col-sm-7"><a target="_blank" rel="noopener" href="https://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=5035">5035</a></dd><dt class="col-md-4 col-sm-5" id="pubchem-substance">PubChem Substance</dt><dd class="col-md-8 col-sm-7"><a target="_blank" rel="noopener" href="https://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?sid=46506514">46506514</a></dd><dt class="col-md-4 col-sm-5" id="chemspider">ChemSpider</dt><dd class="col-md-8 col-sm-7"><a target="_blank" rel="noopener" href="https://www.chemspider.com/Chemical-Structure.4859.html">4859</a></dd><dt class="col-md-4 col-sm-5" id="bindingdb">BindingDB</dt><dd class="col-md-8 col-sm-7"><a target="_blank" rel="noopener" href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19441">19441</a></dd><dt class="col-md-4 col-sm-5" id="rxnav">RxNav</dt><dd class="col-md-8 col-sm-7"><a target="_blank" rel="noopener" href="https://mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&amp;searchTerm=72143">72143</a></dd><dt class="col-md-4 col-sm-5" id="chebi">ChEBI</dt><dd class="col-md-8 col-sm-7"><a target="_blank" rel="noopener" href="https://www.ebi.ac.uk/chebi/searchId.do?chebiId=8772">8772</a></dd><dt class="col-md-4 col-sm-5" id="chembl">ChEMBL</dt><dd class="col-md-8 col-sm-7"><a target="_blank" rel="noopener" href="https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/CHEMBL81">CHEMBL81</a></dd><dt class="col-md-4 col-sm-5" id="zinc">ZINC</dt><dd class="col-md-8 col-sm-7"><a target="_blank" rel="noopener" href="https://zinc.docking.org/substances/ZINC000000538275">ZINC000000538275</a></dd><dt class="col-md-4 col-sm-5" id="therapeutic-targets-database">Therapeutic Targets Database</dt><dd class="col-md-8 col-sm-7"><a target="_blank" rel="noopener" href="http://bidd.nus.edu.sg/group/cjttd/ZFTTDDRUG.asp?ID=DAP000792">DAP000792</a></dd><dt class="col-md-4 col-sm-5" id="pharmgkb">PharmGKB</dt><dd class="col-md-8 col-sm-7"><a target="_blank" rel="noopener" href="http://www.pharmgkb.org/drug/PA451221">PA451221</a></dd><dt class="col-md-4 col-sm-5" id="guide-to-pharmacology">Guide to Pharmacology</dt><dd class="col-md-8 col-sm-7"><a target="_blank" rel="noopener" href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2820">GtP Drug Page</a></dd><dt class="col-md-4 col-sm-5" id="pdbe-ligand">PDBe Ligand</dt><dd class="col-md-8 col-sm-7"><a target="_blank" rel="noopener" href="https://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/RAL">RAL</a></dd><dt class="col-md-4 col-sm-5" id="rxlist">RxList</dt><dd class="col-md-8 col-sm-7"><a target="_blank" rel="noopener" href="http://www.rxlist.com/cgi/generic/raloxif.htm">RxList Drug Page</a></dd><dt class="col-md-4 col-sm-5" id="drugs-com">Drugs.com</dt><dd class="col-md-8 col-sm-7"><a target="_blank" rel="noopener" href="https://www.drugs.com/cdi/raloxifene.html">Drugs.com Drug Page</a></dd><dt class="col-md-4 col-sm-5" id="pdrhealth">PDRhealth</dt><dd class="col-md-8 col-sm-7"><a target="_blank" rel="noopener" href="http://www.pdrhealth.com/drug_info/rxdrugprofiles/drugs/evi1169.shtml">PDRhealth Drug Page</a></dd><dt class="col-md-4 col-sm-5" id="wikipedia">Wikipedia</dt><dd class="col-md-8 col-sm-7"><a target="_blank" rel="noopener" href="https://en.wikipedia.org/wiki/Raloxifene">Raloxifene</a></dd></dl></dd><dt class="col-xl-2 col-md-3 col-sm-4" id="pdb-entries">PDB Entries</dt><dd class="col-xl-10 col-md-9 col-sm-8"><span class="inline-separated-list-container"><span class="simple-separated-list-item"><a target="_blank" rel="noopener" href="http://www.rcsb.org/pdb/explore.do?structureId=1err">1err</a></span><span class="list-separator"> / </span><span class="simple-separated-list-item"><a target="_blank" rel="noopener" href="http://www.rcsb.org/pdb/explore.do?structureId=1qkn">1qkn</a></span><span class="list-separator"> / </span><span class="simple-separated-list-item"><a target="_blank" rel="noopener" href="http://www.rcsb.org/pdb/explore.do?structureId=2jfa">2jfa</a></span><span class="list-separator"> / </span><span class="simple-separated-list-item"><a target="_blank" rel="noopener" href="http://www.rcsb.org/pdb/explore.do?structureId=2qxs">2qxs</a></span><span class="list-separator"> / </span><span class="simple-separated-list-item"><a target="_blank" rel="noopener" href="http://www.rcsb.org/pdb/explore.do?structureId=2y05">2y05</a></span><span class="list-separator"> / </span><span class="simple-separated-list-item"><a target="_blank" rel="noopener" href="http://www.rcsb.org/pdb/explore.do?structureId=7kbs">7kbs</a></span><span class="list-separator"> / </span><span class="simple-separated-list-item"><a target="_blank" rel="noopener" href="http://www.rcsb.org/pdb/explore.do?structureId=7kca">7kca</a></span><span class="list-separator"> / </span><span class="simple-separated-list-item"><a target="_blank" rel="noopener" href="http://www.rcsb.org/pdb/explore.do?structureId=7ndo">7ndo</a></span><span class="list-separator"> / </span><span class="simple-separated-list-item"><a target="_blank" rel="noopener" href="http://www.rcsb.org/pdb/explore.do?structureId=7opn">7opn</a></span><span class="list-separator"> / </span><span class="simple-separated-list-item"><a target="_blank" rel="noopener" href="http://www.rcsb.org/pdb/explore.do?structureId=7orc">7orc</a></span></span></dd><dt class="col-xl-2 col-md-3 col-sm-4" id="fda-label">FDA label</dt><dd class="col-xl-10 col-md-9 col-sm-8"><div id="label-reference"><a href="//s3-us-west-2.amazonaws.com/drugbank/fda_labels/DB00481.pdf?1557952506">Download</a> <span class="text-muted">(286 KB) </span></div></dd><dt class="col-xl-2 col-md-3 col-sm-4" id="msds">MSDS</dt><dd class="col-xl-10 col-md-9 col-sm-8"><div id="msds-reference"><a href="//s3-us-west-2.amazonaws.com/drugbank/msds/DB00481.pdf?1557956624">Download</a> <span class="text-muted">(507 KB) </span></div></dd></dl><h2 id="clinical-trials-header" class="section-header">Clinical Trials</h2><dl><dt class="col-xl-2 col-md-3 col-sm-4" id="clinical-trials">Clinical Trials <a tabindex="0" role="button" data-toggle="popover" data-content="Clinical trial data extracted from government clinical trial databases. The commercial version includes title, phase, status, dates, and conditions with associated ICD10 or MedDRA identifiers. — <a target=&quot;_blank&quot; href=&quot;https://www.drugbank.com/scientific&quot;>Learn More</a>" title="" id="clinical-trials-info" class="drug-info-popup" href="javascript:void(0);" data-original-title="About Clinical Trials"><div class="drugbank-icon icon-information"><svg class="icon" role="img" title="information">
<use xlink:href="/assets/icons-539be351b538129271b9ee92cb0ebbd16efad4fccf6e2fe95aa6234f1e7417fa.svg#information"></use>
</svg>
</div></a></dt><dd class="col-xl-10 col-md-9 col-sm-8"><table class="clinical-trials table table-sm dt-responsive datatable-remote" data-source="/drugs/DB00481/clinical_trials/aggregate.json" data-total="48" style="width: 100%"><thead><tr><th>Phase</th><th>Status</th><th>Purpose</th><th>Conditions</th><th>Count</th></tr></thead><tbody><tr><td>4</td><td>Completed</td><td>Prevention</td><td><a href="/indications/DBCOND0132512">Healthy Subjects (HS)</a></td><td><a href="/drugs/DB00481/clinical_trials?conditions=DBCOND0132512&amp;phase=4&amp;purpose=prevention&amp;status=completed">1</a></td></tr><tr><td>4</td><td>Completed</td><td>Treatment</td><td><a href="/indications/DBCOND0030233">Compliance</a> <span>/</span> <a href="/indications/DBCOND0030339">Postmenopausal Osteoporosis</a></td><td><a href="/drugs/DB00481/clinical_trials?conditions=DBCOND0030233%2CDBCOND0030339&amp;phase=4&amp;purpose=treatment&amp;status=completed">1</a></td></tr><tr><td>4</td><td>Completed</td><td>Treatment</td><td><a href="/indications/DBCOND0018735">Depression</a> <span>/</span> <a href="/indications/DBCOND0028100">Perimenopausal Depression</a></td><td><a href="/drugs/DB00481/clinical_trials?conditions=DBCOND0018735%2CDBCOND0028100&amp;phase=4&amp;purpose=treatment&amp;status=completed">1</a></td></tr><tr><td>4</td><td>Completed</td><td>Treatment</td><td><a href="/indications/DBCOND0015928">Osteoporosis</a></td><td><a href="/drugs/DB00481/clinical_trials?conditions=DBCOND0015928&amp;phase=4&amp;purpose=treatment&amp;status=completed">5</a></td></tr><tr><td>4</td><td>Completed</td><td>Treatment</td><td><a href="/indications/DBCOND0030339">Postmenopausal Osteoporosis</a></td><td><a href="/drugs/DB00481/clinical_trials?conditions=DBCOND0030339&amp;phase=4&amp;purpose=treatment&amp;status=completed">5</a></td></tr><tr><td>4</td><td>Completed</td><td>Treatment</td><td><a href="/indications/DBCOND0033299">Schizoaffective Disorders</a> <span>/</span> <a href="/indications/DBCOND0018504">Schizophrenia</a></td><td><a href="/drugs/DB00481/clinical_trials?conditions=DBCOND0033299%2CDBCOND0018504&amp;phase=4&amp;purpose=treatment&amp;status=completed">1</a></td></tr><tr><td>4</td><td>Completed</td><td>Treatment</td><td><a href="/indications/DBCOND0033299">Schizoaffective Disorders</a> <span>/</span> <a href="/indications/DBCOND0018504">Schizophrenia</a> <span>/</span> <a href="/indications/DBCOND0031772">Schizophreniform Disorders</a></td><td><a href="/drugs/DB00481/clinical_trials?conditions=DBCOND0033299%2CDBCOND0018504%2CDBCOND0031772&amp;phase=4&amp;purpose=treatment&amp;status=completed">1</a></td></tr><tr><td>4</td><td>Completed</td><td>Treatment</td><td><a href="/indications/DBCOND0018504">Schizophrenia</a></td><td><a href="/drugs/DB00481/clinical_trials?conditions=DBCOND0018504&amp;phase=4&amp;purpose=treatment&amp;status=completed">2</a></td></tr><tr><td>4</td><td>Recruiting</td><td>Treatment</td><td><a href="/indications/DBCOND0018735">Depression</a></td><td><a href="/drugs/DB00481/clinical_trials?conditions=DBCOND0018735&amp;phase=4&amp;purpose=treatment&amp;status=recruiting">1</a></td></tr><tr><td>4</td><td>Recruiting</td><td>Treatment</td><td><a href="/indications/DBCOND0015928">Osteoporosis</a> <span>/</span> <a href="/indications/DBCOND0030339">Postmenopausal Osteoporosis</a></td><td><a href="/drugs/DB00481/clinical_trials?conditions=DBCOND0015928%2CDBCOND0030339&amp;phase=4&amp;purpose=treatment&amp;status=recruiting">1</a></td></tr></tbody></table></dd></dl><h2 id="pharmacoeconomics-header" class="section-header">Pharmacoeconomics</h2><dl><dt class="col-xl-2 col-md-3 col-sm-4" id="manufacturers">Manufacturers</dt><dd class="col-xl-10 col-md-9 col-sm-8"><div class="manufacturer-columns"><ul class="list-unstyled table-list"><li>Eli lilly and co</li></ul></div></dd><dt class="col-xl-2 col-md-3 col-sm-4" id="packagers">Packagers</dt><dd class="col-xl-10 col-md-9 col-sm-8"><div class="packager-columns"><ul class="list-unstyled table-list"><li>AQ Pharmaceuticals Inc.</li>
<li>A-S Medication Solutions LLC</li>
<li>Atlantic Biologicals Corporation</li>
<li>Cardinal Health</li>
<li>Eli Lilly &amp; Co.</li>
<li>Kaiser Foundation Hospital</li>
<li>Lilly Del Caribe Inc.</li>
<li>Murfreesboro Pharmaceutical Nursing Supply</li>
<li>PD-Rx Pharmaceuticals Inc.</li>
<li>Physicians Total Care Inc.</li>
<li>Prepak Systems Inc.</li>
<li>Resource Optimization and Innovation LLC</li></ul></div></dd><dt class="col-xl-2 col-md-3 col-sm-4" id="dosage-forms">Dosage Forms</dt><dd class="col-xl-10 col-md-9 col-sm-8"><table class="table table-sm datatable" id="dosages"><thead><tr><th>Form</th><th>Route</th><th>Strength</th></tr></thead><tbody><tr><td>Tablet, coated</td><td>Oral</td><td>60 mg</td></tr><tr><td>Tablet</td><td>Oral</td><td>60 mg/1</td></tr><tr><td>Tablet</td><td>Oral</td><td>60 mg</td></tr><tr><td>Tablet</td><td>Oral</td><td></td></tr><tr><td>Tablet, film coated</td><td>Oral</td><td>60 mg</td></tr><tr><td>Tablet, film coated</td><td>Oral</td><td></td></tr><tr><td>Tablet, coated</td><td>Oral</td><td>60 mg/1</td></tr><tr><td>Tablet, film coated</td><td>Oral</td><td>60 mg/1</td></tr><tr><td>Tablet, film coated</td><td>Oral</td><td>60.0 mg</td></tr></tbody></table></dd><dt class="col-xl-2 col-md-3 col-sm-4" id="prices">Prices</dt><dd class="col-xl-10 col-md-9 col-sm-8"><table class="table table-sm datatable" id="prices"><thead><tr><th>Unit description</th><th>Cost</th><th>Unit</th></tr></thead><tbody><tr><td>Evista 60 mg tablet</td><td>4.37USD </td><td>tablet</td></tr></tbody></table><div class="alert alert-warning clearfix price-alert"><span class="glyphicon glyphicon-info-sign"> </span> DrugBank does not sell nor buy drugs. Pricing information is supplied for informational purposes only. </div></dd><dt class="col-xl-2 col-md-3 col-sm-4" id="patents">Patents</dt><dd class="col-xl-10 col-md-9 col-sm-8"><table class="table table-sm datatable dt-responsive" id="patents" style="width: 100%"><thead><tr><th>Patent Number</th><th>Pediatric Extension</th><th>Approved</th><th>Expires (estimated)</th><th><span class="hidden-title">Region</span></th></tr></thead><tbody><tr><td><a target="_blank" rel="noopener" href="https://patents.google.com/patent/US5393763">US5393763</a></td><td><span class="badge badge-secondary badge-pill ">No</span></td><td>1995-02-28</td><td>2012-07-28</td><td class="country"><span class="country"><span hidden="hidden">US</span><img loading="lazy" title="US" alt="US flag" src="/assets/countries/us-827348b033d3b349931e036455f341029a75d10b2533057ebfbfdb0ca0e45c47.svg"></span></td></tr><tr><td><a target="_blank" rel="noopener" href="https://patents.google.com/patent/CA2158400">CA2158400</a></td><td><span class="badge badge-secondary badge-pill ">No</span></td><td>2006-10-24</td><td>2015-09-15</td><td class="country"><span class="country"><span hidden="hidden">Canada</span><img loading="lazy" title="Canada" alt="Canada flag" src="/assets/countries/ca-64ffe8c476c257597eca3ded684da90a2b1a500bd6389ebd2ca5e213b1cc7574.svg"></span></td></tr><tr><td><a target="_blank" rel="noopener" href="https://patents.google.com/patent/CA2101356">CA2101356</a></td><td><span class="badge badge-secondary badge-pill ">No</span></td><td>1998-11-17</td><td>2013-07-27</td><td class="country"><span class="country"><span hidden="hidden">Canada</span><img loading="lazy" title="Canada" alt="Canada flag" src="/assets/countries/ca-64ffe8c476c257597eca3ded684da90a2b1a500bd6389ebd2ca5e213b1cc7574.svg"></span></td></tr><tr><td><a target="_blank" rel="noopener" href="https://patents.google.com/patent/US6458811">US6458811</a></td><td><span class="badge badge-secondary badge-pill ">No</span></td><td>2002-10-01</td><td>2017-03-10</td><td class="country"><span class="country"><span hidden="hidden">US</span><img loading="lazy" title="US" alt="US flag" src="/assets/countries/us-827348b033d3b349931e036455f341029a75d10b2533057ebfbfdb0ca0e45c47.svg"></span></td></tr><tr><td><a target="_blank" rel="noopener" href="https://patents.google.com/patent/US6894064">US6894064</a></td><td><span class="badge badge-secondary badge-pill ">No</span></td><td>2005-05-17</td><td>2017-03-10</td><td class="country"><span class="country"><span hidden="hidden">US</span><img loading="lazy" title="US" alt="US flag" src="/assets/countries/us-827348b033d3b349931e036455f341029a75d10b2533057ebfbfdb0ca0e45c47.svg"></span></td></tr><tr><td><a target="_blank" rel="noopener" href="https://patents.google.com/patent/US6797719">US6797719</a></td><td><span class="badge badge-secondary badge-pill ">No</span></td><td>2004-09-28</td><td>2017-03-10</td><td class="country"><span class="country"><span hidden="hidden">US</span><img loading="lazy" title="US" alt="US flag" src="/assets/countries/us-827348b033d3b349931e036455f341029a75d10b2533057ebfbfdb0ca0e45c47.svg"></span></td></tr><tr><td><a target="_blank" rel="noopener" href="https://patents.google.com/patent/US8030330">US8030330</a></td><td><span class="badge badge-secondary badge-pill ">No</span></td><td>2011-10-04</td><td>2017-03-10</td><td class="country"><span class="country"><span hidden="hidden">US</span><img loading="lazy" title="US" alt="US flag" src="/assets/countries/us-827348b033d3b349931e036455f341029a75d10b2533057ebfbfdb0ca0e45c47.svg"></span></td></tr></tbody></table></dd></dl><h2 id="properties-header" class="section-header">Properties</h2><dl><dt class="col-xl-2 col-md-3 col-sm-4" id="state">State</dt><dd class="col-xl-10 col-md-9 col-sm-8">Solid</dd><dt class="col-xl-2 col-md-3 col-sm-4" id="experimental-properties">Experimental Properties</dt><dd class="col-xl-10 col-md-9 col-sm-8"><table class="table table-sm table-bordered" id="experimental-properties"><thead><tr><th class="head-medium">Property</th><th class="head-large">Value</th><th>Source</th></tr></thead><tbody><tr><td>melting point (°C)</td><td>268-272</td><td>MSDS</td></tr><tr><td>water solubility</td><td>Insoluble</td><td>MSDS</td></tr><tr><td>logP</td><td>5.2</td><td><span class="not-available">Not Available</span></td></tr></tbody></table></dd><dt class="col-xl-2 col-md-3 col-sm-4" id="predicted-properties">Predicted Properties</dt><dd class="col-xl-10 col-md-9 col-sm-8"><table class="table table-sm responsive-table" id="drug-moldb-properties"><thead><tr><th class="head-medium">Property</th><th class="head-large">Value</th><th>Source</th></tr></thead><tbody><tr><td>Water Solubility</td><td>0.000512 mg/mL</td><td><a target="_blank" rel="noopener" href="http://www.vcclab.org/lab/alogps/">ALOGPS</a></td></tr><tr><td>logP</td><td>5.45</td><td><a target="_blank" rel="noopener" href="http://www.vcclab.org/lab/alogps/">ALOGPS</a></td></tr><tr><td>logP</td><td>5.46</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-predictors/#logp_logd">ChemAxon</a></td></tr><tr><td>logS</td><td>-6</td><td><a target="_blank" rel="noopener" href="http://www.vcclab.org/lab/alogps/">ALOGPS</a></td></tr><tr><td>pKa (Strongest Acidic)</td><td>9</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-predictors/#pka">ChemAxon</a></td></tr><tr><td>pKa (Strongest Basic)</td><td>8.42</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-predictors/#pka">ChemAxon</a></td></tr><tr><td>Physiological Charge</td><td>1</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-predictors/#pka">ChemAxon</a></td></tr><tr><td>Hydrogen Acceptor Count</td><td>5</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-calculations/#h_bond">ChemAxon</a></td></tr><tr><td>Hydrogen Donor Count</td><td>2</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-calculations/#h_bond">ChemAxon</a></td></tr><tr><td>Polar Surface Area</td><td>70 Å<sup>2</sup></td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-calculations/#topolgical_surface">ChemAxon</a></td></tr><tr><td>Rotatable Bond Count</td><td>7</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-calculations/#topology_analysis">ChemAxon</a></td></tr><tr><td>Refractivity</td><td>135.48 m<sup>3</sup>·mol<sup>-1</sup></td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-calculations/#refractivity">ChemAxon</a></td></tr><tr><td>Polarizability</td><td>52.55 Å<sup>3</sup></td><td><a href="http://www.chemaxon.com/products/calculator-plugins/molecular-modelling/#polarization">ChemAxon</a></td></tr><tr><td>Number of Rings</td><td>5</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-calculations/#topology_analysis">ChemAxon</a></td></tr><tr><td>Bioavailability</td><td>1</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/molecular-modelling/#polarization">ChemAxon</a></td></tr><tr><td>Rule of Five</td><td>No</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/molecular-modelling/#polarization">ChemAxon</a></td></tr><tr><td>Ghose Filter</td><td>No</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/molecular-modelling/#polarization">ChemAxon</a></td></tr><tr><td>Veber's Rule</td><td>No</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/molecular-modelling/#polarization">ChemAxon</a></td></tr><tr><td>MDDR-like Rule</td><td>Yes</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/molecular-modelling/#polarization">ChemAxon</a></td></tr></tbody></table></dd><dt class="col-xl-2 col-md-3 col-sm-4" id="predicted-admet-features">Predicted ADMET Features</dt><dd class="col-xl-10 col-md-9 col-sm-8"><table class="table table-sm responsive-table" id="drug-predicted-admet"><thead><tr><th>Property</th><th>Value</th><th>Probability</th></tr></thead><tbody><tr><td>Human Intestinal Absorption</td><td>+</td><td>0.9865</td></tr><tr><td>Blood Brain Barrier</td><td>+</td><td>0.8661</td></tr><tr><td>Caco-2 permeable</td><td>-</td><td>0.8957</td></tr><tr><td>P-glycoprotein substrate</td><td>Substrate</td><td>0.7751</td></tr><tr><td>P-glycoprotein inhibitor I</td><td>Non-inhibitor</td><td>0.6231</td></tr><tr><td>P-glycoprotein inhibitor II</td><td>Inhibitor</td><td>0.9366</td></tr><tr><td>Renal organic cation transporter</td><td>Inhibitor</td><td>0.634</td></tr><tr><td>CYP450 2C9 substrate</td><td>Non-substrate</td><td>0.7897</td></tr><tr><td>CYP450 2D6 substrate</td><td>Non-substrate</td><td>0.9116</td></tr><tr><td>CYP450 3A4 substrate</td><td>Substrate</td><td>0.5198</td></tr><tr><td>CYP450 1A2 substrate</td><td>Non-inhibitor</td><td>0.9045</td></tr><tr><td>CYP450 2C9 inhibitor</td><td>Non-inhibitor</td><td>0.9071</td></tr><tr><td>CYP450 2D6 inhibitor</td><td>Inhibitor</td><td>0.8932</td></tr><tr><td>CYP450 2C19 inhibitor</td><td>Inhibitor</td><td>0.8986</td></tr><tr><td>CYP450 3A4 inhibitor</td><td>Inhibitor</td><td>0.7617</td></tr><tr><td>CYP450 inhibitory promiscuity</td><td>High CYP Inhibitory Promiscuity</td><td>0.8222</td></tr><tr><td>Ames test</td><td>Non AMES toxic</td><td>0.8487</td></tr><tr><td>Carcinogenicity</td><td>Non-carcinogens</td><td>0.9433</td></tr><tr><td>Biodegradation</td><td>Not ready biodegradable</td><td>0.9587</td></tr><tr><td>Rat acute toxicity</td><td>2.5287 LD50, mol/kg </td><td><span class="not-available">Not applicable</span></td></tr><tr><td>hERG inhibition (predictor I)</td><td>Weak inhibitor</td><td>0.6322</td></tr><tr><td>hERG inhibition (predictor II)</td><td>Inhibitor</td><td>0.5779</td></tr></tbody></table><div class="alert alert-warning clearfix admetsar-alert"><span class="glyphicon glyphicon-info-sign"> </span> ADMET data is predicted using <a href="http://lmmd.ecust.edu.cn:8000">admetSAR</a>, a free tool for evaluating chemical ADMET properties. (<a target="_blank" rel="noopener" href="https://www.ncbi.nlm.nih.gov/pubmed/23092397">23092397</a>) </div></dd></dl><h2 id="spectra-header" class="section-header">Spectra</h2><dl><dt class="col-xl-2 col-md-3 col-sm-4" id="mass-spec">Mass Spec (NIST)</dt><dd class="col-xl-10 col-md-9 col-sm-8"><span class="not-available">Not Available</span></dd><dt class="col-xl-2 col-md-3 col-sm-4" id="spectra">Spectra</dt><dd class="col-xl-10 col-md-9 col-sm-8"><table class="table table-sm responsive-table" id="spectra-table"><thead><tr><th>Spectrum</th><th>Spectrum Type</th><th><a target="_blank" rel="noopener" href="http://splash.fiehnlab.ucdavis.edu/">Splash Key</a></th></tr></thead><tbody data-no-turbolink=""><tr><td><a href="/spectra/c_ms/23231">Predicted GC-MS Spectrum - GC-MS</a></td><td>Predicted GC-MS</td><td class="break-cell"><span class="not-available">Not Available</span></td></tr><tr><td><a href="/spectra/ms_ms/80550">Predicted MS/MS Spectrum - 10V, Positive (Annotated)</a></td><td>Predicted LC-MS/MS</td><td class="break-cell"><span class="not-available">Not Available</span></td></tr><tr><td><a href="/spectra/ms_ms/80551">Predicted MS/MS Spectrum - 20V, Positive (Annotated)</a></td><td>Predicted LC-MS/MS</td><td class="break-cell"><span class="not-available">Not Available</span></td></tr><tr><td><a href="/spectra/ms_ms/80552">Predicted MS/MS Spectrum - 40V, Positive (Annotated)</a></td><td>Predicted LC-MS/MS</td><td class="break-cell"><span class="not-available">Not Available</span></td></tr><tr><td><a href="/spectra/ms_ms/141447">Predicted MS/MS Spectrum - 10V, Negative (Annotated)</a></td><td>Predicted LC-MS/MS</td><td class="break-cell"><span class="not-available">Not Available</span></td></tr><tr><td><a href="/spectra/ms_ms/141448">Predicted MS/MS Spectrum - 20V, Negative (Annotated)</a></td><td>Predicted LC-MS/MS</td><td class="break-cell"><span class="not-available">Not Available</span></td></tr><tr><td><a href="/spectra/ms_ms/141449">Predicted MS/MS Spectrum - 40V, Negative (Annotated)</a></td><td>Predicted LC-MS/MS</td><td class="break-cell"><span class="not-available">Not Available</span></td></tr><tr><td><a href="/spectra/ms_ms/440611">LC-MS/MS Spectrum - LC-ESI-QFT , negative</a></td><td>LC-MS/MS</td><td class="break-cell"><a target="_blank" rel="noopener" href="http://mona.fiehnlab.ucdavis.edu/#/spectra/splash/splash10-0229-0035900000-dcf0b4afb1abd2691c7c">splash10-0229-0035900000-dcf0b4afb1abd2691c7c</a></td></tr><tr><td><a href="/spectra/ms_ms/452370">LC-MS/MS Spectrum - LC-ESI-QFT , positive</a></td><td>LC-MS/MS</td><td class="break-cell"><a target="_blank" rel="noopener" href="http://mona.fiehnlab.ucdavis.edu/#/spectra/splash/splash10-0229-6600900000-ea14790ae9aed263379b">splash10-0229-6600900000-ea14790ae9aed263379b</a></td></tr></tbody></table></dd></dl><div class="bond-list-container targets" id="targets"><h3>Targets</h3><div class="bond-list"><a class="locked-incopy track-link" target="_blank" data-link-id="locked/drug-targets-desktop-2" href="https://bit.ly/3iYePSn?li=locked/drug-targets-desktop-2"><div class="incopy-left incopy-drugtargets2"><img class="locked-drugtargets2-img" src="/assets/locked/DrugTargets2-682eb846d210ae4bf33ca03febccfb57bb1c61318e699b729e5df4dfab2c5b67.png"><div class="incopy-text drugtargets2-text"><div class="title"><strong>Build, predict &amp; validate machine-learning models</strong></div><div class="subtitle">Use our structured and evidence-based datasets to <strong>unlock new<br>insights and accelerate drug research.</strong></div></div></div><div class="incopy-button btn btn-pink-filled">Learn more<div class=" drugbank-icon icon-see_more"><svg class="icon" role="img" title="see_more"> <use xlink:href="/assets/plus/icons-70333afa0729472c7516e40340ba51254bb889e8a9a12dcd9b4434a43b7ee583.svg#see_more"> </use></svg></div></div></a><a class="locked-incopy locked-incopy-mobile track-link" target="_blank" data-link-id="locked/drug-targets-mobile-2" href="https://bit.ly/3zOIrse?li=locked/drug-targets-mobile-2" style=""><div class="title">Use our structured and evidence-based datasets to unlock new insights and accelerate drug research.</div><div class="button-container"><div class="incopy-button btn btn-pink-filled">Learn more</div></div></a><div class="bond card" id="BE0000123"><div aria-hidden="true" aria-labelledby="binding properties" class="modal fade" id="BE0000123-binding-properties" role="dialog" tabindex="-1"><div class="modal-dialog modal-dialog-centered"><div class="modal-content"><div class="modal-header"><h5 class="modal-title">Binding Properties</h5><button aria-hidden="true" class="close" data-dismiss="modal" type="button">×</button></div><div class="modal-body"><div class="table-responsive"><table class="table table-sm"><thead><tr><th>Property</th><th>Measurement</th><th>pH</th><th>Temperature (°C)</th><th>References</th></tr></thead><tbody><tr><td>EC 50 (nM)</td><td>2.4</td><td>7.4</td><td>22</td><td><span class="separated-list-container"><span class="separated-list col-lg-12 col-xl-6"><span class="separated-list-item"><a target="_blank" href="/articles/A28344">A28344</a></span><span class="list-separator"> / </span><span class="separated-list-item"><a target="_blank" href="/articles/A28352">A28352</a></span></span></span></td></tr><tr><td>EC 50 (nM)</td><td>22</td><td><span class="not-available">N/A</span></td><td><span class="not-available">N/A</span></td><td><span class="separated-list-container"><span class="separated-list col-lg-12 col-xl-6"><span class="separated-list-item"><a target="_blank" href="/articles/A28361">A28361</a></span></span></span></td></tr><tr><td>EC 50 (nM)</td><td>4.32</td><td>7.5</td><td>22</td><td><span class="separated-list-container"><span class="separated-list col-lg-12 col-xl-6"><span class="separated-list-item"><a target="_blank" href="/articles/A28357">A28357</a></span></span></span></td></tr><tr><td>IC 50 (nM)</td><td>0.3</td><td><span class="not-available">N/A</span></td><td><span class="not-available">N/A</span></td><td><span class="separated-list-container"><span class="separated-list col-lg-12 col-xl-6"><span class="separated-list-item"><a target="_blank" href="/articles/A28364">A28364</a></span></span></span></td></tr><tr><td>IC 50 (nM)</td><td>0.46</td><td><span class="not-available">N/A</span></td><td><span class="not-available">N/A</span></td><td><span class="separated-list-container"><span class="separated-list col-lg-12 col-xl-6"><span class="separated-list-item"><a target="_blank" href="/articles/A28358">A28358</a></span></span></span></td></tr><tr><td>IC 50 (nM)</td><td>0.7</td><td><span class="not-available">N/A</span></td><td><span class="not-available">N/A</span></td><td><span class="separated-list-container"><span class="separated-list col-lg-12 col-xl-6"><span class="separated-list-item"><a target="_blank" href="/articles/A28340">A28340</a></span></span></span></td></tr><tr><td>IC 50 (nM)</td><td>0.73</td><td><span class="not-available">N/A</span></td><td><span class="not-available">N/A</span></td><td><span class="separated-list-container"><span class="separated-list col-lg-12 col-xl-6"><span class="separated-list-item"><a target="_blank" href="/articles/A28353">A28353</a></span></span></span></td></tr><tr><td>IC 50 (nM)</td><td>0.89</td><td><span class="not-available">N/A</span></td><td><span class="not-available">N/A</span></td><td><span class="separated-list-container"><span class="separated-list col-lg-12 col-xl-6"><span class="separated-list-item"><a target="_blank" href="/articles/A28354">A28354</a></span></span></span></td></tr><tr><td>IC 50 (nM)</td><td>1.8</td><td><span class="not-available">N/A</span></td><td><span class="not-available">N/A</span></td><td><span class="separated-list-container"><span class="separated-list col-lg-12 col-xl-6"><span class="separated-list-item"><a target="_blank" href="/articles/A28341">A28341</a></span><span class="list-separator"> / </span><span class="separated-list-item"><a target="_blank" href="/articles/A28345">A28345</a></span><span class="list-separator"> / </span><span class="separated-list-item"><a target="_blank" href="/articles/A28346">A28346</a></span><span class="list-separator"> / </span><span class="separated-list-item"><a target="_blank" href="/articles/A28347">A28347</a></span><span class="list-separator"> / </span><span class="separated-list-item"><a target="_blank" href="/articles/A28348">A28348</a></span><span class="list-separator"> / </span><span class="separated-list-item"><a target="_blank" href="/articles/A28349">A28349</a></span><span class="list-separator"> / </span><span class="separated-list-item"><a target="_blank" href="/articles/A28350">A28350</a></span><span class="list-separator"> / </span><span class="separated-list-item"><a target="_blank" href="/articles/A28351">A28351</a></span><span class="list-separator"> / </span><span class="separated-list-item"><a target="_blank" href="/articles/A28356">A28356</a></span><span class="list-separator"> / </span><span class="separated-list-item"><a target="_blank" href="/articles/A28359">A28359</a></span><span class="list-separator"> / </span><span class="separated-list-item"><a target="_blank" href="/articles/A28363">A28363</a></span></span></span></td></tr><tr><td>IC 50 (nM)</td><td>20.6</td><td>7.5</td><td>22</td><td><span class="separated-list-container"><span class="separated-list col-lg-12 col-xl-6"><span class="separated-list-item"><a target="_blank" href="/articles/A28360">A28360</a></span></span></span></td></tr><tr><td>IC 50 (nM)</td><td>22</td><td>7.4</td><td>22</td><td><span class="separated-list-container"><span class="separated-list col-lg-12 col-xl-6"><span class="separated-list-item"><a target="_blank" href="/articles/A27496">A27496</a></span><span class="list-separator"> / </span><span class="separated-list-item"><a target="_blank" href="/articles/A28344">A28344</a></span><span class="list-separator"> / </span><span class="separated-list-item"><a target="_blank" href="/articles/A28352">A28352</a></span></span></span></td></tr><tr><td>IC 50 (nM)</td><td>222</td><td><span class="not-available">N/A</span></td><td><span class="not-available">N/A</span></td><td><span class="separated-list-container"><span class="separated-list col-lg-12 col-xl-6"><span class="separated-list-item"><a target="_blank" href="/articles/A28363">A28363</a></span></span></span></td></tr><tr><td>IC 50 (nM)</td><td>24</td><td><span class="not-available">N/A</span></td><td><span class="not-available">N/A</span></td><td><span class="separated-list-container"><span class="separated-list col-lg-12 col-xl-6"><span class="separated-list-item"><a target="_blank" href="/articles/A28363">A28363</a></span></span></span></td></tr><tr><td>IC 50 (nM)</td><td>4</td><td><span class="not-available">N/A</span></td><td><span class="not-available">N/A</span></td><td><span class="separated-list-container"><span class="separated-list col-lg-12 col-xl-6"><span class="separated-list-item"><a target="_blank" href="/articles/A27495">A27495</a></span></span></span></td></tr><tr><td>IC 50 (nM)</td><td>7</td><td><span class="not-available">N/A</span></td><td><span class="not-available">N/A</span></td><td><span class="separated-list-container"><span class="separated-list col-lg-12 col-xl-6"><span class="separated-list-item"><a target="_blank" href="/articles/A28343">A28343</a></span></span></span></td></tr><tr><td>Ki (nM)</td><td>0.03</td><td><span class="not-available">N/A</span></td><td><span class="not-available">N/A</span></td><td><span class="separated-list-container"><span class="separated-list col-lg-12 col-xl-6"><span class="separated-list-item"><a target="_blank" href="/articles/A28355">A28355</a></span></span></span></td></tr><tr><td>Ki (nM)</td><td>0.22</td><td><span class="not-available">N/A</span></td><td><span class="not-available">N/A</span></td><td><span class="separated-list-container"><span class="separated-list col-lg-12 col-xl-6"><span class="separated-list-item"><a target="_blank" href="/articles/A28339">A28339</a></span></span></span></td></tr><tr><td>Ki (nM)</td><td>0.37</td><td>7.5</td><td>22</td><td><span class="separated-list-container"><span class="separated-list col-lg-12 col-xl-6"><span class="separated-list-item"><a target="_blank" href="/articles/A28357">A28357</a></span></span></span></td></tr><tr><td>Ki (nM)</td><td>0.4</td><td><span class="not-available">N/A</span></td><td><span class="not-available">N/A</span></td><td><span class="separated-list-container"><span class="separated-list col-lg-12 col-xl-6"><span class="separated-list-item"><a target="_blank" href="/articles/A28342">A28342</a></span></span></span></td></tr><tr><td>Ki (nM)</td><td>2</td><td><span class="not-available">N/A</span></td><td><span class="not-available">N/A</span></td><td><span class="separated-list-container"><span class="separated-list col-lg-12 col-xl-6"><span class="separated-list-item"><a target="_blank" href="/articles/A28362">A28362</a></span></span></span></td></tr></tbody></table></div></div></div></div></div><div class="card-header"><a class="btn btn-drugbank-secondary btn-sm bond-details-link ml-3" href="/polypeptides/P03372"><div class="drugbank-icon icon-expand"><svg class="icon" role="img" title="expand">
<use xlink:href="/assets/icons-539be351b538129271b9ee92cb0ebbd16efad4fccf6e2fe95aa6234f1e7417fa.svg#expand"></use>
</svg>
</div> Details</a><button class="btn btn-sm btn-drugbank-secondary" data-target="#BE0000123-binding-properties" data-toggle="modal" type="button"><div class="drugbank-icon icon-details"><svg class="icon" role="img" title="details">
<use xlink:href="/assets/icons-539be351b538129271b9ee92cb0ebbd16efad4fccf6e2fe95aa6234f1e7417fa.svg#details"></use>
</svg>
</div> <span class="full-binding-label">Binding Properties</span></button><strong>1. <a href="/polypeptides/P03372">Estrogen receptor alpha</a></strong></div><div class="card-body"><div class="row"><div class="col-sm-12 col-lg-5"><dl><dt class="col-md-5 col-sm-6" id="kind">Kind</dt><dd class="col-md-7 col-sm-6">Protein</dd><dt class="col-md-5 col-sm-6" id="organism">Organism</dt><dd class="col-md-7 col-sm-6">Humans</dd><dt class="col-md-5 col-sm-6" id="pharmacological-action">Pharmacological action</dt><dd class="col-md-7 col-sm-6"><div class="badge badge badge-yes">Yes</div></dd><dt class="col-md-5 col-sm-6" id="actions">Actions</dt><dd class="col-md-7 col-sm-6"><div class="badge badge-pill badge-action">Agonist</div></dd></dl></div><div class="col-sm-12 col-lg-7"><dl><dt class="col-md-5 col-sm-6" id="general-function">General Function</dt><dd class="col-md-7 col-sm-6">Zinc ion binding</dd><dt class="col-md-5 col-sm-6" id="specific-function">Specific Function</dt><dd class="col-md-7 col-sm-6">Nuclear hormone receptor. The steroid hormones and their receptors are involved in the regulation of eukaryotic gene expression and affect cellular proliferation and differentiation in target tissu...</dd><dt class="col-md-5 col-sm-6" id="gene-name">Gene Name</dt><dd class="col-md-7 col-sm-6">ESR1</dd><dt class="col-md-5 col-sm-6" id="uniprot-id">Uniprot ID</dt><dd class="col-md-7 col-sm-6"><a target="_blank" rel="noopener" href="http://www.uniprot.org/uniprot/P03372">P03372</a></dd><dt class="col-md-5 col-sm-6" id="uniprot-name">Uniprot Name</dt><dd class="col-md-7 col-sm-6">Estrogen receptor</dd><dt class="col-md-5 col-sm-6" id="molecular-weight">Molecular Weight</dt><dd class="col-md-7 col-sm-6">66215.45 Da</dd></dl></div></div><h5>References</h5><div class="references"><ol class="cite-this-references"><li id="reference-A718">Khovidhunkit W, Shoback DM: Clinical effects of raloxifene hydrochloride in women. Ann Intern Med. 1999 Mar 2;130(5):431-9. [<a target="_blank" href="/articles/A718">Article</a>] </li><li id="reference-A719">Cummings SR, Eckert S, Krueger KA, Grady D, Powles TJ, Cauley JA, Norton L, Nickelsen T, Bjarnason NH, Morrow M, Lippman ME, Black D, Glusman JE, Costa A, Jordan VC: The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple Outcomes of Raloxifene Evaluation. JAMA. 1999 Jun 16;281(23):2189-97. [<a target="_blank" href="/articles/A719">Article</a>] </li><li id="reference-A720">Bryant HU, Glasebrook AL, Yang NN, Sato M: An estrogen receptor basis for raloxifene action in bone. J Steroid Biochem Mol Biol. 1999 Apr-Jun;69(1-6):37-44. [<a target="_blank" href="/articles/A720">Article</a>] </li><li id="reference-A4975">Figtree GA, Lu Y, Webb CM, Collins P: Raloxifene acutely relaxes rabbit coronary arteries in vitro by an estrogen receptor-dependent and nitric oxide-dependent mechanism. Circulation. 1999 Sep 7;100(10):1095-101. [<a target="_blank" href="/articles/A4975">Article</a>] </li><li id="reference-A4976">Schafer JI, Liu H, Tonetti DA, Jordan VC: The interaction of raloxifene and the active metabolite of the antiestrogen EM-800 (SC 5705) with the human estrogen receptor. Cancer Res. 1999 Sep 1;59(17):4308-13. [<a target="_blank" href="/articles/A4976">Article</a>] </li><li id="reference-A9">Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. [<a target="_blank" href="/articles/A9">Article</a>] </li><li id="reference-A4977">Scott JA, Da Camara CC, Early JE: Raloxifene: a selective estrogen receptor modulator. Am Fam Physician. 1999 Sep 15;60(4):1131-9. [<a target="_blank" href="/articles/A4977">Article</a>] </li><li id="reference-A4978">Matsumoto T: [Selective estrogen receptor modulators (SERMs)]. Clin Calcium. 2006 Sep;16(9):1520-25. [<a target="_blank" href="/articles/A4978">Article</a>] </li><li id="reference-A4979">Moen MD, Keating GM: Raloxifene: a review of its use in the prevention of invasive breast cancer. Drugs. 2008;68(14):2059-83. [<a target="_blank" href="/articles/A4979">Article</a>] </li></ol></div></div></div><div class="bond card" id="BE0000792"><div aria-hidden="true" aria-labelledby="binding properties" class="modal fade" id="BE0000792-binding-properties" role="dialog" tabindex="-1"><div class="modal-dialog modal-dialog-centered"><div class="modal-content"><div class="modal-header"><h5 class="modal-title">Binding Properties</h5><button aria-hidden="true" class="close" data-dismiss="modal" type="button">×</button></div><div class="modal-body"><div class="table-responsive"><table class="table table-sm"><thead><tr><th>Property</th><th>Measurement</th><th>pH</th><th>Temperature (°C)</th><th>References</th></tr></thead><tbody><tr><td>EC 50 (nM)</td><td>341</td><td>7.4</td><td>22</td><td><span class="separated-list-container"><span class="separated-list col-lg-12 col-xl-6"><span class="separated-list-item"><a target="_blank" href="/articles/A28344">A28344</a></span><span class="list-separator"> / </span><span class="separated-list-item"><a target="_blank" href="/articles/A28352">A28352</a></span></span></span></td></tr><tr><td>EC 50 (nM)</td><td>4.32</td><td>7.5</td><td>22</td><td><span class="separated-list-container"><span class="separated-list col-lg-12 col-xl-6"><span class="separated-list-item"><a target="_blank" href="/articles/A28357">A28357</a></span></span></span></td></tr><tr><td>IC 50 (nM)</td><td>1.6</td><td><span class="not-available">N/A</span></td><td><span class="not-available">N/A</span></td><td><span class="separated-list-container"><span class="separated-list col-lg-12 col-xl-6"><span class="separated-list-item"><a target="_blank" href="/articles/A28354">A28354</a></span></span></span></td></tr><tr><td>IC 50 (nM)</td><td>1.9</td><td><span class="not-available">N/A</span></td><td><span class="not-available">N/A</span></td><td><span class="separated-list-container"><span class="separated-list col-lg-12 col-xl-6"><span class="separated-list-item"><a target="_blank" href="/articles/A28365">A28365</a></span></span></span></td></tr><tr><td>IC 50 (nM)</td><td>12</td><td><span class="not-available">N/A</span></td><td><span class="not-available">N/A</span></td><td><span class="separated-list-container"><span class="separated-list col-lg-12 col-xl-6"><span class="separated-list-item"><a target="_blank" href="/articles/A28341">A28341</a></span><span class="list-separator"> / </span><span class="separated-list-item"><a target="_blank" href="/articles/A28345">A28345</a></span><span class="list-separator"> / </span><span class="separated-list-item"><a target="_blank" href="/articles/A28346">A28346</a></span><span class="list-separator"> / </span><span class="separated-list-item"><a target="_blank" href="/articles/A28347">A28347</a></span><span class="list-separator"> / </span><span class="separated-list-item"><a target="_blank" href="/articles/A28348">A28348</a></span><span class="list-separator"> / </span><span class="separated-list-item"><a target="_blank" href="/articles/A28349">A28349</a></span><span class="list-separator"> / </span><span class="separated-list-item"><a target="_blank" href="/articles/A28350">A28350</a></span><span class="list-separator"> / </span><span class="separated-list-item"><a target="_blank" href="/articles/A28351">A28351</a></span><span class="list-separator"> / </span><span class="separated-list-item"><a target="_blank" href="/articles/A28356">A28356</a></span></span></span></td></tr><tr><td>IC 50 (nM)</td><td>15</td><td><span class="not-available">N/A</span></td><td><span class="not-available">N/A</span></td><td><span class="separated-list-container"><span class="separated-list col-lg-12 col-xl-6"><span class="separated-list-item"><a target="_blank" href="/articles/A28340">A28340</a></span></span></span></td></tr><tr><td>IC 50 (nM)</td><td>18.9</td><td><span class="not-available">N/A</span></td><td><span class="not-available">N/A</span></td><td><span class="separated-list-container"><span class="separated-list col-lg-12 col-xl-6"><span class="separated-list-item"><a target="_blank" href="/articles/A28353">A28353</a></span></span></span></td></tr><tr><td>IC 50 (nM)</td><td>260</td><td>7.4</td><td>22</td><td><span class="separated-list-container"><span class="separated-list col-lg-12 col-xl-6"><span class="separated-list-item"><a target="_blank" href="/articles/A27496">A27496</a></span><span class="list-separator"> / </span><span class="separated-list-item"><a target="_blank" href="/articles/A28344">A28344</a></span><span class="list-separator"> / </span><span class="separated-list-item"><a target="_blank" href="/articles/A28352">A28352</a></span></span></span></td></tr><tr><td>IC 50 (nM)</td><td>43</td><td><span class="not-available">N/A</span></td><td><span class="not-available">N/A</span></td><td><span class="separated-list-container"><span class="separated-list col-lg-12 col-xl-6"><span class="separated-list-item"><a target="_blank" href="/articles/A27495">A27495</a></span></span></span></td></tr><tr><td>IC 50 (nM)</td><td>470</td><td><span class="not-available">N/A</span></td><td><span class="not-available">N/A</span></td><td><span class="separated-list-container"><span class="separated-list col-lg-12 col-xl-6"><span class="separated-list-item"><a target="_blank" href="/articles/A28343">A28343</a></span></span></span></td></tr><tr><td>IC 50 (nM)</td><td>557</td><td>7.5</td><td>22</td><td><span class="separated-list-container"><span class="separated-list col-lg-12 col-xl-6"><span class="separated-list-item"><a target="_blank" href="/articles/A28360">A28360</a></span></span></span></td></tr><tr><td>IC 50 (nM)</td><td>6.9</td><td><span class="not-available">N/A</span></td><td><span class="not-available">N/A</span></td><td><span class="separated-list-container"><span class="separated-list col-lg-12 col-xl-6"><span class="separated-list-item"><a target="_blank" href="/articles/A28364">A28364</a></span></span></span></td></tr><tr><td>IC 50 (nM)</td><td>8.2</td><td><span class="not-available">N/A</span></td><td><span class="not-available">N/A</span></td><td><span class="separated-list-container"><span class="separated-list col-lg-12 col-xl-6"><span class="separated-list-item"><a target="_blank" href="/articles/A28359">A28359</a></span><span class="list-separator"> / </span><span class="separated-list-item"><a target="_blank" href="/articles/A28363">A28363</a></span></span></span></td></tr><tr><td>Ki (nM)</td><td>10</td><td><span class="not-available">N/A</span></td><td><span class="not-available">N/A</span></td><td><span class="separated-list-container"><span class="separated-list col-lg-12 col-xl-6"><span class="separated-list-item"><a target="_blank" href="/articles/A28339">A28339</a></span></span></span></td></tr><tr><td>Ki (nM)</td><td>2.74</td><td>7.5</td><td>22</td><td><span class="separated-list-container"><span class="separated-list col-lg-12 col-xl-6"><span class="separated-list-item"><a target="_blank" href="/articles/A28357">A28357</a></span></span></span></td></tr><tr><td>Ki (nM)</td><td>23</td><td><span class="not-available">N/A</span></td><td><span class="not-available">N/A</span></td><td><span class="separated-list-container"><span class="separated-list col-lg-12 col-xl-6"><span class="separated-list-item"><a target="_blank" href="/articles/A28362">A28362</a></span></span></span></td></tr><tr><td>Ki (nM)</td><td>4.3</td><td><span class="not-available">N/A</span></td><td><span class="not-available">N/A</span></td><td><span class="separated-list-container"><span class="separated-list col-lg-12 col-xl-6"><span class="separated-list-item"><a target="_blank" href="/articles/A28342">A28342</a></span></span></span></td></tr><tr><td>Ki (nM)</td><td>4.5</td><td><span class="not-available">N/A</span></td><td><span class="not-available">N/A</span></td><td><span class="separated-list-container"><span class="separated-list col-lg-12 col-xl-6"><span class="separated-list-item"><a target="_blank" href="/articles/A28355">A28355</a></span></span></span></td></tr></tbody></table></div></div></div></div></div><div class="card-header"><a class="btn btn-drugbank-secondary btn-sm bond-details-link ml-3" href="/polypeptides/Q92731"><div class="drugbank-icon icon-expand"><svg class="icon" role="img" title="expand">
<use xlink:href="/assets/icons-539be351b538129271b9ee92cb0ebbd16efad4fccf6e2fe95aa6234f1e7417fa.svg#expand"></use>
</svg>
</div> Details</a><button class="btn btn-sm btn-drugbank-secondary" data-target="#BE0000792-binding-properties" data-toggle="modal" type="button"><div class="drugbank-icon icon-details"><svg class="icon" role="img" title="details">
<use xlink:href="/assets/icons-539be351b538129271b9ee92cb0ebbd16efad4fccf6e2fe95aa6234f1e7417fa.svg#details"></use>
</svg>
</div> <span class="full-binding-label">Binding Properties</span></button><strong>2. <a href="/polypeptides/Q92731">Estrogen receptor beta</a></strong></div><div class="card-body"><div class="row"><div class="col-sm-12 col-lg-5"><dl><dt class="col-md-5 col-sm-6" id="kind">Kind</dt><dd class="col-md-7 col-sm-6">Protein</dd><dt class="col-md-5 col-sm-6" id="organism">Organism</dt><dd class="col-md-7 col-sm-6">Humans</dd><dt class="col-md-5 col-sm-6" id="pharmacological-action">Pharmacological action</dt><dd class="col-md-7 col-sm-6"><div class="badge badge badge-yes">Yes</div></dd><dt class="col-md-5 col-sm-6" id="actions">Actions</dt><dd class="col-md-7 col-sm-6"><div class="badge badge-pill badge-action">Agonist</div></dd></dl></div><div class="col-sm-12 col-lg-7"><dl><dt class="col-md-5 col-sm-6" id="general-function">General Function</dt><dd class="col-md-7 col-sm-6">Zinc ion binding</dd><dt class="col-md-5 col-sm-6" id="specific-function">Specific Function</dt><dd class="col-md-7 col-sm-6">Nuclear hormone receptor. Binds estrogens with an affinity similar to that of ESR1, and activates expression of reporter genes containing estrogen response elements (ERE) in an estrogen-dependent m...</dd><dt class="col-md-5 col-sm-6" id="gene-name">Gene Name</dt><dd class="col-md-7 col-sm-6">ESR2</dd><dt class="col-md-5 col-sm-6" id="uniprot-id">Uniprot ID</dt><dd class="col-md-7 col-sm-6"><a target="_blank" rel="noopener" href="http://www.uniprot.org/uniprot/Q92731">Q92731</a></dd><dt class="col-md-5 col-sm-6" id="uniprot-name">Uniprot Name</dt><dd class="col-md-7 col-sm-6">Estrogen receptor beta</dd><dt class="col-md-5 col-sm-6" id="molecular-weight">Molecular Weight</dt><dd class="col-md-7 col-sm-6">59215.765 Da</dd></dl></div></div><h5>References</h5><div class="references"><ol class="cite-this-references"><li id="reference-A720">Bryant HU, Glasebrook AL, Yang NN, Sato M: An estrogen receptor basis for raloxifene action in bone. J Steroid Biochem Mol Biol. 1999 Apr-Jun;69(1-6):37-44. [<a target="_blank" href="/articles/A720">Article</a>] </li><li id="reference-A11856">Iannone MA, Consler TG, Pearce KH, Stimmel JB, Parks DJ, Gray JG: Multiplexed molecular interactions of nuclear receptors using fluorescent microspheres. Cytometry. 2001 Aug 1;44(4):326-37. [<a target="_blank" href="/articles/A11856">Article</a>] </li><li id="reference-A11857">Zhou W, Koldzic-Zivanovic N, Clarke CH, de Beun R, Wassermann K, Bury PS, Cunningham KA, Thomas ML: Selective estrogen receptor modulator effects in the rat brain. Neuroendocrinology. 2002 Jan;75(1):24-33. [<a target="_blank" href="/articles/A11857">Article</a>] </li><li id="reference-A11858">Sun J, Huang YR, Harrington WR, Sheng S, Katzenellenbogen JA, Katzenellenbogen BS: Antagonists selective for estrogen receptor alpha. Endocrinology. 2002 Mar;143(3):941-7. [<a target="_blank" href="/articles/A11858">Article</a>] </li><li id="reference-A11859">Kim IY, Seong DH, Kim BC, Lee DK, Remaley AT, Leach F, Morton RA, Kim SJ: Raloxifene, a selective estrogen receptor modulator, induces apoptosis in androgen-responsive human prostate cancer cell line LNCaP through an androgen-independent pathway. Cancer Res. 2002 Jul 1;62(13):3649-53. [<a target="_blank" href="/articles/A11859">Article</a>] </li><li id="reference-A9">Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. [<a target="_blank" href="/articles/A9">Article</a>] </li></ol></div></div></div><div class="bond card" id="BE0008982"><div class="card-header"><a class="btn btn-drugbank-secondary btn-sm bond-details-link ml-3" href="/polypeptides/P50453"><div class="drugbank-icon icon-expand"><svg class="icon" role="img" title="expand">
<use xlink:href="/assets/icons-539be351b538129271b9ee92cb0ebbd16efad4fccf6e2fe95aa6234f1e7417fa.svg#expand"></use>
</svg>
</div> Details</a><strong>3. <a href="/polypeptides/P50453">Serpin B9</a></strong></div><div class="card-body"><div class="row"><div class="col-sm-12 col-lg-5"><dl><dt class="col-md-5 col-sm-6" id="kind">Kind</dt><dd class="col-md-7 col-sm-6">Protein</dd><dt class="col-md-5 col-sm-6" id="organism">Organism</dt><dd class="col-md-7 col-sm-6">Humans</dd><dt class="col-md-5 col-sm-6" id="pharmacological-action">Pharmacological action</dt><dd class="col-md-7 col-sm-6"><div class="badge badge badge-unknown">Unknown</div></dd></dl></div><div class="col-sm-12 col-lg-7"><dl><dt class="col-md-5 col-sm-6" id="general-function">General Function</dt><dd class="col-md-7 col-sm-6">Granzyme B inhibitor.</dd><dt class="col-md-5 col-sm-6" id="specific-function">Specific Function</dt><dd class="col-md-7 col-sm-6">Cysteine-type endopeptidase inhibitor activity involved in apoptotic process</dd><dt class="col-md-5 col-sm-6" id="gene-name">Gene Name</dt><dd class="col-md-7 col-sm-6">SERPINB9</dd><dt class="col-md-5 col-sm-6" id="uniprot-id">Uniprot ID</dt><dd class="col-md-7 col-sm-6"><a target="_blank" rel="noopener" href="http://www.uniprot.org/uniprot/P50453">P50453</a></dd><dt class="col-md-5 col-sm-6" id="uniprot-name">Uniprot Name</dt><dd class="col-md-7 col-sm-6">Serpin B9</dd><dt class="col-md-5 col-sm-6" id="molecular-weight">Molecular Weight</dt><dd class="col-md-7 col-sm-6">42403.185 Da</dd></dl></div></div><h5>References</h5><div class="references"><ol class="cite-this-references"><li id="reference-A19883">Krieg AJ, Krieg SA, Ahn BS, Shapiro DJ: Interplay between estrogen response element sequence and ligands controls in vivo binding of estrogen receptor to regulated genes. J Biol Chem. 2004 Feb 6;279(6):5025-34. Epub 2003 Nov 14. [<a target="_blank" href="/articles/A19883">Article</a>] </li></ol></div></div></div><div class="bond card" id="BE0008981"><div class="card-header"><a class="btn btn-drugbank-secondary btn-sm bond-details-link ml-3" href="/polypeptides/P04155"><div class="drugbank-icon icon-expand"><svg class="icon" role="img" title="expand">
<use xlink:href="/assets/icons-539be351b538129271b9ee92cb0ebbd16efad4fccf6e2fe95aa6234f1e7417fa.svg#expand"></use>
</svg>
</div> Details</a><strong>4. <a href="/polypeptides/P04155">Trefoil factor 1</a></strong></div><div class="card-body"><div class="row"><div class="col-sm-12 col-lg-5"><dl><dt class="col-md-5 col-sm-6" id="kind">Kind</dt><dd class="col-md-7 col-sm-6">Protein</dd><dt class="col-md-5 col-sm-6" id="organism">Organism</dt><dd class="col-md-7 col-sm-6">Humans</dd><dt class="col-md-5 col-sm-6" id="pharmacological-action">Pharmacological action</dt><dd class="col-md-7 col-sm-6"><div class="badge badge badge-unknown">Unknown</div></dd></dl></div><div class="col-sm-12 col-lg-7"><dl><dt class="col-md-5 col-sm-6" id="general-function">General Function</dt><dd class="col-md-7 col-sm-6">Stabilizer of the mucous gel overlying the gastrointestinal mucosa that provides a physical barrier against various noxious agents. May inhibit the growth of calcium oxalate crystals in urine.</dd><dt class="col-md-5 col-sm-6" id="specific-function">Specific Function</dt><dd class="col-md-7 col-sm-6">Growth factor activity</dd><dt class="col-md-5 col-sm-6" id="gene-name">Gene Name</dt><dd class="col-md-7 col-sm-6">TFF1</dd><dt class="col-md-5 col-sm-6" id="uniprot-id">Uniprot ID</dt><dd class="col-md-7 col-sm-6"><a target="_blank" rel="noopener" href="http://www.uniprot.org/uniprot/P04155">P04155</a></dd><dt class="col-md-5 col-sm-6" id="uniprot-name">Uniprot Name</dt><dd class="col-md-7 col-sm-6">Trefoil factor 1</dd><dt class="col-md-5 col-sm-6" id="molecular-weight">Molecular Weight</dt><dd class="col-md-7 col-sm-6">9149.435 Da</dd></dl></div></div><h5>References</h5><div class="references"><ol class="cite-this-references"><li id="reference-A19883">Krieg AJ, Krieg SA, Ahn BS, Shapiro DJ: Interplay between estrogen response element sequence and ligands controls in vivo binding of estrogen receptor to regulated genes. J Biol Chem. 2004 Feb 6;279(6):5025-34. Epub 2003 Nov 14. [<a target="_blank" href="/articles/A19883">Article</a>] </li></ol></div></div></div></div></div><div class="bond-list-container enzymes" id="enzymes"><h3>Enzymes</h3><div class="bond-list"><div class="bond card" id="BE0003549"><div class="card-header"><a class="btn btn-drugbank-secondary btn-sm bond-details-link ml-3" href="/polypeptides/P20813"><div class="drugbank-icon icon-expand"><svg class="icon" role="img" title="expand">
<use xlink:href="/assets/icons-539be351b538129271b9ee92cb0ebbd16efad4fccf6e2fe95aa6234f1e7417fa.svg#expand"></use>
</svg>
</div> Details</a><strong>1. <a href="/polypeptides/P20813">Cytochrome P450 2B6</a></strong></div><div class="card-body"><div class="row"><div class="col-sm-12 col-lg-5"><dl><dt class="col-md-5 col-sm-6" id="kind">Kind</dt><dd class="col-md-7 col-sm-6">Protein</dd><dt class="col-md-5 col-sm-6" id="organism">Organism</dt><dd class="col-md-7 col-sm-6">Humans</dd><dt class="col-md-5 col-sm-6" id="pharmacological-action">Pharmacological action</dt><dd class="col-md-7 col-sm-6"><div class="badge badge badge-unknown">Unknown</div></dd><dt class="col-md-5 col-sm-6" id="actions">Actions</dt><dd class="col-md-7 col-sm-6"><div class="badge badge-pill badge-action">Inhibitor</div></dd></dl></div><div class="col-sm-12 col-lg-7"><dl><dt class="col-md-5 col-sm-6" id="general-function">General Function</dt><dd class="col-md-7 col-sm-6">Steroid hydroxylase activity</dd><dt class="col-md-5 col-sm-6" id="specific-function">Specific Function</dt><dd class="col-md-7 col-sm-6">Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It oxidizes a variety of structurally un...</dd><dt class="col-md-5 col-sm-6" id="gene-name">Gene Name</dt><dd class="col-md-7 col-sm-6">CYP2B6</dd><dt class="col-md-5 col-sm-6" id="uniprot-id">Uniprot ID</dt><dd class="col-md-7 col-sm-6"><a target="_blank" rel="noopener" href="http://www.uniprot.org/uniprot/P20813">P20813</a></dd><dt class="col-md-5 col-sm-6" id="uniprot-name">Uniprot Name</dt><dd class="col-md-7 col-sm-6">Cytochrome P450 2B6</dd><dt class="col-md-5 col-sm-6" id="molecular-weight">Molecular Weight</dt><dd class="col-md-7 col-sm-6">56277.81 Da</dd></dl></div></div><h5>References</h5><div class="references"><ol class="cite-this-references"><li id="reference-A14854">Walsky RL, Astuccio AV, Obach RS: Evaluation of 227 drugs for in vitro inhibition of cytochrome P450 2B6. J Clin Pharmacol. 2006 Dec;46(12):1426-38. [<a target="_blank" href="/articles/A14854">Article</a>] </li></ol></div></div></div><div class="bond card" id="BE0002887"><div class="card-header"><a class="btn btn-drugbank-secondary btn-sm bond-details-link ml-3" href="/polypeptides/P10632"><div class="drugbank-icon icon-expand"><svg class="icon" role="img" title="expand">
<use xlink:href="/assets/icons-539be351b538129271b9ee92cb0ebbd16efad4fccf6e2fe95aa6234f1e7417fa.svg#expand"></use>
</svg>
</div> Details</a><strong>2. <a href="/polypeptides/P10632">Cytochrome P450 2C8</a></strong></div><div class="card-body"><div class="row"><div class="col-sm-12 col-lg-5"><dl><dt class="col-md-5 col-sm-6" id="kind">Kind</dt><dd class="col-md-7 col-sm-6">Protein</dd><dt class="col-md-5 col-sm-6" id="organism">Organism</dt><dd class="col-md-7 col-sm-6">Humans</dd><dt class="col-md-5 col-sm-6" id="pharmacological-action">Pharmacological action</dt><dd class="col-md-7 col-sm-6"><div class="badge badge badge-unknown">Unknown</div></dd><dt class="col-md-5 col-sm-6" id="actions">Actions</dt><dd class="col-md-7 col-sm-6"><div class="badge badge-pill badge-action">Inhibitor</div></dd></dl></div><div class="col-sm-12 col-lg-7"><dl><dt class="col-md-5 col-sm-6" id="general-function">General Function</dt><dd class="col-md-7 col-sm-6">Steroid hydroxylase activity</dd><dt class="col-md-5 col-sm-6" id="specific-function">Specific Function</dt><dd class="col-md-7 col-sm-6">Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It oxidizes a variety of structurally un...</dd><dt class="col-md-5 col-sm-6" id="gene-name">Gene Name</dt><dd class="col-md-7 col-sm-6">CYP2C8</dd><dt class="col-md-5 col-sm-6" id="uniprot-id">Uniprot ID</dt><dd class="col-md-7 col-sm-6"><a target="_blank" rel="noopener" href="http://www.uniprot.org/uniprot/P10632">P10632</a></dd><dt class="col-md-5 col-sm-6" id="uniprot-name">Uniprot Name</dt><dd class="col-md-7 col-sm-6">Cytochrome P450 2C8</dd><dt class="col-md-5 col-sm-6" id="molecular-weight">Molecular Weight</dt><dd class="col-md-7 col-sm-6">55824.275 Da</dd></dl></div></div><h5>References</h5><div class="references"><ol class="cite-this-references"><li id="reference-A15162">Walsky RL, Gaman EA, Obach RS: Examination of 209 drugs for inhibition of cytochrome P450 2C8. J Clin Pharmacol. 2005 Jan;45(1):68-78. [<a target="_blank" href="/articles/A15162">Article</a>] </li><li id="reference-A184157">VandenBrink BM, Davis JA, Pearson JT, Foti RS, Wienkers LC, Rock DA: Cytochrome p450 architecture and cysteine nucleophile placement impact raloxifene-mediated mechanism-based inactivation. Mol Pharmacol. 2012 Nov;82(5):835-42. doi: 10.1124/mol.112.080739. Epub 2012 Aug 2. [<a target="_blank" href="/articles/A184157">Article</a>] </li></ol></div></div></div><div class="bond card" id="BE0003539"><div aria-hidden="true" aria-labelledby="binding properties" class="modal fade" id="BE0003539-binding-properties" role="dialog" tabindex="-1"><div class="modal-dialog modal-dialog-centered"><div class="modal-content"><div class="modal-header"><h5 class="modal-title">Binding Properties</h5><button aria-hidden="true" class="close" data-dismiss="modal" type="button">×</button></div><div class="modal-body"><div class="table-responsive"><table class="table table-sm"><thead><tr><th>Property</th><th>Measurement</th><th>pH</th><th>Temperature (°C)</th><th>References</th></tr></thead><tbody><tr><td>IC 50 (nM)</td><td>3</td><td><span class="not-available">N/A</span></td><td><span class="not-available">N/A</span></td><td><span class="separated-list-container"><span class="separated-list col-lg-12 col-xl-6"><span class="separated-list-item"><a target="_blank" href="/articles/A27340">A27340</a></span></span></span></td></tr><tr><td>Ki (nM)</td><td>0.9</td><td><span class="not-available">N/A</span></td><td><span class="not-available">N/A</span></td><td><span class="separated-list-container"><span class="separated-list col-lg-12 col-xl-6"><span class="separated-list-item"><a target="_blank" href="/articles/A27340">A27340</a></span></span></span></td></tr></tbody></table></div></div></div></div></div><div class="card-header"><a class="btn btn-drugbank-secondary btn-sm bond-details-link ml-3" href="/polypeptides/Q06278"><div class="drugbank-icon icon-expand"><svg class="icon" role="img" title="expand">
<use xlink:href="/assets/icons-539be351b538129271b9ee92cb0ebbd16efad4fccf6e2fe95aa6234f1e7417fa.svg#expand"></use>
</svg>
</div> Details</a><button class="btn btn-sm btn-drugbank-secondary" data-target="#BE0003539-binding-properties" data-toggle="modal" type="button"><div class="drugbank-icon icon-details"><svg class="icon" role="img" title="details">
<use xlink:href="/assets/icons-539be351b538129271b9ee92cb0ebbd16efad4fccf6e2fe95aa6234f1e7417fa.svg#details"></use>
</svg>
</div> <span class="full-binding-label">Binding Properties</span></button><strong>3. <a href="/polypeptides/Q06278">Aldehyde oxidase</a></strong></div><div class="card-body"><div class="row"><div class="col-sm-12 col-lg-5"><dl><dt class="col-md-5 col-sm-6" id="kind">Kind</dt><dd class="col-md-7 col-sm-6">Protein</dd><dt class="col-md-5 col-sm-6" id="organism">Organism</dt><dd class="col-md-7 col-sm-6">Humans</dd><dt class="col-md-5 col-sm-6" id="pharmacological-action">Pharmacological action</dt><dd class="col-md-7 col-sm-6"><div class="badge badge badge-unknown">Unknown</div></dd><dt class="col-md-5 col-sm-6" id="actions">Actions</dt><dd class="col-md-7 col-sm-6"><div class="badge badge-pill badge-action">Inhibitor</div></dd></dl></div><div class="col-sm-12 col-lg-7"><dl><dt class="col-md-5 col-sm-6" id="general-function">General Function</dt><dd class="col-md-7 col-sm-6">Xanthine dehydrogenase activity</dd><dt class="col-md-5 col-sm-6" id="specific-function">Specific Function</dt><dd class="col-md-7 col-sm-6">Oxidase with broad substrate specificity, oxidizing aromatic azaheterocycles, such as N1-methylnicotinamide and N-methylphthalazinium, as well as aldehydes, such as benzaldehyde, retinal, pyridoxal...</dd><dt class="col-md-5 col-sm-6" id="gene-name">Gene Name</dt><dd class="col-md-7 col-sm-6">AOX1</dd><dt class="col-md-5 col-sm-6" id="uniprot-id">Uniprot ID</dt><dd class="col-md-7 col-sm-6"><a target="_blank" rel="noopener" href="http://www.uniprot.org/uniprot/Q06278">Q06278</a></dd><dt class="col-md-5 col-sm-6" id="uniprot-name">Uniprot Name</dt><dd class="col-md-7 col-sm-6">Aldehyde oxidase</dd><dt class="col-md-5 col-sm-6" id="molecular-weight">Molecular Weight</dt><dd class="col-md-7 col-sm-6">147916.735 Da</dd></dl></div></div><h5>References</h5><div class="references"><ol class="cite-this-references"><li id="reference-A15054">Obach RS: Potent inhibition of human liver aldehyde oxidase by raloxifene. Drug Metab Dispos. 2004 Jan;32(1):89-97. [<a target="_blank" href="/articles/A15054">Article</a>] </li><li id="reference-A15055">Obach RS, Huynh P, Allen MC, Beedham C: Human liver aldehyde oxidase: inhibition by 239 drugs. J Clin Pharmacol. 2004 Jan;44(1):7-19. [<a target="_blank" href="/articles/A15055">Article</a>] </li><li id="reference-A15056">Sahi J, Khan KK, Black CB: Aldehyde oxidase activity and inhibition in hepatocytes and cytosolic fractions from mouse, rat, monkey and human. Drug Metab Lett. 2008 Aug;2(3):176-83. [<a target="_blank" href="/articles/A15056">Article</a>] </li></ol></div></div></div><div class="bond card" id="BE0002090"><div class="card-header"><a class="btn btn-drugbank-secondary btn-sm bond-details-link ml-3" href="/polypeptides/P11511"><div class="drugbank-icon icon-expand"><svg class="icon" role="img" title="expand">
<use xlink:href="/assets/icons-539be351b538129271b9ee92cb0ebbd16efad4fccf6e2fe95aa6234f1e7417fa.svg#expand"></use>
</svg>
</div> Details</a><strong>4. <a href="/polypeptides/P11511">Cytochrome P450 19A1</a></strong></div><div class="card-body"><div class="row"><div class="col-sm-12 col-lg-5"><dl><dt class="col-md-5 col-sm-6" id="kind">Kind</dt><dd class="col-md-7 col-sm-6">Protein</dd><dt class="col-md-5 col-sm-6" id="organism">Organism</dt><dd class="col-md-7 col-sm-6">Humans</dd><dt class="col-md-5 col-sm-6" id="pharmacological-action">Pharmacological action</dt><dd class="col-md-7 col-sm-6"><div class="badge badge badge-unknown">Unknown</div></dd><dt class="col-md-5 col-sm-6" id="actions">Actions</dt><dd class="col-md-7 col-sm-6"><div class="badge badge-pill badge-action">Inhibitor</div></dd></dl></div><div class="col-sm-12 col-lg-7"><dl><dt class="col-md-5 col-sm-6" id="general-function">General Function</dt><dd class="col-md-7 col-sm-6">Oxygen binding</dd><dt class="col-md-5 col-sm-6" id="specific-function">Specific Function</dt><dd class="col-md-7 col-sm-6">Catalyzes the formation of aromatic C18 estrogens from C19 androgens.</dd><dt class="col-md-5 col-sm-6" id="gene-name">Gene Name</dt><dd class="col-md-7 col-sm-6">CYP19A1</dd><dt class="col-md-5 col-sm-6" id="uniprot-id">Uniprot ID</dt><dd class="col-md-7 col-sm-6"><a target="_blank" rel="noopener" href="http://www.uniprot.org/uniprot/P11511">P11511</a></dd><dt class="col-md-5 col-sm-6" id="uniprot-name">Uniprot Name</dt><dd class="col-md-7 col-sm-6">Aromatase</dd><dt class="col-md-5 col-sm-6" id="molecular-weight">Molecular Weight</dt><dd class="col-md-7 col-sm-6">57882.48 Da</dd></dl></div></div><h5>References</h5><div class="references"><ol class="cite-this-references"><li id="reference-A23769">Fiorelli G, Picariello L, Martineti V, Tonelli F, Brandi ML: Estrogen synthesis in human colon cancer epithelial cells. J Steroid Biochem Mol Biol. 1999 Dec 31;71(5-6):223-30. [<a target="_blank" href="/articles/A23769">Article</a>] </li></ol></div></div></div><div class="bond card" id="BE0002638"><div aria-hidden="true" aria-labelledby="binding properties" class="modal fade" id="BE0002638-binding-properties" role="dialog" tabindex="-1"><div class="modal-dialog modal-dialog-centered"><div class="modal-content"><div class="modal-header"><h5 class="modal-title">Binding Properties</h5><button aria-hidden="true" class="close" data-dismiss="modal" type="button">×</button></div><div class="modal-body"><div class="table-responsive"><table class="table table-sm"><thead><tr><th>Property</th><th>Measurement</th><th>pH</th><th>Temperature (°C)</th><th>References</th></tr></thead><tbody><tr><td>Ki (nM)</td><td>9900</td><td><span class="not-available">N/A</span></td><td><span class="not-available">N/A</span></td><td><span class="separated-list-container"><span class="separated-list col-lg-12 col-xl-6"><span class="separated-list-item"><a target="_blank" href="/articles/A18342">A18342</a></span><span class="list-separator"> / </span><span class="separated-list-item"><a target="_blank" href="/articles/A27452">A27452</a></span></span></span></td></tr></tbody></table></div></div></div></div></div><div class="card-header"><a class="btn btn-drugbank-secondary btn-sm bond-details-link ml-3" href="/polypeptides/P08684"><div class="drugbank-icon icon-expand"><svg class="icon" role="img" title="expand">
<use xlink:href="/assets/icons-539be351b538129271b9ee92cb0ebbd16efad4fccf6e2fe95aa6234f1e7417fa.svg#expand"></use>
</svg>
</div> Details</a><button class="btn btn-sm btn-drugbank-secondary" data-target="#BE0002638-binding-properties" data-toggle="modal" type="button"><div class="drugbank-icon icon-details"><svg class="icon" role="img" title="details">
<use xlink:href="/assets/icons-539be351b538129271b9ee92cb0ebbd16efad4fccf6e2fe95aa6234f1e7417fa.svg#details"></use>
</svg>
</div> <span class="full-binding-label">Binding Properties</span></button><strong>5. <a href="/polypeptides/P08684">Cytochrome P450 3A4</a></strong></div><div class="card-body"><div class="row"><div class="col-sm-12 col-lg-5"><dl><dt class="col-md-5 col-sm-6" id="kind">Kind</dt><dd class="col-md-7 col-sm-6">Protein</dd><dt class="col-md-5 col-sm-6" id="organism">Organism</dt><dd class="col-md-7 col-sm-6">Humans</dd><dt class="col-md-5 col-sm-6" id="pharmacological-action">Pharmacological action</dt><dd class="col-md-7 col-sm-6"><div class="badge badge badge-unknown">Unknown</div></dd><dt class="col-md-5 col-sm-6" id="actions">Actions</dt><dd class="col-md-7 col-sm-6"><div class="badge badge-pill badge-action">Inhibitor</div></dd></dl></div><div class="col-sm-12 col-lg-7"><dl><dt class="col-md-5 col-sm-6" id="general-function">General Function</dt><dd class="col-md-7 col-sm-6">Vitamin d3 25-hydroxylase activity</dd><dt class="col-md-5 col-sm-6" id="specific-function">Specific Function</dt><dd class="col-md-7 col-sm-6">Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It performs a variety of oxidation react...</dd><dt class="col-md-5 col-sm-6" id="gene-name">Gene Name</dt><dd class="col-md-7 col-sm-6">CYP3A4</dd><dt class="col-md-5 col-sm-6" id="uniprot-id">Uniprot ID</dt><dd class="col-md-7 col-sm-6"><a target="_blank" rel="noopener" href="http://www.uniprot.org/uniprot/P08684">P08684</a></dd><dt class="col-md-5 col-sm-6" id="uniprot-name">Uniprot Name</dt><dd class="col-md-7 col-sm-6">Cytochrome P450 3A4</dd><dt class="col-md-5 col-sm-6" id="molecular-weight">Molecular Weight</dt><dd class="col-md-7 col-sm-6">57342.67 Da</dd></dl></div></div><h5>References</h5><div class="references"><ol class="cite-this-references"><li id="reference-A38602">Moore CD, Reilly CA, Yost GS: CYP3A4-Mediated oxygenation versus dehydrogenation of raloxifene. Biochemistry. 2010 Jun 1;49(21):4466-75. doi: 10.1021/bi902213r. [<a target="_blank" href="/articles/A38602">Article</a>] </li><li id="reference-A184157">VandenBrink BM, Davis JA, Pearson JT, Foti RS, Wienkers LC, Rock DA: Cytochrome p450 architecture and cysteine nucleophile placement impact raloxifene-mediated mechanism-based inactivation. Mol Pharmacol. 2012 Nov;82(5):835-42. doi: 10.1124/mol.112.080739. Epub 2012 Aug 2. [<a target="_blank" href="/articles/A184157">Article</a>] </li></ol></div></div></div><div class="bond card" id="BE0003541"><div class="card-header"><a class="btn btn-drugbank-secondary btn-sm bond-details-link ml-3" href="/polypeptides/P22309"><div class="drugbank-icon icon-expand"><svg class="icon" role="img" title="expand">
<use xlink:href="/assets/icons-539be351b538129271b9ee92cb0ebbd16efad4fccf6e2fe95aa6234f1e7417fa.svg#expand"></use>
</svg>
</div> Details</a><strong>6. <a href="/polypeptides/P22309">UDP-glucuronosyltransferase 1-1</a></strong></div><div class="card-body"><div class="row"><div class="col-sm-12 col-lg-5"><dl><dt class="col-md-5 col-sm-6" id="kind">Kind</dt><dd class="col-md-7 col-sm-6">Protein</dd><dt class="col-md-5 col-sm-6" id="organism">Organism</dt><dd class="col-md-7 col-sm-6">Humans</dd><dt class="col-md-5 col-sm-6" id="pharmacological-action">Pharmacological action</dt><dd class="col-md-7 col-sm-6"><div class="badge badge badge-no">No</div></dd><dt class="col-md-5 col-sm-6" id="actions">Actions</dt><dd class="col-md-7 col-sm-6"><div class="badge badge-pill badge-action">Substrate</div></dd></dl></div><div class="col-sm-12 col-lg-7"><dl><dt class="col-md-5 col-sm-6" id="general-function">General Function</dt><dd class="col-md-7 col-sm-6">Steroid binding</dd><dt class="col-md-5 col-sm-6" id="specific-function">Specific Function</dt><dd class="col-md-7 col-sm-6">UDPGT is of major importance in the conjugation and subsequent elimination of potentially toxic xenobiotics and endogenous compounds. This isoform glucuronidates bilirubin IX-alpha to form both the...</dd><dt class="col-md-5 col-sm-6" id="gene-name">Gene Name</dt><dd class="col-md-7 col-sm-6">UGT1A1</dd><dt class="col-md-5 col-sm-6" id="uniprot-id">Uniprot ID</dt><dd class="col-md-7 col-sm-6"><a target="_blank" rel="noopener" href="http://www.uniprot.org/uniprot/P22309">P22309</a></dd><dt class="col-md-5 col-sm-6" id="uniprot-name">Uniprot Name</dt><dd class="col-md-7 col-sm-6">UDP-glucuronosyltransferase 1-1</dd><dt class="col-md-5 col-sm-6" id="molecular-weight">Molecular Weight</dt><dd class="col-md-7 col-sm-6">59590.91 Da</dd></dl></div></div><h5>References</h5><div class="references"><ol class="cite-this-references"><li id="reference-A34242">Williams JA, Hyland R, Jones BC, Smith DA, Hurst S, Goosen TC, Peterkin V, Koup JR, Ball SE: Drug-drug interactions for UDP-glucuronosyltransferase substrates: a pharmacokinetic explanation for typically observed low exposure (AUCi/AUC) ratios. Drug Metab Dispos. 2004 Nov;32(11):1201-8. doi: 10.1124/dmd.104.000794. Epub 2004 Aug 10. [<a target="_blank" href="/articles/A34242">Article</a>] </li></ol></div></div></div><div class="bond card" id="BE0003678"><div class="card-header"><a class="btn btn-drugbank-secondary btn-sm bond-details-link ml-3" href="/polypeptides/Q9HAW8"><div class="drugbank-icon icon-expand"><svg class="icon" role="img" title="expand">
<use xlink:href="/assets/icons-539be351b538129271b9ee92cb0ebbd16efad4fccf6e2fe95aa6234f1e7417fa.svg#expand"></use>
</svg>
</div> Details</a><strong>7. <a href="/polypeptides/Q9HAW8">UDP-glucuronosyltransferase 1-10</a></strong></div><div class="card-body"><div class="row"><div class="col-sm-12 col-lg-5"><dl><dt class="col-md-5 col-sm-6" id="kind">Kind</dt><dd class="col-md-7 col-sm-6">Protein</dd><dt class="col-md-5 col-sm-6" id="organism">Organism</dt><dd class="col-md-7 col-sm-6">Humans</dd><dt class="col-md-5 col-sm-6" id="pharmacological-action">Pharmacological action</dt><dd class="col-md-7 col-sm-6"><div class="badge badge badge-no">No</div></dd><dt class="col-md-5 col-sm-6" id="actions">Actions</dt><dd class="col-md-7 col-sm-6"><div class="badge badge-pill badge-action">Substrate</div></dd></dl></div><div class="col-sm-12 col-lg-7"><dl><dt class="col-md-5 col-sm-6" id="general-function">General Function</dt><dd class="col-md-7 col-sm-6">Protein kinase c binding</dd><dt class="col-md-5 col-sm-6" id="specific-function">Specific Function</dt><dd class="col-md-7 col-sm-6">UDPGT is of major importance in the conjugation and subsequent elimination of potentially toxic xenobiotics and endogenous compounds. Isoform 2 lacks transferase activity but acts as a negative reg...</dd><dt class="col-md-5 col-sm-6" id="gene-name">Gene Name</dt><dd class="col-md-7 col-sm-6">UGT1A10</dd><dt class="col-md-5 col-sm-6" id="uniprot-id">Uniprot ID</dt><dd class="col-md-7 col-sm-6"><a target="_blank" rel="noopener" href="http://www.uniprot.org/uniprot/Q9HAW8">Q9HAW8</a></dd><dt class="col-md-5 col-sm-6" id="uniprot-name">Uniprot Name</dt><dd class="col-md-7 col-sm-6">UDP-glucuronosyltransferase 1-10</dd><dt class="col-md-5 col-sm-6" id="molecular-weight">Molecular Weight</dt><dd class="col-md-7 col-sm-6">59809.075 Da</dd></dl></div></div><h5>References</h5><div class="references"><ol class="cite-this-references"><li id="reference-A178939">Kemp DC, Fan PW, Stevens JC: Characterization of raloxifene glucuronidation in vitro: contribution of intestinal metabolism to presystemic clearance. Drug Metab Dispos. 2002 Jun;30(6):694-700. [<a target="_blank" href="/articles/A178939">Article</a>] </li><li id="reference-A178936">Sun D, Jones NR, Manni A, Lazarus P: Characterization of raloxifene glucuronidation: potential role of UGT1A8 genotype on raloxifene metabolism in vivo. Cancer Prev Res (Phila). 2013 Jul;6(7):719-30. doi: 10.1158/1940-6207.CAPR-12-0448. Epub 2013 May 16. [<a target="_blank" href="/articles/A178936">Article</a>] </li></ol></div></div></div><div class="bond card" id="BE0003682"><div class="card-header"><a class="btn btn-drugbank-secondary btn-sm bond-details-link ml-3" href="/polypeptides/Q9HAW9"><div class="drugbank-icon icon-expand"><svg class="icon" role="img" title="expand">
<use xlink:href="/assets/icons-539be351b538129271b9ee92cb0ebbd16efad4fccf6e2fe95aa6234f1e7417fa.svg#expand"></use>
</svg>
</div> Details</a><strong>8. <a href="/polypeptides/Q9HAW9">UDP-glucuronosyltransferase 1-8</a></strong></div><div class="card-body"><div class="row"><div class="col-sm-12 col-lg-5"><dl><dt class="col-md-5 col-sm-6" id="kind">Kind</dt><dd class="col-md-7 col-sm-6">Protein</dd><dt class="col-md-5 col-sm-6" id="organism">Organism</dt><dd class="col-md-7 col-sm-6">Humans</dd><dt class="col-md-5 col-sm-6" id="pharmacological-action">Pharmacological action</dt><dd class="col-md-7 col-sm-6"><div class="badge badge badge-no">No</div></dd><dt class="col-md-5 col-sm-6" id="actions">Actions</dt><dd class="col-md-7 col-sm-6"><div class="badge badge-pill badge-action">Substrate</div></dd></dl></div><div class="col-sm-12 col-lg-7"><dl><dt class="col-md-5 col-sm-6" id="general-function">General Function</dt><dd class="col-md-7 col-sm-6">Steroid binding</dd><dt class="col-md-5 col-sm-6" id="specific-function">Specific Function</dt><dd class="col-md-7 col-sm-6">UDPGT is of major importance in the conjugation and subsequent elimination of potentially toxic xenobiotics and endogenous compounds. Isoform 2 lacks transferase activity but acts as a negative reg...</dd><dt class="col-md-5 col-sm-6" id="gene-name">Gene Name</dt><dd class="col-md-7 col-sm-6">UGT1A8</dd><dt class="col-md-5 col-sm-6" id="uniprot-id">Uniprot ID</dt><dd class="col-md-7 col-sm-6"><a target="_blank" rel="noopener" href="http://www.uniprot.org/uniprot/Q9HAW9">Q9HAW9</a></dd><dt class="col-md-5 col-sm-6" id="uniprot-name">Uniprot Name</dt><dd class="col-md-7 col-sm-6">UDP-glucuronosyltransferase 1-8</dd><dt class="col-md-5 col-sm-6" id="molecular-weight">Molecular Weight</dt><dd class="col-md-7 col-sm-6">59741.035 Da</dd></dl></div></div><h5>References</h5><div class="references"><ol class="cite-this-references"><li id="reference-A178936">Sun D, Jones NR, Manni A, Lazarus P: Characterization of raloxifene glucuronidation: potential role of UGT1A8 genotype on raloxifene metabolism in vivo. Cancer Prev Res (Phila). 2013 Jul;6(7):719-30. doi: 10.1158/1940-6207.CAPR-12-0448. Epub 2013 May 16. [<a target="_blank" href="/articles/A178936">Article</a>] </li><li id="reference-A178939">Kemp DC, Fan PW, Stevens JC: Characterization of raloxifene glucuronidation in vitro: contribution of intestinal metabolism to presystemic clearance. Drug Metab Dispos. 2002 Jun;30(6):694-700. [<a target="_blank" href="/articles/A178939">Article</a>] </li></ol></div></div></div></div></div><div class="bond-list-container carriers" id="carriers"><h3>Carriers</h3><div class="bond-list"><div class="bond card" id="BE0000530"><div class="card-header"><a class="btn btn-drugbank-secondary btn-sm bond-details-link ml-3" href="/polypeptides/P02768"><div class="drugbank-icon icon-expand"><svg class="icon" role="img" title="expand">
<use xlink:href="/assets/icons-539be351b538129271b9ee92cb0ebbd16efad4fccf6e2fe95aa6234f1e7417fa.svg#expand"></use>
</svg>
</div> Details</a><strong>1. <a href="/polypeptides/P02768">Serum albumin</a></strong></div><div class="card-body"><div class="row"><div class="col-sm-12 col-lg-5"><dl><dt class="col-md-5 col-sm-6" id="kind">Kind</dt><dd class="col-md-7 col-sm-6">Protein</dd><dt class="col-md-5 col-sm-6" id="organism">Organism</dt><dd class="col-md-7 col-sm-6">Humans</dd><dt class="col-md-5 col-sm-6" id="pharmacological-action">Pharmacological action</dt><dd class="col-md-7 col-sm-6"><div class="badge badge badge-no">No</div></dd><dt class="col-md-5 col-sm-6" id="actions">Actions</dt><dd class="col-md-7 col-sm-6"><div class="badge badge-pill badge-action">Binder</div></dd></dl></div><div class="col-sm-12 col-lg-7"><dl><dt class="col-md-5 col-sm-6" id="general-function">General Function</dt><dd class="col-md-7 col-sm-6">Toxic substance binding</dd><dt class="col-md-5 col-sm-6" id="specific-function">Specific Function</dt><dd class="col-md-7 col-sm-6">Serum albumin, the main protein of plasma, has a good binding capacity for water, Ca(2+), Na(+), K(+), fatty acids, hormones, bilirubin and drugs. Its main function is the regulation of the colloid...</dd><dt class="col-md-5 col-sm-6" id="gene-name">Gene Name</dt><dd class="col-md-7 col-sm-6">ALB</dd><dt class="col-md-5 col-sm-6" id="uniprot-id">Uniprot ID</dt><dd class="col-md-7 col-sm-6"><a target="_blank" rel="noopener" href="http://www.uniprot.org/uniprot/P02768">P02768</a></dd><dt class="col-md-5 col-sm-6" id="uniprot-name">Uniprot Name</dt><dd class="col-md-7 col-sm-6">Serum albumin</dd><dt class="col-md-5 col-sm-6" id="molecular-weight">Molecular Weight</dt><dd class="col-md-7 col-sm-6">69365.94 Da</dd></dl></div></div></div></div><div class="bond card" id="BE0000925"><div class="card-header"><a class="btn btn-drugbank-secondary btn-sm bond-details-link ml-3" href="/polypeptides/P02763"><div class="drugbank-icon icon-expand"><svg class="icon" role="img" title="expand">
<use xlink:href="/assets/icons-539be351b538129271b9ee92cb0ebbd16efad4fccf6e2fe95aa6234f1e7417fa.svg#expand"></use>
</svg>
</div> Details</a><strong>2. <a href="/polypeptides/P02763">Alpha-1-acid glycoprotein 1</a></strong></div><div class="card-body"><div class="row"><div class="col-sm-12 col-lg-5"><dl><dt class="col-md-5 col-sm-6" id="kind">Kind</dt><dd class="col-md-7 col-sm-6">Protein</dd><dt class="col-md-5 col-sm-6" id="organism">Organism</dt><dd class="col-md-7 col-sm-6">Humans</dd><dt class="col-md-5 col-sm-6" id="pharmacological-action">Pharmacological action</dt><dd class="col-md-7 col-sm-6"><div class="badge badge badge-no">No</div></dd><dt class="col-md-5 col-sm-6" id="actions">Actions</dt><dd class="col-md-7 col-sm-6"><div class="badge badge-pill badge-action">Binder</div></dd></dl></div><div class="col-sm-12 col-lg-7"><dl><dt class="col-md-5 col-sm-6" id="general-function">General Function</dt><dd class="col-md-7 col-sm-6"><span class="not-available">Not Available</span></dd><dt class="col-md-5 col-sm-6" id="specific-function">Specific Function</dt><dd class="col-md-7 col-sm-6">Functions as transport protein in the blood stream. Binds various ligands in the interior of its beta-barrel domain. Also binds synthetic drugs and influences their distribution and availability in...</dd><dt class="col-md-5 col-sm-6" id="gene-name">Gene Name</dt><dd class="col-md-7 col-sm-6">ORM1</dd><dt class="col-md-5 col-sm-6" id="uniprot-id">Uniprot ID</dt><dd class="col-md-7 col-sm-6"><a target="_blank" rel="noopener" href="http://www.uniprot.org/uniprot/P02763">P02763</a></dd><dt class="col-md-5 col-sm-6" id="uniprot-name">Uniprot Name</dt><dd class="col-md-7 col-sm-6">Alpha-1-acid glycoprotein 1</dd><dt class="col-md-5 col-sm-6" id="molecular-weight">Molecular Weight</dt><dd class="col-md-7 col-sm-6">23511.38 Da</dd></dl></div></div></div></div></div></div><div class="bond-list-container transporters" id="transporters"><h3>Transporters</h3><div class="bond-list"><div class="bond card" id="BE0001004"><div class="card-header"><a class="btn btn-drugbank-secondary btn-sm bond-details-link ml-3" href="/polypeptides/Q9Y6L6"><div class="drugbank-icon icon-expand"><svg class="icon" role="img" title="expand">
<use xlink:href="/assets/icons-539be351b538129271b9ee92cb0ebbd16efad4fccf6e2fe95aa6234f1e7417fa.svg#expand"></use>
</svg>
</div> Details</a><strong>1. <a href="/polypeptides/Q9Y6L6">Solute carrier organic anion transporter family member 1B1</a></strong></div><div class="card-body"><div class="row"><div class="col-sm-12 col-lg-5"><dl><dt class="col-md-5 col-sm-6" id="kind">Kind</dt><dd class="col-md-7 col-sm-6">Protein</dd><dt class="col-md-5 col-sm-6" id="organism">Organism</dt><dd class="col-md-7 col-sm-6">Humans</dd><dt class="col-md-5 col-sm-6" id="pharmacological-action">Pharmacological action</dt><dd class="col-md-7 col-sm-6"><div class="badge badge badge-unknown">Unknown</div></dd><dt class="col-md-5 col-sm-6" id="actions">Actions</dt><dd class="col-md-7 col-sm-6"><div class="badge badge-pill badge-action">Substrate</div></dd></dl></div><div class="col-sm-12 col-lg-7"><dl><dt class="col-md-5 col-sm-6" id="general-function">General Function</dt><dd class="col-md-7 col-sm-6">Sodium-independent organic anion transmembrane transporter activity</dd><dt class="col-md-5 col-sm-6" id="specific-function">Specific Function</dt><dd class="col-md-7 col-sm-6">Mediates the Na(+)-independent uptake of organic anions such as pravastatin, taurocholate, methotrexate, dehydroepiandrosterone sulfate, 17-beta-glucuronosyl estradiol, estrone sulfate, prostagland...</dd><dt class="col-md-5 col-sm-6" id="gene-name">Gene Name</dt><dd class="col-md-7 col-sm-6">SLCO1B1</dd><dt class="col-md-5 col-sm-6" id="uniprot-id">Uniprot ID</dt><dd class="col-md-7 col-sm-6"><a target="_blank" rel="noopener" href="http://www.uniprot.org/uniprot/Q9Y6L6">Q9Y6L6</a></dd><dt class="col-md-5 col-sm-6" id="uniprot-name">Uniprot Name</dt><dd class="col-md-7 col-sm-6">Solute carrier organic anion transporter family member 1B1</dd><dt class="col-md-5 col-sm-6" id="molecular-weight">Molecular Weight</dt><dd class="col-md-7 col-sm-6">76447.99 Da</dd></dl></div></div><h5>References</h5><div class="references"><ol class="cite-this-references"><li id="reference-A178906">Trdan Lusin T, Stieger B, Marc J, Mrhar A, Trontelj J, Zavratnik A, Ostanek B: Organic anion transporting polypeptides OATP1B1 and OATP1B3 and their genetic variants influence the pharmacokinetics and pharmacodynamics of raloxifene. J Transl Med. 2012 Apr 25;10:76. doi: 10.1186/1479-5876-10-76. [<a target="_blank" href="/articles/A178906">Article</a>] </li></ol></div></div></div><div class="bond card" id="BE0003659"><div class="card-header"><a class="btn btn-drugbank-secondary btn-sm bond-details-link ml-3" href="/polypeptides/Q9NPD5"><div class="drugbank-icon icon-expand"><svg class="icon" role="img" title="expand">
<use xlink:href="/assets/icons-539be351b538129271b9ee92cb0ebbd16efad4fccf6e2fe95aa6234f1e7417fa.svg#expand"></use>
</svg>
</div> Details</a><strong>2. <a href="/polypeptides/Q9NPD5">Solute carrier organic anion transporter family member 1B3</a></strong></div><div class="card-body"><div class="row"><div class="col-sm-12 col-lg-5"><dl><dt class="col-md-5 col-sm-6" id="kind">Kind</dt><dd class="col-md-7 col-sm-6">Protein</dd><dt class="col-md-5 col-sm-6" id="organism">Organism</dt><dd class="col-md-7 col-sm-6">Humans</dd><dt class="col-md-5 col-sm-6" id="pharmacological-action">Pharmacological action</dt><dd class="col-md-7 col-sm-6"><div class="badge badge badge-unknown">Unknown</div></dd><dt class="col-md-5 col-sm-6" id="actions">Actions</dt><dd class="col-md-7 col-sm-6"><div class="badge badge-pill badge-action">Substrate</div></dd></dl></div><div class="col-sm-12 col-lg-7"><dl><dt class="col-md-5 col-sm-6" id="general-function">General Function</dt><dd class="col-md-7 col-sm-6">Sodium-independent organic anion transmembrane transporter activity</dd><dt class="col-md-5 col-sm-6" id="specific-function">Specific Function</dt><dd class="col-md-7 col-sm-6">Mediates the Na(+)-independent uptake of organic anions such as 17-beta-glucuronosyl estradiol, taurocholate, triiodothyronine (T3), leukotriene C4, dehydroepiandrosterone sulfate (DHEAS), methotre...</dd><dt class="col-md-5 col-sm-6" id="gene-name">Gene Name</dt><dd class="col-md-7 col-sm-6">SLCO1B3</dd><dt class="col-md-5 col-sm-6" id="uniprot-id">Uniprot ID</dt><dd class="col-md-7 col-sm-6"><a target="_blank" rel="noopener" href="http://www.uniprot.org/uniprot/Q9NPD5">Q9NPD5</a></dd><dt class="col-md-5 col-sm-6" id="uniprot-name">Uniprot Name</dt><dd class="col-md-7 col-sm-6">Solute carrier organic anion transporter family member 1B3</dd><dt class="col-md-5 col-sm-6" id="molecular-weight">Molecular Weight</dt><dd class="col-md-7 col-sm-6">77402.175 Da</dd></dl></div></div><h5>References</h5><div class="references"><ol class="cite-this-references"><li id="reference-A178906">Trdan Lusin T, Stieger B, Marc J, Mrhar A, Trontelj J, Zavratnik A, Ostanek B: Organic anion transporting polypeptides OATP1B1 and OATP1B3 and their genetic variants influence the pharmacokinetics and pharmacodynamics of raloxifene. J Transl Med. 2012 Apr 25;10:76. doi: 10.1186/1479-5876-10-76. [<a target="_blank" href="/articles/A178906">Article</a>] </li></ol></div></div></div><div class="bond card" id="BE0001032"><div class="card-header"><a class="btn btn-drugbank-secondary btn-sm bond-details-link ml-3" href="/polypeptides/P08183"><div class="drugbank-icon icon-expand"><svg class="icon" role="img" title="expand">
<use xlink:href="/assets/icons-539be351b538129271b9ee92cb0ebbd16efad4fccf6e2fe95aa6234f1e7417fa.svg#expand"></use>
</svg>
</div> Details</a><strong>3. <a href="/polypeptides/P08183">P-glycoprotein 1</a></strong></div><div class="card-body"><div class="row"><div class="col-sm-12 col-lg-5"><dl><dt class="col-md-5 col-sm-6" id="kind">Kind</dt><dd class="col-md-7 col-sm-6">Protein</dd><dt class="col-md-5 col-sm-6" id="organism">Organism</dt><dd class="col-md-7 col-sm-6">Humans</dd><dt class="col-md-5 col-sm-6" id="pharmacological-action">Pharmacological action</dt><dd class="col-md-7 col-sm-6"><div class="badge badge badge-unknown">Unknown</div></dd><dt class="col-md-5 col-sm-6" id="actions">Actions</dt><dd class="col-md-7 col-sm-6"><div class="badge badge-pill badge-action">Substrate</div></dd></dl></div><div class="col-sm-12 col-lg-7"><dl><dt class="col-md-5 col-sm-6" id="general-function">General Function</dt><dd class="col-md-7 col-sm-6">Xenobiotic-transporting atpase activity</dd><dt class="col-md-5 col-sm-6" id="specific-function">Specific Function</dt><dd class="col-md-7 col-sm-6">Energy-dependent efflux pump responsible for decreased drug accumulation in multidrug-resistant cells.</dd><dt class="col-md-5 col-sm-6" id="gene-name">Gene Name</dt><dd class="col-md-7 col-sm-6">ABCB1</dd><dt class="col-md-5 col-sm-6" id="uniprot-id">Uniprot ID</dt><dd class="col-md-7 col-sm-6"><a target="_blank" rel="noopener" href="http://www.uniprot.org/uniprot/P08183">P08183</a></dd><dt class="col-md-5 col-sm-6" id="uniprot-name">Uniprot Name</dt><dd class="col-md-7 col-sm-6">Multidrug resistance protein 1</dd><dt class="col-md-5 col-sm-6" id="molecular-weight">Molecular Weight</dt><dd class="col-md-7 col-sm-6">141477.255 Da</dd></dl></div></div><h5>References</h5><div class="references"><ol class="cite-this-references"><li id="reference-A178909">Trdan Lusin T, Mrhar A, Stieger B, Kullak-Ublick GA, Marc J, Ostanek B, Zavratnik A, Kristl A, Berginc K, Delic K, Trontelj J: Influence of hepatic and intestinal efflux transporters and their genetic variants on the pharmacokinetics and pharmacodynamics of raloxifene in osteoporosis treatment. Transl Res. 2012 Oct;160(4):298-308. doi: 10.1016/j.trsl.2012.03.002. Epub 2012 Mar 28. [<a target="_blank" href="/articles/A178909">Article</a>] </li><li id="reference-A178915">Chang JH, Kochansky CJ, Shou M: The role of P-glycoprotein in the bioactivation of raloxifene. Drug Metab Dispos. 2006 Dec;34(12):2073-8. doi: 10.1124/dmd.106.012179. Epub 2006 Sep 7. [<a target="_blank" href="/articles/A178915">Article</a>] </li></ol></div></div></div><div class="bond card" id="BE0001067"><div class="card-header"><a class="btn btn-drugbank-secondary btn-sm bond-details-link ml-3" href="/polypeptides/Q9UNQ0"><div class="drugbank-icon icon-expand"><svg class="icon" role="img" title="expand">
<use xlink:href="/assets/icons-539be351b538129271b9ee92cb0ebbd16efad4fccf6e2fe95aa6234f1e7417fa.svg#expand"></use>
</svg>
</div> Details</a><strong>4. <a href="/polypeptides/Q9UNQ0">ATP-binding cassette sub-family G member 2</a></strong></div><div class="card-body"><div class="row"><div class="col-sm-12 col-lg-5"><dl><dt class="col-md-5 col-sm-6" id="kind">Kind</dt><dd class="col-md-7 col-sm-6">Protein</dd><dt class="col-md-5 col-sm-6" id="organism">Organism</dt><dd class="col-md-7 col-sm-6">Humans</dd><dt class="col-md-5 col-sm-6" id="pharmacological-action">Pharmacological action</dt><dd class="col-md-7 col-sm-6"><div class="badge badge badge-unknown">Unknown</div></dd><dt class="col-md-5 col-sm-6" id="actions">Actions</dt><dd class="col-md-7 col-sm-6"><div class="badge badge-pill badge-action">Substrate</div></dd></dl></div><div class="col-sm-12 col-lg-7"><dl><dt class="col-md-5 col-sm-6" id="general-function">General Function</dt><dd class="col-md-7 col-sm-6">Xenobiotic-transporting atpase activity</dd><dt class="col-md-5 col-sm-6" id="specific-function">Specific Function</dt><dd class="col-md-7 col-sm-6">High-capacity urate exporter functioning in both renal and extrarenal urate excretion. Plays a role in porphyrin homeostasis as it is able to mediates the export of protoporhyrin IX (PPIX) both fro...</dd><dt class="col-md-5 col-sm-6" id="gene-name">Gene Name</dt><dd class="col-md-7 col-sm-6">ABCG2</dd><dt class="col-md-5 col-sm-6" id="uniprot-id">Uniprot ID</dt><dd class="col-md-7 col-sm-6"><a target="_blank" rel="noopener" href="http://www.uniprot.org/uniprot/Q9UNQ0">Q9UNQ0</a></dd><dt class="col-md-5 col-sm-6" id="uniprot-name">Uniprot Name</dt><dd class="col-md-7 col-sm-6">ATP-binding cassette sub-family G member 2</dd><dt class="col-md-5 col-sm-6" id="molecular-weight">Molecular Weight</dt><dd class="col-md-7 col-sm-6">72313.47 Da</dd></dl></div></div><h5>References</h5><div class="references"><ol class="cite-this-references"><li id="reference-A178909">Trdan Lusin T, Mrhar A, Stieger B, Kullak-Ublick GA, Marc J, Ostanek B, Zavratnik A, Kristl A, Berginc K, Delic K, Trontelj J: Influence of hepatic and intestinal efflux transporters and their genetic variants on the pharmacokinetics and pharmacodynamics of raloxifene in osteoporosis treatment. Transl Res. 2012 Oct;160(4):298-308. doi: 10.1016/j.trsl.2012.03.002. Epub 2012 Mar 28. [<a target="_blank" href="/articles/A178909">Article</a>] </li></ol></div></div></div><div class="bond card" id="BE0001069"><div class="card-header"><a class="btn btn-drugbank-secondary btn-sm bond-details-link ml-3" href="/polypeptides/Q92887"><div class="drugbank-icon icon-expand"><svg class="icon" role="img" title="expand">
<use xlink:href="/assets/icons-539be351b538129271b9ee92cb0ebbd16efad4fccf6e2fe95aa6234f1e7417fa.svg#expand"></use>
</svg>
</div> Details</a><strong>5. <a href="/polypeptides/Q92887">Canalicular multispecific organic anion transporter 1</a></strong></div><div class="card-body"><div class="row"><div class="col-sm-12 col-lg-5"><dl><dt class="col-md-5 col-sm-6" id="kind">Kind</dt><dd class="col-md-7 col-sm-6">Protein</dd><dt class="col-md-5 col-sm-6" id="organism">Organism</dt><dd class="col-md-7 col-sm-6">Humans</dd><dt class="col-md-5 col-sm-6" id="pharmacological-action">Pharmacological action</dt><dd class="col-md-7 col-sm-6"><div class="badge badge badge-unknown">Unknown</div></dd><dt class="col-md-5 col-sm-6" id="actions">Actions</dt><dd class="col-md-7 col-sm-6"><div class="badge badge-pill badge-action">Substrate</div></dd></dl></div><div class="col-sm-12 col-lg-7"><dl><dt class="col-md-5 col-sm-6" id="general-function">General Function</dt><dd class="col-md-7 col-sm-6">Organic anion transmembrane transporter activity</dd><dt class="col-md-5 col-sm-6" id="specific-function">Specific Function</dt><dd class="col-md-7 col-sm-6">Mediates hepatobiliary excretion of numerous organic anions. May function as a cellular cisplatin transporter.</dd><dt class="col-md-5 col-sm-6" id="gene-name">Gene Name</dt><dd class="col-md-7 col-sm-6">ABCC2</dd><dt class="col-md-5 col-sm-6" id="uniprot-id">Uniprot ID</dt><dd class="col-md-7 col-sm-6"><a target="_blank" rel="noopener" href="http://www.uniprot.org/uniprot/Q92887">Q92887</a></dd><dt class="col-md-5 col-sm-6" id="uniprot-name">Uniprot Name</dt><dd class="col-md-7 col-sm-6">Canalicular multispecific organic anion transporter 1</dd><dt class="col-md-5 col-sm-6" id="molecular-weight">Molecular Weight</dt><dd class="col-md-7 col-sm-6">174205.64 Da</dd></dl></div></div><h5>References</h5><div class="references"><ol class="cite-this-references"><li id="reference-A178909">Trdan Lusin T, Mrhar A, Stieger B, Kullak-Ublick GA, Marc J, Ostanek B, Zavratnik A, Kristl A, Berginc K, Delic K, Trontelj J: Influence of hepatic and intestinal efflux transporters and their genetic variants on the pharmacokinetics and pharmacodynamics of raloxifene in osteoporosis treatment. Transl Res. 2012 Oct;160(4):298-308. doi: 10.1016/j.trsl.2012.03.002. Epub 2012 Mar 28. [<a target="_blank" href="/articles/A178909">Article</a>] </li></ol></div></div></div><div class="bond card" id="BE0001061"><div class="card-header"><a class="btn btn-drugbank-secondary btn-sm bond-details-link ml-3" href="/polypeptides/O15438"><div class="drugbank-icon icon-expand"><svg class="icon" role="img" title="expand">
<use xlink:href="/assets/icons-539be351b538129271b9ee92cb0ebbd16efad4fccf6e2fe95aa6234f1e7417fa.svg#expand"></use>
</svg>
</div> Details</a><strong>6. <a href="/polypeptides/O15438">Canalicular multispecific organic anion transporter 2</a></strong></div><div class="card-body"><div class="row"><div class="col-sm-12 col-lg-5"><dl><dt class="col-md-5 col-sm-6" id="kind">Kind</dt><dd class="col-md-7 col-sm-6">Protein</dd><dt class="col-md-5 col-sm-6" id="organism">Organism</dt><dd class="col-md-7 col-sm-6">Humans</dd><dt class="col-md-5 col-sm-6" id="pharmacological-action">Pharmacological action</dt><dd class="col-md-7 col-sm-6"><div class="badge badge badge-unknown">Unknown</div></dd><dt class="col-md-5 col-sm-6" id="actions">Actions</dt><dd class="col-md-7 col-sm-6"><div class="badge badge-pill badge-action">Substrate</div></dd></dl></div><div class="col-sm-12 col-lg-7"><dl><dt class="col-md-5 col-sm-6" id="general-function">General Function</dt><dd class="col-md-7 col-sm-6">Organic anion transmembrane transporter activity</dd><dt class="col-md-5 col-sm-6" id="specific-function">Specific Function</dt><dd class="col-md-7 col-sm-6">May act as an inducible transporter in the biliary and intestinal excretion of organic anions. Acts as an alternative route for the export of bile acids and glucuronides from cholestatic hepatocyte...</dd><dt class="col-md-5 col-sm-6" id="gene-name">Gene Name</dt><dd class="col-md-7 col-sm-6">ABCC3</dd><dt class="col-md-5 col-sm-6" id="uniprot-id">Uniprot ID</dt><dd class="col-md-7 col-sm-6"><a target="_blank" rel="noopener" href="http://www.uniprot.org/uniprot/O15438">O15438</a></dd><dt class="col-md-5 col-sm-6" id="uniprot-name">Uniprot Name</dt><dd class="col-md-7 col-sm-6">Canalicular multispecific organic anion transporter 2</dd><dt class="col-md-5 col-sm-6" id="molecular-weight">Molecular Weight</dt><dd class="col-md-7 col-sm-6">169341.14 Da</dd></dl></div></div><h5>References</h5><div class="references"><ol class="cite-this-references"><li id="reference-A178909">Trdan Lusin T, Mrhar A, Stieger B, Kullak-Ublick GA, Marc J, Ostanek B, Zavratnik A, Kristl A, Berginc K, Delic K, Trontelj J: Influence of hepatic and intestinal efflux transporters and their genetic variants on the pharmacokinetics and pharmacodynamics of raloxifene in osteoporosis treatment. Transl Res. 2012 Oct;160(4):298-308. doi: 10.1016/j.trsl.2012.03.002. Epub 2012 Mar 28. [<a target="_blank" href="/articles/A178909">Article</a>] </li></ol></div></div></div><div class="bond card" id="BE0001188"><div class="card-header"><a class="btn btn-drugbank-secondary btn-sm bond-details-link ml-3" href="/polypeptides/O15439"><div class="drugbank-icon icon-expand"><svg class="icon" role="img" title="expand">
<use xlink:href="/assets/icons-539be351b538129271b9ee92cb0ebbd16efad4fccf6e2fe95aa6234f1e7417fa.svg#expand"></use>
</svg>
</div> Details</a><strong>7. <a href="/polypeptides/O15439">Multidrug resistance-associated protein 4</a></strong></div><div class="card-body"><div class="row"><div class="col-sm-12 col-lg-5"><dl><dt class="col-md-5 col-sm-6" id="kind">Kind</dt><dd class="col-md-7 col-sm-6">Protein</dd><dt class="col-md-5 col-sm-6" id="organism">Organism</dt><dd class="col-md-7 col-sm-6">Humans</dd><dt class="col-md-5 col-sm-6" id="pharmacological-action">Pharmacological action</dt><dd class="col-md-7 col-sm-6"><div class="badge badge badge-unknown">Unknown</div></dd><dt class="col-md-5 col-sm-6" id="actions">Actions</dt><dd class="col-md-7 col-sm-6"><div class="badge badge-pill badge-action">Substrate</div></dd></dl></div><div class="col-sm-12 col-lg-7"><dl><dt class="col-md-5 col-sm-6" id="general-function">General Function</dt><dd class="col-md-7 col-sm-6">Atpase activity, coupled to transmembrane movement of substances</dd><dt class="col-md-5 col-sm-6" id="specific-function">Specific Function</dt><dd class="col-md-7 col-sm-6">May be an organic anion pump relevant to cellular detoxification.</dd><dt class="col-md-5 col-sm-6" id="gene-name">Gene Name</dt><dd class="col-md-7 col-sm-6">ABCC4</dd><dt class="col-md-5 col-sm-6" id="uniprot-id">Uniprot ID</dt><dd class="col-md-7 col-sm-6"><a target="_blank" rel="noopener" href="http://www.uniprot.org/uniprot/O15439">O15439</a></dd><dt class="col-md-5 col-sm-6" id="uniprot-name">Uniprot Name</dt><dd class="col-md-7 col-sm-6">Multidrug resistance-associated protein 4</dd><dt class="col-md-5 col-sm-6" id="molecular-weight">Molecular Weight</dt><dd class="col-md-7 col-sm-6">149525.33 Da</dd></dl></div></div><h5>References</h5><div class="references"><ol class="cite-this-references"><li id="reference-A178912">Zhou X, Wang S, Sun H, Wu B: Sulfonation of raloxifene in HEK293 cells overexpressing SULT1A3: Involvement of breast cancer resistance protein (BCRP/ABCG2) and multidrug resistance-associated protein 4 (MRP4/ABCC4) in excretion of sulfate metabolites. Drug Metab Pharmacokinet. 2015 Dec;30(6):425-33. doi: 10.1016/j.dmpk.2015.09.001. Epub 2015 Oct 9. [<a target="_blank" href="/articles/A178912">Article</a>] </li></ol></div></div></div></div></div><div aria-hidden="true" aria-labelledby="locked-modal-header" class="modal fade" id="locked-interactions-modal" role="dialog" tabindex="-1"><div class="modal-dialog modal-dialog-centered"><div class="modal-content"><div class="modal-body"><button aria-hidden="true" class="close" data-dismiss="modal" type="button">×</button><div class="locked-interactions-content"><img class="locked-interactions-img" src="/assets/locked/Interactions-a0b9baf74954e8e26155347c9fde26bca0898cecdb887b212605f778364855c2.png"><div class="locked-panel-header">Identify potential medication risks</div><div class="locked-panel-subheader">Easily compare up to 40 drugs with our drug interaction checker.</div><div class="locked-panel-subheader"><strong>Get severity rating, description, and management advice. </strong></div><a class="btn btn-pink-filled track-link" target="_blank" data-link-id="locked/drug-interactions-mobile-2" href="https://bit.ly/2TFmz2P?li=locked/drug-interactions-mobile-2">Learn more <div class=" drugbank-icon icon-see_more"><svg class="icon" role="img" title="see_more"> <use xlink:href="/assets/plus/icons-70333afa0729472c7516e40340ba51254bb889e8a9a12dcd9b4434a43b7ee583.svg#see_more"> </use></svg></div></a></div></div></div></div></div><p class="bt-2 px-sm-0" id="drug-meta">Drug created at June 13, 2005 13:24 / Updated at March 10, 2022 07:01 </p></div><div aria-hidden="true" aria-labelledby="package-image" class="modal fade" id="modal-package" role="dialog" tabindex="-1"><div class="modal-dialog modal-dialog-centered"><div class="modal-content"><div class="modal-header"><h4 class="modal-title">Product Image</h4><button aria-hidden="true" class="close" data-dismiss="modal" type="button">×</button></div><div class="modal-body"><img class="img-thumbnail modal-package-picture mb-4" src=""><a class="full-image float-right btn btn-drugbank-primary btn-sm mt-2" href="">Show full image</a><div class="package-description"></div></div></div></div></div></div></div></div></main><footer><div class="row p-3 p-sm-4 m-0"><div class="col-md-5 footer-content"><div class="footer-item footer-commercial hidden"><img style="width: 130px; height: 100px;" src="/assets/plus/Data_Pink-68da9b7525141f098e2e0ebcbd888ce950fe6032fd0da3a227c22117cedd7062.png"><h2>Interested in using DrugBank in a <strong>commercial product</strong> or <strong>application?</strong></h2><a class="btn btn-pink-filled" target="_blank" href="https://www.drugbank.com/">Visit DrugBank.com <div class=" drugbank-icon icon-see_more"><svg class="icon" role="img" title="see_more"> <use xlink:href="/assets/plus/icons-70333afa0729472c7516e40340ba51254bb889e8a9a12dcd9b4434a43b7ee583.svg#see_more"> </use></svg></div></a></div><div class="footer-item footer-newsletter" id="newsletter-1"><div class="newsletter-header"><img style="width: 131px; height: 100px;" src="/assets/plus/Article_Dark_Pink-17ef3dc892e28e001abbb0ae6bfc47fca8a64cd76af37ec2a80dbce89fe3bc72.png"><h2>Stay up-to-date with the <br><strong>latest from DrugBank!</strong></h2></div><form action="https://dev.drugbank.com/contacts" class="form" id="newsletter-form" method="post"><input class="form-control hidden" id="contact_name" name="contact[name]" type="hidden" value="New Subscriber"><input class="form-control hidden" id="contact_mailing_list" name="contact[mailing_list]" type="hidden" value="yes"><input class="form-control hidden" id="data_type" name="data_type" type="hidden" value="json"><input class="form-control hidden" id="contact_address" name="contact[address]" type="hidden"><input class="form-control hidden" name="contact[return_url]" type="hidden" value="https://go.drugbank.com/#newsletter-3"><input class="form-control hidden" name="contact[form_url]" type="hidden" value="https://go.drugbank.com/"><input class="form-control hidden" id="referer" name="contact[referer]" type="hidden" value=""><input class="form-control hidden" id="type" name="contact[type]" type="hidden" value="newsletter"><input class="form-control hidden" id="ga_client_id" name="contact[ga_client_id]" type="hidden" value="243346760.1646930944"><div class="input-group"><input class="form-control" id="contact_email" name="contact[email]" placeholder="Enter your email" required="" type="text"><span class="input-group-btn"><button class="btn btn-pink-filled" id="subscribe" type="submit">Subscribe</button></span></div><div class="help-block with-errors"></div></form></div><div class="footer-item footer-newsletter hidden" id="newsletter-3"><div class="newsletter-header"><img style="width: 131px; height: 100px;" src="/assets/plus/Article_Dark_Pink-17ef3dc892e28e001abbb0ae6bfc47fca8a64cd76af37ec2a80dbce89fe3bc72.png"><h2><strong>Thank you</strong> <br>for subscribing!</h2></div></div></div><div class="col-md-7 footer-links"><div class="container"><div class="row footer-row"><div class="col-sm-4 footer-col"><div class="footer-header">About</div><div class="footer-list"><ul class="list-unstyled"><li><a href="/about">About DrugBank Online</a></li><li><a target="_blank" href="https://blog.drugbank.com/">Blog</a></li><li><a target="_blank" href="http://www.wishartlab.com">Wishart Research Group</a></li><li><a href="https://www.drugbank.com/about/careers">Careers</a></li><li><a href="/legal/terms_of_use">Terms of Use</a></li><li><a href="/legal/privacy_policy">Privacy Policy</a></li></ul></div></div><div class="col-sm-4 footer-col"><div class="footer-header">Support</div><div class="footer-list"><ul class="list-unstyled"><li><a target="_blank" href="https://dev.drugbank.com/guides/index">Help Center</a></li><li><a target="_blank" href="https://dev.drugbank.com/guides/faqs">DrugBank Online FAQs</a></li><li><a href="/contact">Contact Support</a></li></ul></div></div><div class="col-sm-4 footer-col"><div class="footer-header"><a href="https://www.drugbank.com/">Products</a></div><div class="footer-list"><ul class="list-unstyled"><li><a target="_blank" href="https://www.drugbank.com/datasets">Commercial Drug Datasets</a></li><li><a target="_blank" href="https://www.drugbank.com/academic_research">Academic Drug Datasets</a></li><li><a target="_blank" href="https://www.drugbank.com/clinical">Clinical API</a></li><li><a target="_blank" href="https://www.drugbank.com/contact/sales?ref=go.drugbank.com%2Fdrugs%2FDB00481">Contact Sales</a></li></ul></div></div></div><div class="row footer-row"><div class="col-sm-12"><div class="social-media"><a class="social-media-link" href="https://www.linkedin.com/company/drugbank/"><div class="drugbank-icon icon-linkedin"><svg class="icon" role="img" title="linkedin">
<use xlink:href="/assets/icons-539be351b538129271b9ee92cb0ebbd16efad4fccf6e2fe95aa6234f1e7417fa.svg#linkedin"></use>
</svg>
</div></a><a class="social-media-link" href="https://twitter.com/DrugBankDB"><div class="drugbank-icon icon-twitter"><svg class="icon" role="img" title="twitter">
<use xlink:href="/assets/icons-539be351b538129271b9ee92cb0ebbd16efad4fccf6e2fe95aa6234f1e7417fa.svg#twitter"></use>
</svg>
</div></a><a class="social-media-link" href="https://www.facebook.com/DrugBankDatabase"><div class="drugbank-icon icon-facebook"><svg class="icon" role="img" title="facebook">
<use xlink:href="/assets/icons-539be351b538129271b9ee92cb0ebbd16efad4fccf6e2fe95aa6234f1e7417fa.svg#facebook"></use>
</svg>
</div></a></div><h6>Website design by Educe Design &amp; Innovation Inc.</h6></div></div></div></div></div></footer><script defer="" src="https://static.cloudflareinsights.com/beacon.min.js/v652eace1692a40cfa3763df669d7439c1639079717194" integrity="sha512-Gi7xpJR8tSkrpF7aordPZQlW2DLtzUlZcumS8dMQjwDHEnw9I7ZLyiOj/6tZStRBGtGgN6ceN6cMH8z7etPGlw==" data-cf-beacon="{&quot;rayId&quot;:&quot;6e9d8b0dad9ebfb6&quot;,&quot;token&quot;:&quot;e28ec36f07f74c1ca13c169ca4430981&quot;,&quot;version&quot;:&quot;2021.12.0&quot;,&quot;si&quot;:100}" crossorigin="anonymous"></script>
<script src="/assets/analytics-1b5960c76af2e5f1a83c45e21ee367baf13121e0a2d42380a71abadf0edaa402.js" media="all" data-turbolinks-track="true"></script><script type="text/javascript" id="hs-script-loader" async="" defer="" src="//js.hs-scripts.com/2224137.js"></script></body></html>